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Abreviações 
 
A1,  A2, A5, A6: Grupamento noradrenérgico A1, A2, A5, A6. 
APC: Área pressora caudal.  
bpm: Batimento por minuto.  
BDA: Amina dextrana biotinilada. 
Böt: Região Bötzinger.  
C1: Grupamento adrenérgico C1. 
CO2: Dióxido de carbono.  
CVL: Região caudoventrolateral. 
CRV: Coluna respiratória ventral.  
cVRG: Grupamento respiratório ventro-caudal. 
FC: Frequência cardíaca.  
GABA: Ácido δ-aminobutírico.  
GAD: Glutamina ácido descarboxilase.  
Itr: Região inter trigeminal.  
KF: Kölliker-Fuse. 
mmHg: Milímetro de mercúrio.  
mM: Milimolar.  
Mo5: Núcleo motor do trigêmio. 
nA: Núcleo Ambígus. 
NPCV: Neurônios pré-ganglionares cardio-vagais. 
NPBL:  Núcleo parabraquial lateral. 
NTS: Núcleos do trato solitário.  
NTScom: Núcleo do trato solitário comissural. 
NRL: Núcleo reticular lateral.  
NRT: Núcleo retrotrapezóide. 
NSPG: Neurônio simpático pré-ganglionar  
O2: Oxigênio.  
PAM: Pressão arterial média.  
pCO2: Pressão parcial de CO2. 
Pn: Núcleo pontino. 
pO2: Pressão parcial de O2. 
pre-BötC: Complexo pré-Bötzinger. 
RVL: Região rostroventrolateral. 
rVRG: Grupamento respiratório ventro-rostral. 
Scp: Peduncúlo cerebelar superior.  
SNC: Sistema nervoso central. 
SO: Oliva superior.  
VGLUT: Vesícula para transporte de glutamato.  
VlPon: Ponte ventrolateral. 
5n: Quinto nervo motor.  
7n: Sétimo nervo motor.  
7: Núcleo motor do facial.  
 
 
Resumo 
 
A presente tese de doutorado vai tentar elucidar os mecanismos 
excitatórios do bulbo relacionados ao controle cardiovascular e respiratório. Para 
tanto serão discutidos 4 trabalhos recentemente publicados (controle 
cardiovascular: Moreira e cols., 2005 e 2007; controle cardio-respiratório: 
Takakura e cols., 2006; Moreira e cols., 2006). 
 
Trabalhos 1 e 2: Relacionado aos mecanismos glutamatérgicos 
responsáveis pelo controle cardiovascular. 
 No presente estudo, procuramos investigar os efeitos cardiovasculares 
promovidos pela inibição da região caudoventrolateral (CVL) do bulbo com a 
injeção bilateral de muscimol, juntamente com o bloqueio glutamatérgico dos 
núcleos do trato solitário (NTS) (região postremal ou comissural) com a injeção de 
ácido quinurênico (antagonista de receptores glutamatérgicos). Foram utilizados 
ratos Holtzman, anestesiados com uretana e alfa-cloralose e registrou-se a 
pressão arterial média (PAM), frequência cardíaca (FC) e fluxo sanguíneo para os 
leitos renal, mesentérico e aórtico. A injeção bilateral de muscimol (agonista 
GABAérgico do sub-tipo A) (2 mM) na região do CVL ou a injeção de ácido 
quinurênico (50 mM) no NTS postremal produzem aumento de PAM (186 ± 11 ou 
142 ± 6 mmHg, respectivamente, vs. controle: 105 ± 4 mmHg), de FC (407 ± 15 ou 
412 ± 18 bpm, respectivamente, vs. controle: 352 ± 12 bpm) e aumento de 
resistência vascular renal, mesentérica e aórtica. A injeção de ácido quinurênico 
no NTS comissural (NTScom) não produz alterações nos valores basais da PAM, 
FC e resistência vascular. Entretanto, em animais com a injeção bilateral de 
muscimol no CVL, a injeção de ácido quinurênico no NTS (postremal ou 
comissural) reduziu a PAM e resistência vascular para valores abaixo do valor 
controle. Do mesmo modo, em ratos com o bloqueio do NTS (postremal ou 
comissural), a subsequente inibição do CVL produziu também uma redução da 
PAM e resistência vascular para valores abaixo do valor controle. Em animais com 
lesão eletrolítica da região do NTScom, a injeção de muscimol na região do CVL 
produziu redução da PAM e resistência vascular para valores abaixo do valor 
controle. 
Dinte disso, os resultados sugerem a existência de importantes 
mecanismos excitatórios no NTS (região postremal e comissural) e no CVL para 
controle da pressão arterial e resistência vascular. 
 
Trabalhos 3 e 4: Relacionado aos mecanismos bulbares ativados pelos 
quimiorreceptores centrais no controle cardio-respiratório. 
 
Trabalho 3: Interação entre quimiorreceptores centrais e periféricos. 
O núcleo retrotapezóide (NRT) contém neurônios sensíveis ao pH e são 
característicos como sendo quimiorreceptores centrais. A hipótese desse trabalho 
é procurar mostrar que a ativação dos quimiorreceptores periféricos promove a 
ativação dos quimiorreceptores centrais no NRT e que essa ativação é mediada 
por uma via direta do NTScom para o NRT. Nesse estudo foram utilizados ratos 
Sprague-Dawley.  
Uma densa projeção do NTScom para a região do NRT foi mostrada com o 
uso de traçadores anterógrados (amina dextrana biotinilada - BDA) injetados por 
iontoforese na região do NTScom. Na região do NRT, mais de 50% dos terminais 
que expressam BDA contêm a vesícula de transporte para glutamato (VGLUT2), 
mas apenas 5% contêm glutamina ácido descarboxilase (GAD67). Em um outro 
grupo de animais, uma semana após a injeção do traçador retrógrado cólera 
toxina B (CTB) no NRT, os animais foram expostos a períodos de hipóxia por 3 
horas. A presença da proteína Fos serviu para identificar os neurônios que eram 
ativados pela hipóxia. Neurônios imunorreativos para Fos e CTB foram 
encontrados na região do NTScom. A grande maioria dos neurônios que eram 
imunorreativos para Fos e CTB, expressavam VGLUT2 mRNA, enquanto uma 
minoria expressou GAD67 mRNA.  
Na segunda parte do estudo foram utilizados animais anestesiados com 
uretana e alfa-cloralose e vagotomizados. A injeção bilateral de muscimol no NRT 
promoveu a eliminação do nervo frênico durante uma situação controle, durante a 
estimulação dos quimiorreceptores centrais (hipercapnia – 10% de CO2) e durante 
a estimulação dos quimiorreceptores periféricos (injeção endovenosa de cianeto 
de sódio ou hipóxia (10-15% de O2).  
A atividade dos neurônios quimiossensíveis do NRT foram registrados em 
animais intactos ou vagotomizados para possíveis comparações. Todos os 
neurônios quimiossensíveis do NRT foram ativados pelos quimiorreceptores 
periféricos. A ativação dos quimiorreceptores periféricos não promoveu a ativação 
dos neurônios do NRT em animais com desnervação dos quimiorreceptores. 
A injeção bilateral de muscimol na região do CVL promoveu a eliminação 
do nervo frênico e a modulação respiratória nos neurônios do NRT. A injeção de 
muscimol não alterou o limiar e a sensibilidade dos neurônios do NRT durante 
uma situação de hipercapnia e também durante a ativação dos quimiorreceptores 
periféricos.  
Portanto, podemos concluir nesse estudo que os neurônios do NRT 
respondem às variações de CO2 devido a presença de 2 mecanismos: sua 
quimiossensibilidade intrínseca e por meio da ativação dos quimiorreptores 
periféricos (via glutamatérgica direta do NTScom para o NRT). 
 
Trabalho 4: Quimiorreceptores centrais e atividade simpática. 
O próximo estudo procurou explorar como elevações na pCO2 pode 
aumentar a atividade simpática. Foram registrados a atividade simpática eferente 
do nervo esplâncnico, atividade do nervo frênico e atividade dos neurônios 
vasomotores da região rostroventrolateral (RVL) do bulbo. Os experimentos foram 
realizados em ratos Sprague-Dawley, anestesiados com halotana e 
completamente desnervados. Hipercapnia (variação do CO2 expirado de 5 para 
10%) promoveu aumento da atividade simpática (97 ± 6%) e da atividade dos 
neurônios do RVL (67 ± 4%). A injeção bilateral de ácido quinurênico no RVL ou 
no NRT  eliminou ou reduziu a atividade do nervo frênico, respectivamente, mas 
não alterou a atividade simpática eferente produzida pela hipercapnia. A injeção 
bilateral de ácido quinurênico ou muscimol na região do CVL eliminou a atividade 
do nervo frênico e promoveu um aumento do efeito estimulatório do CO2 na 
atividade simpática. A injeção de muscimol na região comissural do NTS não 
alterou as respostas estimulatórias do CO2 sobre a atividade simpática e atividade 
do nervo frênico. Como esperado, a injeção de ácido quinurênico no RVL ou a 
injeção de muscimol no NTS comissural, em ratos intactos, bloqueou os efeitos 
cardio-respiratórios da estimulação dos quimiorreceptores periféricos com a 
injeção endovenosa de cianeto de sódio.  
Em conclusão, a hipercapnia aumentou a atividade simpática por ativação 
dos neurônios bulbo-espinais do RVL. Os neurônios excitatórios do RVL podem 
ser sensíveis a variações de CO2 e/ou receber projeções excitatórias dos 
quimiorreceptores centrais da região do NRT. Durante uma situação de 
hipercapnia, o total de aumento da atividade simpática produzido pela ativação 
dos quimiorreceptores centrais parece estar reduzido. Esse efeito é, portanto, 
mediado pela ativação de neurônios barossensíveis da região do CVL ou, então, 
pela inibição dos quimiorreceptores centrais do NRT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
 
The present thesis will try to elucidate important excitatory mechanisms in 
the brainstem related to cardio-respiratory control. We will discuss 4 recently 
published papers (cardiovascular control: Moreira e cols., 2005 e 2007; cardio-
respiratory control: Takakura e cols., 2006; Moreira e cols., 2006).  
 
Papers 1 and 2: Glutamatergic mechanisms related to cardiovascular control. 
In the present study, we investigated the effects of inhibition of the caudal 
ventrolateral medulla (CVLM) with the GABA(A) agonist muscimol combined with 
the blockade of glutamatergic mechanism in the nucleus of the solitary tract (NTS) 
with kynurenic acid (kyn) on mean arterial pressure (MAP), heart rate (HR), and 
regional vascular resistances. In male Holtzman rats anesthetized intravenously 
with urethane/chloralose, bilateral injections of muscimol (120 pmol) into the CVLM 
or bilateral injections of kyn (2.7 nmol) into the NTS alone increased MAP to 186 ± 
11 and to 142 ± 6 mmHg, respectively, vs. control: 105 ± 4 mmHg; HR to 407 ± 15 
and to 412 ± 18 beats per minute (bpm), respectively, vs. control: 352 ± 12 bpm; 
and renal, mesenteric and hindquarter vascular resistances. However, in rats with 
the CVLM bilaterally blocked by muscimol, additional injections of kyn into the NTS 
reduced MAP to 88 ± 5 mmHg and mesenteric and hindquarter vascular 
resistances below control baseline levels. Moreover, in rats with the glutamatergic 
mechanisms of the NTS blocked by bilateral injections of kyn, additional injections 
of muscimol into the CVLM also reduced MAP to 92 ± 2 mmHg and mesenteric 
and hindquarter vascular resistances below control baseline levels. Simultaneous 
blockade of NTS and CVLM did not modify the increase in HR but also abolished 
the increase in renal vascular resistance produced by each treatment alone.  
The results suggest that important pressor mechanisms arise from the NTS 
and CVLM to control vascular resistance and arterial pressure under the conditions 
of the present study. 
 
Papers 3 and 4: Central chemoreceptors brainstem mechanisms related to 
cardio-respiratory control. 
 
Paper 3: Interaction between central and peripheral chemoreceptors. 
The rat retrotrapezoid nucleus (RTN) contains pH-sensitive neurons that are 
putative central chemoreceptors. Here, we examined whether these neurons 
respond to peripheral chemoreceptor stimulation and whether the input is direct 
from the solitary tract nucleus (NTS) or indirect via the respiratory network. A 
dense neuronal projection from commissural NTS (commNTS) to RTN was 
revealed using the anterograde tracer biotinylated dextran amine (BDA). Within 
RTN, 51% of BDA-labelled axonal varicosities contained detectable levels of 
vesicular glutamate transporter-2 (VGLUT2) but only 5% contained glutamic acid 
decarboxylase-67 (GAD67). Awake rats were exposed to hypoxia (n = 6) or 
normoxia (n = 5) 1 week after injection of the retrograde tracer cholera toxin B 
(CTB) into RTN. Hypoxia-activated neurons were identified by the presence of Fos-
immunoreactive nuclei. CommNTS neurons immunoreactive for both Fos and CTB 
were found only in hypoxia-treated rats. VGLUT2 mRNA was detected in 92 ± 13% 
of these neurons whereas only 12 ± 9% contained GAD67 mRNA.  
In urethane-chloralose-anaesthetized rats, bilateral inhibition of the RTN 
with muscimol eliminated the phrenic nerve discharge (PND) at rest, during 
hyperoxic hypercapnia (10% CO2), and during peripheral chemoreceptor 
stimulation (hypoxia and/or i.v. sodium cyanide, NaCN). RTN CO2-activated 
neurons were recorded extracellularly in anaesthetized intact or vagotomized rats. 
These neurons were strongly activated by hypoxia (10-15% O2; 30 s) or by NaCN. 
Hypoxia and NaCN were ineffective in rats with carotid chemoreceptor 
denervation. Bilateral injection of muscimol into the ventral respiratory column 1.5 
mm caudal to RTN eliminated PND and the respiratory modulation of RTN 
neurons. Muscimol did not change the threshold and sensitivity of RTN neurons to 
hyperoxic hypercapnia nor their activation by peripheral chemoreceptor stimulation.  
In conclusion, RTN neurons respond to brain pCO2 presumably via their 
intrinsic chemosensitivity and to carotid chemoreceptor activation via a direct 
glutamatergic pathway from commNTS that bypasses the respiratory network. RTN 
neurons probably contribute a portion of the chemical drive to breathe. 
 
Paper 4: Central chemoreceptors and sympathetic vasomotor outflow. 
The present study explores how elevations in brain pCO2 increase the 
sympathetic nerve discharge (SND). SND, phrenic nerve discharge (PND) and 
putative sympathoexcitatory vasomotor neurons of the rostral ventrolateral medulla 
(RVLM) were recorded in anaesthetized sino-aortic denervated and vagotomized 
rats. Hypercapnia (end-expiratory CO2 from 5% to 10%) increased SND (97 ± 6%) 
and the activity of RVLM neurons (67 ± 4%). Injection of kynurenic acid (Kyn, 
ionotropic glutamate receptor antagonist) into RVLM or the retrotrapezoid nucleus 
(RTN) eliminated or reduced PND, respectively, but did not change the effect of 
CO2 on SND. Bilateral injection of Kyn or muscimol into the rostral ventral 
respiratory group (rVRG-pre-Botzinger region, also called CVLM) eliminated PND 
while increasing the stimulatory effect of CO2 on SND. Muscimol injection into 
commissural part of the solitary tract nucleus (commNTS) had no effect on PND or 
SND activation by CO2. As expected, injection of Kyn into RVLM or muscimol into 
commNTS virtually blocked the effect of carotid body stimulation on SND in rats 
with intact carotid sinus nerves.  
In conclusion, CO2 increases SND by activating RVLM sympathoexcitatory 
neurons. The relevant central chemoreceptors are probably located within or close 
to RVLM and not in the NTS or in the rVRG-pre-Botzinger/CVLM region. RVLM 
sympathoexcitatory neurons may be intrinsically pH-sensitive and/or receive 
excitatory synaptic inputs from RTN chemoreceptors. Activation of the central 
respiratory network reduces the overall sympathetic response to CO2, presumably 
by activating barosensitive CVLM neurons and inhibiting RTN chemoreceptors. 
 
 
 
 
 
Introdução 
O sistema nervoso neurovegetativo é, tradicionalmente, descrito como um 
sistema motor que promove o controle das funções viscerais que são críticas para 
o controle da homeostasia. Esse sistema consiste em uma coleção de aferências 
e eferências que permite a conexão entre o sistema nervoso central (SNC) e os 
orgãos viscerais (Blessing, 1997; Loewy e Spyer, 1990). O sistema nervoso 
neurovegetativo possui dois grandes ramos eferentes que são classificados como 
sistema nervoso simpático e o parassimpático, os quais permitem o controle de 
várias funções fisiológicas. Esse controle, na maioria dos casos, é antagônico nas 
suas funções. Um exemplo clássico é a inervação para o coração. A estimulação 
simpática causa taquicardia, enquanto que a estimulação parassimpática promove 
bradicardia (Dampney, 1994; Guyenet, 2006). 
Da mesma maneira, o controle neural do sistema cardiovascular é regulado 
pelo sistema nevoso neurovegetativo (Blessing, 1987; Loewy e Spyer, 1990). A 
regulação neural do sistema cardiovascular envolve a ativação de diferentes 
grupos de sensores periféricos (barorreceptores, receptores cardiopulmonares e 
quimiorreceptores, entre outros), os quais projetam suas aferências para 
estruturas do SNC via nervos vago e glossofaríngeo. O processamento destas 
informações aferentes no SNC irá resultar na modulação das vias autonômicas 
eferentes, controlando as variáveis cardiovasculares no sentido de manter a 
homeostase nas diversas situações comportamentais em que os mamíferos são 
submetidos. No sistema cardiovascular, as variáveis reguladas pelo sistema 
nervoso neurovegetativo são a freqüência cardíaca, o volume sistólico (força de 
contração) e a resistência periférica, as quais são determinantes da pressão 
arterial. 
O envolvimento do SNC na manutenção da homeostase do sistema 
cardiovascular é conhecido desde o século XIX. Os estudos clássicos realizados 
por Claude Bernard, na França, e publicados em 1863 (apud Gebber, 1990), já 
mostravam que a transecção da medula espinal cervical em qualquer nível 
produzia pronunciada queda da PA. No entanto, foram os estudos de Dittmar, em 
1873 (apud Gebber, 1990), que primeiro demonstraram a participação do bulbo na 
manutenção da pressão arterial, sobretudo as porções ventrolaterais bulbares. 
Nesses estudos, foi observado que a destruição da região ventral do bulbo 
produzia queda da pressão arterial, o mesmo não acontecia se a destruição fosse 
realizada na região dorsal. Disso surgiu a hipótese de que a região ventral do 
bulbo exerceria fundamental importância na manutenção dos níveis considerados 
normais de pressão arterial, e foi introduzido na época o conceito de tônus 
vasomotor simpático.  
Posteriormente, Bayliss lançou a hipótese de que existiria um centro 
vasomotor, localizado na região ventral do bulbo e que seria constituído por áreas 
tanto pressoras como depressoras (Bayliss, 1901). 
Mais tarde, o aparecimento da técnica de estereotaxia associada à 
eletrofisiologia (estimulação elétrica) possibilitou o mapeamento de todo o tronco 
cerebral e foram identificadas regiões pressoras e depressoras situadas em toda a 
formação reticular bulbar, que se estendiam desde a região dorsal até a ventral do 
bulbo (Wang & Ranson, 1939; Alexander, 1946). A idéia de um centro vasomotor 
simpático com localização delimitada, como proposto por Dittmar passou então a 
ser desacreditada. Entretanto, os dados obtidos utilizando-se da técnica de 
estimulação elétrica, que reconhecidamente interfere não só sobre os corpos 
celulares dos neurônios, como também sobre fibras de passagem, não permitia 
delimitar com exatidão a localização das regiões envolvidas no controle 
cardiovascular.  
Os estudos de Feldberg & Guertzenstein (1972) e Guertzenstein (1973) 
foram os primeiros a demonstrar a existência da atividade tônica de neurônios 
localizados na superfície ventral do bulbo rostral de gatos sobre a manutenção da 
pressão arterial. Inicialmente, eles demonstraram que a administração 
intracerebroventricular de pentobarbital sódico produzia queda da pressão arterial; 
a mesma dose administrada endovenosamente ou quando o aqueduto cerebral 
que liga o terceiro ao quarto ventrículo era obstruído, a hipotensão desaparecia, 
sugerindo que o pentobarbital atuava na região bulbar (Feldberg & Guertzenstein, 
1972). Os dois autores utilizaram-se de drogas que agem, preferencialmente, em 
corpos celulares, como o ácido gama-aminobutírico (GABA) e glicina que, ao 
serem aplicados topicamente por meio de anéis plásticos sobre a região estudada 
(superfície ventral bulbar rostral), produziam acentuada queda da pressão arterial. 
Foi também demonstrado que a aplicação unilateral de glicina causava uma queda 
muito maior, atingindo níveis considerados espinais agudos, ou seja, níveis de 
pressão arterial por volta de 60 mmHg (Guertzenstein & Silver, 1974). Com tais 
experimentos, foi possível localizar mais precisamente a região bulbar ventral 
responsável pela manutenção da pressão arterial. Novamente, a idéia de um 
centro vasomotor delimitado voltou a ser considerada. 
A partir das publicações de Guertzenstein e colaboradores (1973, 1974, 
1977 e 1984), diferentes grupos de pesquisa começaram a enfocar a participação 
do bulbo ventrolateral no controle cardiovascular, na tentativa de melhor 
compreender o papel desta região, não somente na manutenção do tônus 
vasomotor simpático, mas também no que diz respeito ao seu papel no controle 
reflexo cardiovascular e ajustes cardiovasculares específicos (Dampney, 1994; 
Guyente, 2006). Até então, ou seja, em meados de 1970, os núcleos do trato 
solitário (NTS) localizados na região dorsal do bulbo eram conhecidos como o 
maior centro integrador cardiovascular, particularmente por receber as 
informações dos aferentes barorreceptores. Outra região considerada importante 
era a coluna intermédio-lateral (IML) da medula espinal, pois era sabido que esta 
região contém os neurônios efetores simpáticos pré-ganglionares. No entanto, o 
centro responsável pela conexão NTS-IML, ou seja, o centro vasomotor tinha 
localização indefinida (Chalmers e Pilowsky, 1991). Dessa forma, sobretudo os 
estudos de Guertzenstein e colaboradores foram fundamentais no sentido de 
delimitar um centro vasomotor simpático integrador localizado no bulbo ventral 
rostral e de fundamental importância para manutenção da homeostase 
cardiovascular.  
Atualmente sabe-se que o bulbo participa no controle cardiovascular, 
gerando sinais que são continuamente modulados pelas informações aferentes 
cardiovasculares (Spyer, 1990). Os nervos depressor aórtico e do seio carotídeo, 
cujas aferências têm acesso ao SNC através dos nervos vago e glossofaríngeo, 
respectivamente, são responsáveis pela condução das informações aferentes dos 
baro- e quimiorreceptores para o SNC, mais precisamente no bulbo, como parte 
integrante na regulação cardiovascular. Os corpos celulares destas fibras vagais e 
glossofaríngeas estão localizados nos gânglios nodoso e petroso, 
respectivamente, tendo suas terminações no NTS (Palkovitz e Zarborsky, 1977). A 
primeira sinapse ou o sítio de terminação destas fibras aferentes no NTS já foi 
investigado anatômica (Torvik, 1956; Cottle, 1964; Palkovits e Zarborsky, 1977) e 
eletrofisiologicamente (Fussey e cols., 1967; Jordan e Spyer, 1977; Jordan e 
Spyer, 1978), bem como a expressão da proteína Fos em neurônios do NTS, após 
a estimulação dos baro- e quimiorreceptores (Erickson e Millhorn, 1991; Weston e 
cols., 2003; Takakura e cols., 2006) em várias espécies. 
 
Centro de integração de aferências cardiovasculares: mecanismos bulbares 
e glutamatérgicos na geração do tônus vasomotor. 
O NTS é constituído por grupos heterogêneos de neurônios, que estão 
dispostos dorsalmente no bulbo e se estendem de forma rostrocaudal, como uma 
coluna bilateral, desde o nível do pólo caudal do núcleo motor do nervo facial até o 
óbex, onde as duas colunas se unem para formar uma única estrutura na linha 
média, que continua caudalmente até a parte caudal da decussação piramidal 
(Ciriello e cols, 1994).  
Em relação ao seu aspecto antero-posterior, o NTS pode ser dividido em 3 
porções, dada a sua proximidade com a área postrema (Cottle, 1964; Loewy, 
1990): NTS rostral; NTS intermediário e NTS comissural. 
 O NTS intermediário e comissural estão diretamente envolvidos no controle 
cardiovascular e respiratório, pois todas as projeções aferentes vagais e 
glossofaríngeas, que conduzem informações cardio-respiratórias, fazem sua 
primeira sinapse nestas duas porções do NTS.  
Sabe-se que a porção intermediária do NTS constitui o principal sítio de 
entrada das aferências dos barorreceptores, utilizando o L-glutamato como 
principal neurotransmissor (Talman e cols., 1980; Weston e cols., 2003). Já a 
porção comissural do NTS constitui o principal sítio no SNC para o qual se 
projetam as aferências dos quimiorreceptores carotídeos (Chitravanshi e cols., 
1993; Finley e Katz, 1992; Ciriello e cols., 1994). Curiosamente, a injeção de L-
glutamato, no NTS intermediário, em animais não anestesiados promoveu 
resposta pressora (Machado e Bonagamba, 1992; Colombari e cols., 1994), 
diferentemente da resposta hipotensora produzida pela estimulação dos 
barorreceptores (Talman e cols., 1980; Ohta e Talman, 1994; Machado e 
Bonagamba, 1992). Como a resposta produzida pela injeção de L-glutamato no 
NTS intermediário é semelhante à resposta produzida pela ativação dos 
quimiorreceptores, uma possibilidade seria que o efeito da injeção de L-glutamato 
no NTS mimetizasse a ativação do quimiorreflexo (Haibara e cols., 1995). Em 
animais normotensos, a lesão do NTS comissural bloqueou a resposta pressora 
do L-glutamato injetado no NTS intermediário e a resposta pressora produzida 
pela estimulação dos quimiorreceptores periféricos com KCN (Colombari e cols., 
1996). Esses resultados levaram à sugestão de que o NTS comissural possui 
importante participação na ativação do sistema nervoso simpático. 
A partir do NTS, as informações provenientes dos receptores periféricos 
podem ser distribuídas para diversas áreas do SNC, dentre as quais destacam-se 
as áreas localizadas na região ventral do bulbo que controlam o tônus simpático 
sobre o sistema cardiovascular.  
O sistema nervoso simpático permite o controle a curto e longo prazo da 
pressão arterial. O nível de atividade do sistema nervoso simpático é controlado 
por uma rede de neurônios localizados na medula espinal, na região 
rostroventrolateral (RVL) do bulbo, na região caudoventrolateral (CVL) do bulbo, 
nos NTS, bem como também em regiões hipotalâmicas (Dampney, 1994; 
Guyenet, 2006).  
 O sistema nervoso simpático eferente parece ser, primeiramente, regulado 
pela região RVL (Dampney e cols., 2002; Guyenet, 2006). Essa região do bulbo 
contém as células adrenérgicas C1 que, por definição, constitui uma das regiões 
do SNC que sintetizam adrenalina (Hokfelt e cols., 1974). A partir do início dos 
anos 80, a porção da região ventrolateral do bulbo que se relacionava com os 
neurônios C1, foi definida como sendo o principal centro de regulação da pressão 
arterial (Brown e Guyenet, 1985; Ross e cols., 1985; Guyenet, 1990; Blessing, 
1997; Schreihofer e Guyenet, 1997; Dampney e cols., 2002; Guyenet, 2006). Os 
neurônios do RVL, responsáveis pelo controle da pressão arterial e atividade 
simpática, projetam-se para os neurônios pré-ganglionares simpáticos na medula 
espinal (Guyenet, 2006). Esses neurônios do RVL liberam L-glutamato como 
neurotransmissor, mas também sintetizam vários outros neurotransmissores, 
incluindo por exemplo a adrenalina. Os neurônios que sintetizam a adrenalina 
correspondem a 70% do total de neurônios da região do RVL e são classificados 
como as células C1 (Ross e cols., 1985; Schreihofer e Guyenet, 1997; Schreihofer 
e cols., 2000). Entretanto, nem todos os neurônios C1 estão sobre o controle do 
barorreflexo; um exemplo clássico de neurônios C1 que não são controlados pelo 
barorreflexo consistem os neurônios que controlam a secreção de adrenalina das 
células cromafins (Cao e Morrison, 2001; Ritter e cols., 2001). Vale ressaltar ainda 
que alguns dos neurônios C1 do RVL também projetam-se para a região 
hipotalâmica (Verbernne e cols., 1999). Esses neurônios são diferentes daqueles 
que se projetam para a medula espinal, mas possuem características 
eletrofisiológicas e neuroquímicas muito semelhantes (Verbernne e cols., 1999). 
Muitos desses neurônios contribuem na modulação excitatória do barorreflexo 
para áreas hipotalâmicas (núcleo paraventricular e núcleo preóptico mediano) que 
estão envolvidas no balanço hidroeletrolítico (Verberne e cols., 1999).  
Sabe-se que o sistema nervoso simpático sofre oscilações em sua 
atividade (aumentando e diminuindo) durante a manutenção da pressão arterial 
(Gebber, 1990; Guyenet 1990; Dampney, 1994; Guyenet, 2006). Essas oscilações 
são determinadas em grande escala pela atividade dos neurônios bulbo-espinais e 
excitatórios do RVL (Gebber, 1990; Guyenet, 2006). Apesar do controle da 
atividade simpática envolver a participação de várias regiões do SNC, em 
situações de anestesia, os neurônios do RVL aparecem como os principais 
reguladores da atividade simpática eferente  (Dampney, 1994; Guyenet, 2006). Na 
maioria das condições anestésicas, o neurotransmissor L-glutamato possui 
apenas uma pequena parcela de contribuição na atividade basal desses 
neurônios. Nessas condições, a injeção do antagonista de receptores 
glutamatérgicos, ácido quinurênico, na região do RVL não produz alterações na 
pressão arterial ou na atividade simpática (Guyenet e cols., 1987; Ito e Sved, 
1997; Horiuchi e cols., 2004). Por outro lado, a transmissão glutamatérgica 
apresenta-se muito mais significante em algumas situações experimentais. O 
bloqueio glutamatérgico na região RVL produz alterações significantes na pressão 
arterial e na atividade simpática eferente em algumas situações peculiares como, 
por exemplo, em animais que sofreram desidratação extracelular, em animais que 
apresentam anormalidade nos gases sanguíneos (altos níveis de CO2 e baixo 
níveis de O2), quando reflexos excitatórios são ativados (quimiorreflexo) ou em 
situações de hipertensão (Guyenet e Stornetta, 2004; Sun, 1996; Brooks e cols., 
2004; Guyenet , 2000; Ito e cols., 2000; Ito e cols., 2001). Esses resultados levam 
a conclusão de que a região do RVL possui um balanço entre os mecanismos 
excitatórios e inibitórios e que esse balanço estaria alterado em algumas situações 
experimentais.  
Em resumo, a atividade dos neurônios do RVL aparece dependente do 
neurotransmissor L-glutamato em proporções que variam de acordo com as 
circunstâncias fisiológicas. Além do L-glutamato, existe uma lista de 
neurotransmissores que regulam a atividade dos neurônios do RVL, como por 
exemplo ácido γ-aminobutírico (GABA), acetilcolina, serotonina, oxitocina, 
angiotensina (Ang), substância P, vasopressina, orexina e também as 
catecolaminas (Guyenet e Stornetta, 2004). 
A área RVL recebe informações de diferentes regiões do bulbo e da ponte. 
Algumas dessas informações são via região CVL, envolvendo a participação de 
neurônios GABAérgicos e a via do barorrefexo (Schreihofer e Guyenet 2003). O 
restante das informações recebidas pelo RVL originam-se da área pressora caudal 
(APC), de regiões mediais do bulbo (depressoras), de vários subnúcleos do NTS, 
da área depressora gigantocelular, da região A5 e do núcleo parabraquial lateral 
(Guyenet e cols., 1987; Koshiya e Guyenet, 1996a; Colombari e  cols., 1996; 
Blessing, 1997; Aicher e cols., 1999; Campos e McAllen, 1999; Moreira e cols., 
2005). Essas regiões bulbares estão, provavelmente, envolvidas também em 
vários reflexos simpáticos somáticos e viscerais (reflexo pressor do exercício, 
reflexo nociceptor, reflexo cardiopulmonar e quimiorreflexo) (Campos e cols., 
1994; Horiuchi e Dampney, 2002; Verberne e cols., 1999; Barman e cols., 2000; 
Guyenet, 2000; Colombari e cols., 2001).  
A área RVL está sob forte influência de dois grandes reflexos cardio-
respiratórios, o barorreflexo e o quimiorreflexo. O mecanismo neural relacionado 
ao baroreflexo, inclui os neurônios GABAérgicos da região CVL, que recebem 
informações excitatórias do NTS, e se projetam para os neurônios pré-simpáticos 
da região RVL (Chan e Sawchenko, 1998; Gordon e Sved, 2002). Os 
interneurônios GABAérgicos do CVL promovem uma intensa e contínua inibição 
sobre os neurônios pré-simpáticos do RVL (Schreihofer e Guyenet, 2002). Essa 
inibição pode também ser independente da via clássica do barorreflexo (Cravo e 
cols., 1991). Muitos dos neurônios do CVL possuem uma atividade basal mesmo 
sem a presença das aferências vagais e possuem, ainda, outras influências além 
do barorreflexo (Cravo e cols., 1991; Schreihofer e Guyenet, 2002). As vias 
neurais independentes do barorreflexo são, ainda, amplamente inexploradas 
levando-se em conta sua importância no controle a longo prazo da pressão 
arterial. A literatura sugere que o barorreflexo possui uma pequena influência no 
controle a longo prazo da pressão arterial (Osborn e cols., 2005). Esse ponto foi, 
originalmente, descrito por Cowley, mostrando que a completa remoção dos 
barorreceptores produzia apenas mudanças transientes na pressão arterial (24 hs) 
em cachorros acordados (Cowley, 1992).  
Em paralelo ao mecanismo do baroreflexo, as aferências dos 
quimiorreceptores periféricos fazem sua primeira sinapse na região comissural do 
NTS (NTScom) (Blessing e cols., 1999; Takakura e cols., 2006). Muitos dos 
neurônios do NTScom que recebem informações dos quimiorreceptores 
periféricos projetam-se para a região ventrolateral do bulbo, mais especificamente, 
para região do RVL (neurônios C1) (Aicher e cols., 1996; Colombari e cols., 1996; 
Koshiya e Guyenet, 1996a; Paton e cols., 2001). A existência de um mecanismo 
excitatório no NTScom foi demonstrado, primeiramente, em experimentos com 
animais anestesiados em que observou-se aumento de pressão arterial produzido 
pelo neurotrasmissor L-glutamato injetado no NTScom, após a inibição da região 
do CVL com muscimol (agonista GABA-A) (Urbanski e Sapru, 1988). Esse 
aumento de pressão arterial, produzido pelo L-glutamato no NTScom, foi abolido 
após o bloqueio prévio de receptores glutamatérgicos na região do RVL (Willette e 
cols., 1987, Urbanski e Sapru, 1988). Mais uma prova da existência de neurônios 
excitatórios do NTScom que se projetam para a região RVL foi realizada em 
animais com lesões eletrolíticas do NTScom (Colombari e cols., 1996). Nesses 
experimentos, a lesão do NTScom foi capaz de abolir a resposta pressora 
produzida pela estimulação dos quimiorreceptores periféricos, sem alterações no 
baroreflexo (Colombari e cols., 1996; Sato e cols., 1999). Evidências 
eletrofisiológicas também comprovaram que neurônios quimiossensíveis da 
porção comissural do NTS eram ativados antidromicamente pelo RVL, sugerindo 
que os neurônios do NTScom projetam-se para o RVL (Koshiya e Guyenet, 
1996a). Estudos da literatura indicam que não apenas os neurônios do NTScom, 
mas também os neurônios do NTS postremal possam estar enviando projeções 
diretas para o RVL (Koshiya e Guyenet, 1996a; Moreira e cols., 2005, 2007).  
 Vale lembrar também que além das projeções inibitórias, estudos recentes 
têm sugerido que a região do CVL pode também enviar projeções excitatórias 
para a região do RVL (Ito e Sved, 1997; Natarajan e Morrison, 2000; Moreira e 
cols., 2005; 2007).  
Embora os mecanismos bulbares referentes ao baro e quimiorreflexo 
estejam estabelecidos (Guyenet, 2006), as projeções excitatórias para os 
neurônios pré-simpáticos do RVL ainda não estão muito bem esclarecidas. O 
aumento da atividade simpática e da pressão arterial produzido pela inibição do 
CVL é sugerido pela desinibição da região do RVL. Entretanto, além das 
projeções inibitórias do CVL, a região RVL pode receber informações excitatórias 
da região do CVL e também do NTS (região adjacente à área postrema e 
comissural) (Moreira e cols., 2005; 2007). Contrariando a literatura, estudos de Ito 
e Sved (1997) mostraram que o bloqueio dos receptores glutamatérgicos na 
região do RVL, associado com a inibição bilateral da região do CVL produziu 
redução da pressão arterial para valores similares ao bloqueio ganglionar com 
hexametônio (Ito e Sved, 1997). Esse trabalho sugere que a região do RVL 
recebe importantes informações excitatórias. Sabe-se que o bloqueio dos 
receptores glutamatérgicos, com ácido quinurênico, não altera os valores basais 
da pressão arterial, indicando que esse mecanismo excitatório parece não estar 
ativado em condições basais. (Ito e Sved, 1997). De acordo com Ito e Sved, em 
condições basais, os mecanismos excitatórios para o RVL é contrabalanceado 
pela atuação dos mecanismos inibitórios do CVL. Quando esse mecanismo 
inibitório é bloqueado (injeção de muscimol na região do CVL), o mecanismo 
excitatório é liberado e a pressão arterial e atividade simpática aumentam (Ito e 
Sved, 1997). 
A situação experimental de inibição da região do CVL parece promover 
uma super-excitação dos neurônios do RVL e também do NTS. Diante disso, 
estudos referentes a essa tese de doutorado demonstraram (Trabalho 1 e 2; 
Moreira e cols., 2005; 2007) que o bloqueio de receptores glutamatérgicos na 
região do NTS (região adjacente à área postrema - postremal) ou comissural, 
simultaneamente com a inibição da região do CVL produziram redução da 
pressão arterial e da resistência vascular para valores abaixo dos valores 
controles, sugerindo que importantes mecanismos excitatórios existem no NTS e 
no CVL para controle e manutenção da pressão arterial e resistência vascular 
(Moreira e cols., 2005; 2007). Portanto, a primeira parte dessa tese de doutorado 
visa investigar a importância de mecanismos excitatórios na região bulbar, em 
especial no NTS e na região do CVL para controle das variáveis cardiovasculares. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
O esquema acima mostra uma representação de um corte sagital do 
encéfalo de rato. Esse esquema procura mostrar as possíveis interconexões entre 
NTS, região CVL e a região RVL discutidas nessa introdução. Neurônios do NTS 
enviam projeções excitatórias para a região CVL e RVL. Os neurônios da região 
CVL (CVL inibitório, verde) enviam projeções (baro dependentes e  baro 
idependente) para a região RVL, promovendo a principal fonte de inibição dos 
neurônios dessa área.  
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Moreira, Thiago Santos, Monica Akemi Sato, Ana Carolina
Thomaz Takakura, Jose´ Vanderlei Menani, and Eduardo Co-
lombari. Role of pressor mechanisms from the NTS and CVLM in
control of arterial pressure. Am J Physiol Regul Integr Comp
Physiol 289: R1416 –R1425, 2005. First published July 28, 2005;
doi:10.1152/ajpregu.00053.2005.—In the present study, we inves-
tigated the effects of inhibition of the caudal ventrolateral medulla
(CVLM) with the GABAA agonist muscimol combined with the
blockade of glutamatergic mechanism in the nucleus of the solitary
tract (NTS) with kynurenic acid (kyn) on mean arterial pressure
(MAP), heart rate (HR), and regional vascular resistances. In male
Holtzman rats anesthetized intravenously with urethane/chloralose,
bilateral injections of muscimol (120 pmol) into the CVLM or
bilateral injections of kyn (2.7 nmol) into the NTS alone increased
MAP to 186  11 and to 142  6 mmHg, respectively, vs. control:
105  4 mmHg; HR to 407  15 and to 412  18 beats per minute
(bpm), respectively, vs. control: 352  12 bpm; and renal, mes-
enteric and hindquarter vascular resistances. However, in rats with
the CVLM bilaterally blocked by muscimol, additional injections
of kyn into the NTS reduced MAP to 88  5 mmHg and mesenteric
and hindquarter vascular resistances below control baseline levels.
Moreover, in rats with the glutamatergic mechanisms of the NTS
blocked by bilateral injections of kyn, additional injections of
muscimol into the CVLM also reduced MAP to 92  2 mmHg and
mesenteric and hindquarter vascular resistances below control
baseline levels. Simultaneous blockade of NTS and CVLM did not
modify the increase in HR but also abolished the increase in renal
vascular resistance produced by each treatment alone. The results
suggest that important pressor mechanisms arise from the NTS and
CVLM to control vascular resistance and arterial pressure under
the conditions of the present study.
ventrolateral medulla; ; -aminobutyric acid; L-glutamate; musci-
mol; sympathetic system
THE MEDULLARY CIRCUIT related to cardiovascular control in-
volves the nucleus of the solitary tract (NTS), nucleus ambig-
uous, and ventrolateral medulla (rostral and caudal) (8, 15, 17).
The NTS is the site of the first synapse of the viscerosensory
afferents in the brain stem, including those related to cardio-
vascular baroreceptor and chemoreceptor afferents. The neu-
rotransmitter released by these afferents in the NTS is sug-
gested to be L-glutamate (8, 15, 16, 32, 48). From the NTS, the
baroreceptor afferent signals project to the caudal ventrolateral
medulla (CVLM) (45, 47). Through GABAergic mechanisms,
the CVLM inhibits neurons in the rostral ventrolateral medulla
(RVLM) that innervate the preganglionic sympathetic neurons
involved in controlling the heart and vascular beds (5, 15, 28,
29, 36, 37). Disinhibition of the RVLM via deactivation of
CVLM by electrolytic lesions or injections of the GABAA
receptor agonist muscimol, or the blockade of GABAergic
transmission in the RVLM, results in sustained sympathoexci-
tation and increase in arterial pressure and heart rate (4, 14,
46). Similar to the deactivation of the CVLM, the blockade of
the NTS with injections of muscimol or the ionotropic
glutamatergic antagonist kynurenic acid (kyn) also produces
sympathoexcitation and increases arterial pressure and heart
rate (18).
Parallel to the inhibitory mechanisms, the RVLM also re-
ceives important excitatory projections (17, 20, 24, 26). Ana-
tomical and immunohistochemical studies have shown that the
NTS sends monosynaptic connections to the RVLM (13, 21,
35, 39, 41) and these projections from the NTS to the RVLM
may convey peripheral chemoreceptor signals (30, 31, 49). The
existence of pressor mechanisms in the NTS is supported by
the increase in arterial pressure produced by L-glutamate in-
jections into the NTS in awake rats (9, 33). Although L-
glutamate injected into the NTS in anesthetized rats usually
reduces arterial pressure, similar to baroreflex activation, L-
glutamate into the NTS induces pressor responses in anesthe-
tized rats after the inhibition of the CVLM with muscimol (49).
This pressor response to L-glutamate into the NTS in anesthe-
tized rats is abolished by the blockade of excitatory amino acid
(EAA) receptors in the RVLM, which suggests the existence of
a pressor pathway from the NTS to the RVLM (50, 54).
Besides the inhibitory projection, there are some studies that
suggest that the CVLM by direct or indirect projections may
activate RVLM neurons (26, 38). In spite of some controver-
sies (25), Ito and Sved (26) have shown that the blockade of the
EAA receptors by bilateral injections of kyn into the RVLM
combined with the inhibition of the CVLM with bilateral
injections of muscimol reduced arterial pressure to a level
similar to that produced by complete autonomic blockade,
suggesting that the RVLM receives important tonic excitatory
drive. However, bilateral injections of kyn alone into the
RVLM in rats do not significantly change resting arterial
pressure, which indicate that these excitatory mechanisms are
not active in resting conditions. According to Ito and Sved
(26), under resting conditions the excitatory drive to the
RVLM is counterbalanced by the activation of the CVLM
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inhibitory mechanisms that, in turn, is also activated by signals
under control of the RVLM excitatory drive. When the inhib-
itory mechanism is blocked by injections of muscimol into the
CVLM, the excitatory mechanisms that reach the RVLM
are released and sympathetic activity and arterial pressure
increase (26).
Therefore, according to the work of Ito and Sved (26), the
deactivation of the inhibitory influences that reach the RVLM
by blocking the CVLM with muscimol or the EAA receptors
with kyn into NTS increases sympathetic activity, arterial
pressure, and heart rate. Additional studies have suggested that
the RVLM also receives excitatory projections from the NTS
and from the CVLM. Considering that the relative importance
of the excitatory and inhibitory signals from the CVLM and
NTS to the RVLM for cardiovascular regulation is still not
completely clear, in the present study, we investigated the
effects produced by the inhibition of the CVLM with muscimol
combined with the blockade of EAA receptors in the NTS with
kyn on mean arterial pressure (MAP), heart rate (HR) and
renal, mesenteric and hindquarter vascular resistances. To
better compare the relative importance of the mechanisms
present in each area for cardiovascular control, two sequences
of treatments were tested in different rats: in one group of rats
the first treatment was muscimol into the CVLM, and the
second treatment, performed 10 min later, was kyn into the
NTS; in another group of rats, the first treatment was kyn into
the NTS followed 10 min later by muscimol into the CVLM.
MATERIALS AND METHODS
Surgical procedures. All experiments were performed in accor-
dance with the Brazilian National Health and Medical Research
Council code of practice for the care and use of animals for scientific
purposes and were approved by the Animal Experimentation Ethics
Committee of the Federal University of Sa˜o Paulo, School of Medi-
cine.
Male Holtzman rats weighing 300–350 g were used. One day
before the experiment, the rats were anesthetized with ketamine (80
mg/kg body wt) combined with xylazine (7 mg/kg body wt), and the
femoral artery and vein were cannulated for arterial pressure mea-
surement and drug administration, respectively. The arterial and
venous catheters (PE-10 connected to PE-50) were tunneled subcuta-
neously and fixed on the back of the rat with suture thread. On the next
day, immediately before the experiments, the animals were anesthe-
tized with urethane (1.0 g/kg iv) combined with -chloralose (60
mg/kg iv). A midline laparotomy was performed and miniature pulsed
Doppler flow probes were placed around the renal artery, superior
mesenteric artery, and lower abdominal aorta for measurement of
renal, mesenteric, and hindquarter blood flows, respectively. The
probes were fixed to the surrounding tissues with suture thread, and
the animals were immediately placed in a stereotaxic apparatus in a
prone position with the incisor bar at 11 mm below the intra-aural line.
A partial occipital craniotomy was performed to expose the dorsal
surface of the caudal brain stem.
Arterial pressure, heart rate and regional blood flow recordings.
The catheter inserted into the femoral artery was connected to a P23
Db pressure transducer (Statham Gould) coupled to a preamplifier
(model ETH-200 Bridge Bio Amplifier, CB Sciences) connected to
the Powerlab computer recording system (model Powerlab 16SP,
ADInstruments) for measurement of pulsatile arterial pressure, MAP,
and HR. The flow probes were connected to a Doppler flowmeter
(Dept. of Bioengineering, University of Iowa, Iowa City, IA) also
coupled to the Powerlab computer recording system. Details of the
Doppler flow recording technique, including the reliability of the
method for estimation of flow velocity, have been described previ-
ously by Haywood and colleagues (22). Relative renal, mesenteric,
and hindquarter vascular resistance changes were calculated as the
ratio of MAP and Doppler shifts. Data from animals in which the
probes moved during the experiment were not considered for analysis.
The rectal temperature was maintained at 37°C with a thermostat-
ically controlled heating pad. During the surgical procedure or record-
ing period, if the animals were responsive to noxious toe pinch, a
supplementary dose of urethane (0.1 g/kg) combined with -chlora-
lose (20 mg/kg) was administered intravenously.
Central injections. Injections (50 nl, delivered over 5 s) of musci-
mol (120 pmol) or saline into the CVLM and kyn (2.7 nmol) or
vehicle into the intermediate regions of the NTS were performed
using the same single-barrel glass pipette (20 m tip diameter)
coupled to a pressure injection apparatus (PicoSpritzer II). An injec-
tion was first performed in one side; the pipette was withdrawn from
the brain and the contralateral injection was made; thus the two
injections were made1 min apart. The volume of each injection was
estimated from the displacement of the fluid meniscus in the pipette
using a calibrated reticule. Injections into the CVLM were made 0.5
mm rostral to the calamus scriptorius, 1.8 mm lateral to midline and
Fig. 1. A: photomicrograph of a coronal section of the brain stem showing the
typical bilateral injections into the intermediate region of the nucleus of the
solitary tract (NTS) and into the caudal ventrolateral medulla (CVLM). Arrows
indicate the center of the injections. B: diagrammatic composite of a transverse
section of the rat medulla showing the sites where muscimol and kyn were
injected approximately at the level 13.7 mm caudal to bregma according to
Paxinos and Watson (40). Solid triangles indicate the centers of injection sites
of kyn into the NTS (n  16) or muscimol into the CVLM (n  16), and open
triangles indicate the centers of injection sites into the neighboring regions of
the NTS (n  9) and CVLM (n  12). Amb, nucleus ambiguus; AP, area
postrema; cc, central canal; LRN, lateral reticular nucleus; X, dorsal motor
vagus nucleus; XII, hypoglossal nucleus.
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1.9 to 2.2 mm below the dorsal surface of the brain stem. Injections into
the NTS were made 0.5 mm rostral to the calamus scriptorius, 0.5 mm
lateral to midline, and 0.5 mm below the dorsal surface of the brain stem.
Drugs. Muscimol and kyn were purchased from Sigma Chemical.
Muscimol was dissolved in isotonic saline. Kyn was initially dissolved in
100 mM sodium bicarbonate (in a volume that corresponded to 10% of
the final volume) and then diluted with isotonic saline until reaching the
final volume. The pH of kynurenic acid solution was around 7.4.
Histology. At the end of the experiments, a 2% solution of Evans
blue was injected into the CVLM and NTS (50 nl) using the same
pipette that was previously used for drug injection. Saline followed by
10% buffered formalin was perfused through the heart. The brains
were removed, fixed in 10% formalin for at least 2 days, frozen, cut
coronally into 50-m sections and stained with Giemsa. The sections
were analyzed by light microscopy to confirm the injections bilater-
ally into the CVLM and NTS.
Statistical analysis. Data are expressed as means  SE. Statistical
analysis of baseline MAP, HR, and changes in vascular resistances
were performed using two-way ANOVA followed by the Student-
Newman-Keuls post hoc test. Significance level was set at P  0.05.
Experimental Protocols1
Effects of kynurenic acid into the NTS on MAP, HR, and regional
vascular resistances in rats pretreated with muscimol into the CVLM.
Blood flows, MAP and HR were continuously recorded during 60 min
and were analyzed at every 10 min starting the recording 10 min after
the connection of the arterial line to the pressure transducer. Control
(baseline) values were recorded for 10 min and were analyzed imme-
diately before bilateral injections of muscimol or saline into the
CVLM (first treatment). These values were used as reference to
calculate the changes produced by the treatments. Ten minutes after
muscimol or saline into the CVLM, kyn or vehicle was bilaterally
injected into the NTS and the cardiovascular responses were evaluated
during the next 40 min.
Four groups of animals (n 8 in each group) were used to investigate
the cardiovascular effects of the combination of injections of muscimol or
saline into the CVLM followed by injections of kyn or vehicle into the
NTS. In each rat, only one of the following combinations was tested: 1)
saline into the CVLM followed by vehicle into the NTS (control); 2)
saline into the CVLM followed by kyn into the NTS; 3) muscimol into
the CVLM followed by vehicle into the NTS; and 4) muscimol into the
CVLM followed by kyn into the NTS.
Effects of muscimol into the CVLM on MAP, HR, and regional
vascular resistances in rats pretreated with kynurenic acid into
the NTS. The protocol used was similar to that described above (item
1), except that the first treatment was kyn or vehicle into the NTS and
the second treatment was muscimol or saline into the CVLM.
Four groups of animals (n  8 each group) were also used, and in
each rat only one of the following combinations was tested: 1) Vehicle
into the NTS followed by saline into the CVLM (control); 2) Kyn
Fig. 2. Typical recording showing changes in pulsatile arterial pressure (PAP), mean arterial pressure (MAP), heart rate (HR), renal (RBF), mesenteric (MBF)
and hindquarter (HBF) blood flows produced by bilateral injections of muscimol (120 pmol/50 nl) injected into the CVLM followed by bilateral injections of
kynurenic acid (kyn, 2.7 nmol/50 nl) into the NTS. Arrows indicated the moment of the injections.
Table 1. Baseline MAP and HR in the different groups of
rats that received injections of saline or muscimol into the
caudal ventrolateral medulla and vehicle or kynurenic acid
into the nucleus of the solitary tract
Treatments Baseline MAP, mmHg Baseline HR, bpm
sal  veh 1056 35212
musc  veh 992 34310
sal  kyn 1023 3687
musc  kyn 1033 3409
veh  sal 1012 33416
kyn  sal 1056 3267
veh  musc 1035 33811
kyn  musc 1004 3328
The results are presented as means  SE; n  8 rats for each treatment. sal,
saline; veh, vehicle; musc, muscimol; kyn, kynurenic acid; MAP, mean arterial
pressure; HR, heart rate.
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into the NTS followed by saline into the CVLM; 3) Vehicle into the
NTS followed by muscimol into the CVLM; and 4) Kyn into the NTS
followed by muscimol into the CVLM.
Baroreflex test in rats treated with muscimol into the CVLM and
kynurenic acid into the NTS. In 6 rats that received muscimol into the
CVLM followed by kyn into the NTS, and in 5 rats treated with
injections of kyn into the NTS followed by injections of muscimol
into the CVLM, the baroreflex was tested by intravenous injection of
a pressor dose of phenylephrine (5 g/kg body wt) and a depressor
dose of sodium nitroprusside (30 g/kg body wt). The injections of
phenylephrine and sodium nitroprusside were performed from 4 to 8
min before the first central injection (control) and from 10 to 20 min
after the second central injection.
Effects of kynurenic acid and muscimol injected in sites outside the
NTS and CVLM on MAP, HR, and regional vascular resistances. To
confirm the specificity of injection sites for the effects of muscimol
and kynurenic acid on MAP, HR, and regional vascular resistances,
results from rats in which the injections did not reach the NTS or the
CVLM bilaterally (misplaced injections) were also analyzed and
presented in the RESULTS section.
RESULTS
Histological analysis. Figure 1A is a photomicrograph
showing the typical sites of the bilateral injections into the
intermediate region of the NTS and into the CVLM in one
rat representative of the rats used in the present study.
Figure 1B is a diagrammatic composite showing the injec-
tion sites into the medulla in rats that received injections of
muscimol and kyn. According to Paxinos and Watson (40),
these coronal sections are located 13.7 mm caudal to
bregma. The injection sites in the NTS shown in Fig. 1 are
the same that previous studies have already shown to pro-
duce depressor responses to L-glutamate injections and pres-
sor responses to bilateral injections of kyn (18, 32). Sym-
pathoinhibitory neurons have been described in the CVLM
in sites similar to those shown in Fig. 1 (1, 3, 28, 34),
and previous studies have showed that bilateral injections
of muscimol in these sites induced pressor responses (25,
26, 49).
Changes in MAP, HR, and regional vascular resistances
induced by kynurenic acid into the NTS in rats pretreated with
muscimol into the CVLM. The baseline levels of MAP and HR
were similar in all four experimental groups tested (Table 1).
Bilateral injections of muscimol (120 pmol/50 nl) into the
CVLM followed by vehicle into the NTS resulted in sustained
(for at least 30 min) hypertension (186  11 mmHg vs. saline:
105  4 mmHg), tachycardia [407  15 beats per minute
(bpm) vs. saline: 352  12 bpm] and increase in renal (364 
38% vs. saline: 6  12%), mesenteric (389  53% vs. saline:
8  4%) and hindquarter vascular resistances (403  48% vs.
saline: 7  9%), whereas renal (	123  51% vs. saline: 5 
5%), mesenteric (	184  46% vs. saline: 11  13%) and
hindquarter (	196  47% vs. saline: 8  10%) blood flows
were reduced (Figs. 2 and 3).
Similar to muscimol into the CVLM, bilateral injections
of kyn (2.7 nmol/50 nl) into the NTS preceded by saline into
the CVLM also increased HR to 397  14 bpm. Although
the other responses were less intense than those produced by
muscimol into the CVLM, bilateral injections of kyn into
the NTS also increased MAP to 144  5 mmHg and renal,
mesenteric, and hindquarter vascular resistances, while the
blood flows in the same beds were reduced for at least 30
min (Figs. 2 and 3). However, in rats pretreated with
muscimol into the CVLM, bilateral injections of kyn (2.7
nmol/50 nl) into the NTS immediately reduced MAP to
88  5 mmHg and mesenteric (	28  19%) and hindquar-
ter vascular resistances (	31  11%) below control prein-
jection baseline levels and abolished the changes in renal
vascular resistance but did not modify the effects of mus-
cimol on HR (Figs. 2-4). Mesenteric (33  12%) and
hindquarter (52  16%) blood flows increased to above
control preinjection baseline levels, and renal blood flow
was restored to control baseline level by the combination of
muscimol into the CVLM and kyn into the NTS (Figs. 3 and
4). No significant changes in breathing occurred after injec-
tions of kyn into the NTS or muscimol into the CVLM.
Fig. 3. A: mean arterial pressure (MAP) and (B) heart rate (HR) in rats treated
with bilateral injections of muscimol (mus; 120 pmol/50 nl) or saline into the
CVLM followed by bilateral injections of kynurenic acid (kyn; 2.7 nmol/50 nl)
or vehicle into the NTS. The results are represented as means  SE. n 
number of rats. ANOVA showed significant differences among the treatments
for MAP [F(3, 165)  32.10, P  0.01] and HR [F(3, 165)  43.51, P 
0.01].
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Changes in MAP, HR, and regional vascular resistances
induced by muscimol into the CVLM in rats pretreated with
kynurenic acid into the NTS. The baseline levels of MAP and
HR were similar in all four experimental groups tested (Ta-
ble 1).
Bilateral injections of kyn (2.7 nmol/50 nl) into the NTS
followed by saline into the CVLM produced sustained (for at
least 30 min) increases in MAP (142  6 mmHg vs. vehicle:
101  2 mmHg), HR (412  18 bpm vs. vehicle: 334  16
bpm) and renal (138  13% vs. saline: 8  9%), mesenteric
(168  26% vs. saline: 11  7%) and hindquarter vascular
resistances (154  34% vs. saline: 6  5%), while renal
(	81  19% vs. saline: 	5  15%), mesenteric (	94  21%
vs. saline: 4  6%), and hindquarter (	72  22% vs. saline:
9  14%) blood flows were reduced (Figs. 5 and 6).
Bilateral injections of muscimol (120 pmol/50 nl) into the
CVLM preceded by vehicle into the NTS also increased MAP
to 183 7 mmHg, HR to 443 11 bpm, and renal, mesenteric
and hindquarter vascular resistances, while the blood flows in
the same beds were reduced for at least 30 min (Figs. 5 and 6).
However, bilateral injections of muscimol (120 pmol/50 nl)
into the CVLM in rats pretreated with kyn (2.7 nmol/50 nl) into
the NTS immediately reduced MAP to 92  2 mmHg and
mesenteric (	24  11%) and hindquarter (	26  9%) vas-
cular resistances below control baseline levels and abolished
the changes in renal vascular resistance but not the changes in
Fig. 4. Changes in (A) renal (RVR), (B) mes-
enteric (MVR) and (C) hindquarter (HVR)
vascular resistances and in (D) RBF, (E)
MBF, and (F) HBF produced by bilateral
injections of mus (120 pmol/50 nl) or saline
into the CVLM followed by bilateral injec-
tions of kyn (2.7 nmol/50 nl) or vehicle into
the NTS. The results are represented as
means  SE. n  number of rats. ANOVA
showed significant differences among the
treatments for renal [F(3, 165)  43.19, P 
0.01], mesenteric [F(3, 165)  29.34, P 
0.01], and hindquarter [F(3, 165)  25.24,
P  0.01] vascular resistances and for renal
[F(3, 165)  188.22, P  0.01], mesenteric
[F(3, 165)  179.74, P  0.01], and hind-
quarter [F(3, 165)  171.40, P  0.01] blood
flows.
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HR (Figs. 5-7). Mesenteric (51  14%) and hindquarter (55 
7%) blood flows increased above control preinjection baseline
levels, and renal blood flow was restored to control baseline
level by the combination of kyn into the NTS and muscimol
into the CVLM (Figs. 6 and 7).
Baroreflex test in rats treated with muscimol into the CVLM
and kynurenic acid into the NTS. The combination of bilateral
injections of muscimol into the CVLM and kyn into the NTS
abolished the reflex bradycardia (	1  2 bpm vs. control:
	54  6 bpm; n  11) produced by an intravenous injection
of phenylephrine (5 g/kg body wt) and also abolished the
reflex tachycardia (3  4 bpm vs. control: 66  7 bpm) to
intravenous injection of sodium nitroprusside (30 g/kg body
wt). The pressor response to intravenous phenylephrine (36 
5 mmHg vs. control: 44  9 mmHg) and the hypotension to
intravenous sodium nitroprusside (	35 3 mmHg vs. control:
	37  5 mmHg) were not modified by the simultaneous
blockade of the CVLM with muscimol and the NTS with kyn.
Effects of muscimol and kynurenic acid injected outside the
CVLM and NTS on MAP, HR, and regional vascular resis-
tances. In the first series of experiments, bilateral injections of
muscimol or kyn outside the CVLM or NTS, respectively (Fig.
1), produced no significant changes in the baseline MAP (8 
3 mmHg vs. vehicle: 9  6 mmHg; n  12 and 8, respec-
tively), HR (13  11 bpm vs. vehicle: 7  7 bpm) or renal
(11  6% vs. vehicle: 9  15%), mesenteric (7  5% vs.
vehicle: 12  17%) and hindquarter (6  8% vs. vehicle: 6 
11%) vascular resistances. Injections of kyn outside the NTS
after muscimol into the CVLM produced no additional changes
in MAP (184  11 mmHg vs. vehicle: 188  8 mmHg; n 
12 and 8, respectively), HR (409  11 bpm vs. vehicle: 413 
7 bpm) or renal (345  26% vs. vehicle: 363  32%),
mesenteric (352  35% vs. vehicle: 366  13%) and hind-
quarter (374  51% vs. vehicle: 358  33%) vascular resis-
tances.
In a second series of experiments, the bilateral injections of
kyn or muscimol outside the NTS or CVLM, respectively,
produced no significant changes in the baseline MAP (4  6
mmHg vs. vehicle: 	2  11 mmHg; n  9 and 8, respec-
tively), HR (7  9 bpm vs. vehicle: 13  6 bpm) or renal
(21  16% vs. vehicle: 23  11%), mesenteric (12  5% vs.
vehicle: 11 11%) and hindquarter (9 12% vs. vehicle: 8
9%) vascular resistances. Injections of muscimol outside the
CVLM after kyn into the NTS produced no additional changes
in MAP (144  9 mmHg vs. vehicle: 138  15 mmHg; n 
9 and 8, respectively), HR (417 9 bpm vs. vehicle: 423 16
bpm) or renal (142  36% vs. vehicle: 153  41%), mesen-
teric (162  25% vs. vehicle: 161  13%) and hindquarter
(159  32% vs. vehicle: 158  19%) vascular resistances.
DISCUSSION
As previously demonstrated, the blockade of the glutama-
tergic receptors in the NTS by injections of kyn or the inhibi-
tion of the CVLM with muscimol increases MAP and HR (15,
18, 26, 53). The novelty in the present study is that the
blockade of the glutamatergic receptors of the NTS simulta-
neously with the inhibition of the CVLM reduces MAP and
mesenteric and hindquarter vascular resistances below control
preinjection baseline levels. Misplaced injections of muscimol
or kyn outside the CVLM or NTS produced no significant
changes in the baseline vascular resistances, MAP, and HR.
Therefore, the present results suggest that important pressor
mechanisms arising from the NTS and the CVLM are involved
Fig. 5. Typical recording showing changes in PAP, MAP, HR, RBF, MBF, and HBF blood flows produced by bilateral injections of kyn (2.7 nmol/50 nl) into
the NTS followed by bilateral injections of mus (120 pmol/50 nl) into the CVLM. Arrows indicated the moment of the injections.
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in the control of vascular resistance and arterial pressure in the
conditions used in the present study.
Important connections among the NTS, CVLM, and RVLM
for cardiovascular regulation have been proposed (11, 30).
Chemoreceptors probably activate an excitatory pathway that
connects the NTS to sympathetic premotor neurons in the
RVLM either directly (10, 31, 49) or through brain stem
pathways that involve neurons also in the A5 region (19).
Baroreceptor afferents provide excitatory inputs to second-
order neurons in the NTS that project to the CVLM and
activate inhibitory projections from CVLM to the RVLM (11,
16). Glutamate is suggested to be the neurotransmitter released
by baroreceptor and chemoreceptor afferent fibers in the NTS
(8, 15, 16, 32, 48). Blocking the baroreflex with injections of
kyn into the NTS, the CVLM inhibitory mechanism is deacti-
vated reducing the inhibition of the RVLM which in turn
increases sympathetic activity, vascular resistance, MAP, and
HR. Injections of muscimol into the CVLM also remove the
inhibition of the RVLM producing effects qualitatively similar
to kyn into the NTS (4, 12, 53). Although baroreceptor signals
that arise through NTS are important to inhibit the RVLM (2,
12, 18, 28), it is necessary to consider that part of the inhibition
that the RVLM receives from the CVLM is not baroreceptor
dependent (12), which may explain why vascular resistance
and MAP increases are almost double after CVLM blockade
with muscimol than after only the blockade of the baroreflex
influences with kyn into the NTS.
Although the treatment with muscimol into the CVLM or
kyn into the NTS independently disinhibits the RVLM and
increases sympathetic activity, vascular resistance, MAP, and
HR, when both treatments are combined simultaneously, MAP
and mesenteric and hindquarter vascular resistances fall below
control preinjection levels without changing the HR increase.
These results suggest that the increases in MAP and regional
vascular resistances produced by the inhibition of the CVLM
alone depend on pressor mechanisms arising from the NTS.
Moreover, the effects on MAP and vascular resistances pro-
duced by the blockade of the glutamatergic mechanisms of the
NTS alone depend on pressor mechanisms that arise from the
CVLM. Excitatory mechanisms arising from different central
areas are important to activate RVLM neurons in resting
conditions or hypertensive states (26, 27, 43). Although the
blockade of EAA receptors in the RVLM produces no signif-
icant effects on baseline arterial pressure in rats (18, 26), it
reduces arterial pressure and sympathetic nerve activity in
rabbits (23). Ito and Sved (26) also showed that arterial
pressure was reduced below control resting levels by the
blockade of EAA receptors with kyn in the RVLM combined
with the blockade of the CVLM with muscimol, which sug-
gests that the increase in arterial pressure produced by the
blockade of the CVLM is dependent on RVLM excitation
produced by EAA release. Similar to Ito and Sved (26), the
present results also support the importance of facilitatory
mechanisms to the RVLM for the pressor response, resulting
from muscimol into the CVLM, with the difference that the
present results suggest that the facilitatory projection to the
RVLM arises and is activated by glutamatergic mechanisms in
the NTS.
The existence of pressor mechanisms in the NTS is sug-
gested by the pressor responses usually produced by L-gluta-
mate injections into the NTS in awake rats or by the anti-
hypertensive effects of commissural NTS lesions in spontane-
ously hypertensive rats (9, 33, 42, 44). Although L-glutamate
injected into the NTS in anesthetized rats usually induces
depressor responses, the same injection into the NTS after the
blockade of the CVLM with muscimol produces pressor re-
sponses in anesthetized rats (49), which suggest that L-gluta-
mate injections into the NTS may also activate pressor mech-
anisms in anesthetized rats. However, in anesthetized rats the
pressor mechanism activated by L-glutamate injections into the
NTS is completely masked by the larger depressor responses
dependent on CVLM. Anatomical and imunohistochemical
studies have suggested the existence of a direct excitatory
projection from the NTS to the RVLM (49, 50), which may
convey peripheral chemoreceptor signals (30, 31). Although
kyn injections into the NTS might block chemoreflex pathways
(6, 7, 51), it is necessary to consider that chemoreceptors are
usually silent in the absence of a proper stimulus. Therefore,
Fig. 6. A: MAP and (B) HR in rats treated with bilateral injections of kyn (2.7
nmol/50 nl) or vehicle into the NTS followed by bilateral injection of mus (120
pmol/50 nl) or saline into the CVLM. The results are represented as means 
SE. n  number of rats. ANOVA showed significant differences among the
treatments for MAP [F(3, 165)  26.15, P  0.01] and HR [F(3, 165) 
19.73, P  0.01].
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during the blockade of the CVLM with muscimol, a mecha-
nism probably not related to the chemoreflex seems to activate
EAA receptors in the NTS causing sympathetic activation and
pressor responses. A previous study suggested that aortic
depressor nerve activity can stimulate pressor mechanisms and
increase arterial pressure when the CVLM was blocked by
muscimol (52). Although the involvement of mechanisms
related to the aortic depressor nerve should be considered, the
present results do not illuminate the mechanism that activates
NTS glutamatergic pressor pathways after muscimol injections
into the CVLM. However, it is clear that MAP and vascular
resistance are strongly dependent on NTS glutamatergic mech-
anisms after the blockade of the CVLM. On the other hand, the
pressor response produced by kyn injections into the NTS is
abolished by muscimol injections into the CVLM, suggesting
that excitatory mechanisms from the CVLM blocked by mus-
cimol injections are involved in the pressor response to kyn
injections into the NTS. Injections of kyn into the RVLM
abolish the pressor response to muscimol injections into the
NTS (26), which suggests that the excitatory projection to the
RVLM arises from other sources in addition to the NTS.
Similar to previous studies (26, 38), the present results showing
Fig. 7. Changes in (A) RVR, (B) MVR, and
(C) HVR vascular resistances and in (D)
RBF, (E) MBF, and (F) HBF blood flows
produced by bilateral injections of kyn (2.7
nmol/50 nl) or vehicle into the NTS followed
by bilateral injection of mus (120 pmol/50 nl)
or saline into the CVLM. The results are
represented as means  SE; n  number of
rats. ANOVA showed significant differences
among the treatments for renal [F(3, 165) 
43.63, P  0.01], mesenteric [F(3, 165) 
28.51, P  0.01], and hindquarter [F(3,
165)  32.44, P  0.01] vascular resistances
and renal [F(3, 165)  145.87, P  0.01],
mesenteric [F(3, 165)  256.82, P  0.01],
and hindquarter [F(3, 165)  241.62, P 
0.01] blood flows.
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that the pressor response to kyn injections into the NTS is
abolished by muscimol injections into the CVLM also suggest
that the CVLM by direct or indirect projections may activate
RVLM neurons. Other studies have already suggested that
nonglutamatergic excitatory projections arise from the CVLM
to the RVLM (26) and that the cardiovascular effects of the
caudal pressor area (CPA) activation also depend on an exci-
tatory projection from the CVLM to the RVLM (38).
It is important to note that independent of the sequence of
the CVLM and NTS blockades, HR increased after the first
blockade, and this increase was not affected by the second
blockade. Therefore, the fact that dual blockade produced
different effects on MAP and HR suggests that different
brainstem mechanisms are activated in these responses and
may also involve changes in parasympathetic activity for the
tachycardic responses. It is also important to consider that the
combination of muscimol into the CVLM and kyn into the
NTS reduced mesenteric and hindquarter vascular resistances
below control baseline levels, while renal vascular resistance
was maintained at the baseline level, which suggests that the
hypotension after the combination of the two treatments de-
pends on vasodilation of specific vascular beds. Although NTS
glutamatergic and CVLM excitatory mechanisms are important
for the increase in renal, mesenteric and hindquarter vascular
resistances after the blockade of each area individually, these
excitatory mechanisms apparently are not important to main-
tain baseline renal vascular resistance when both areas are
blocked simultaneously. This differs from hindquarter and
mesenteric vascular resistances that are dependent on NTS and
CVLM excitatory mechanisms to maintain resting levels.
In conclusion, the present results suggest that the pressor
responses produced by the blockade of the inhibitory mecha-
nism to the RVLM are strongly dependent on the excitatory
projections that arise from the CVLM and from the NTS. In
addition, these excitatory pressor mechanisms are also impor-
tant to maintain baseline arterial pressure and vascular resis-
tance because the blockade of both mechanisms simulta-
neously reduced MAP and vascular resistance to below control
resting levels
Perspectives
One important mechanism still not completely understood is
how RVLM neurons are activated to maintain tonic baseline
activity of sympathetic nervous system. Besides the impor-
tance of the inhibitory mechanisms to control RVLM and
sympathetic activity, recent studies have suggested that exci-
tatory projections to the RVLM seem to play an important role
in cardiovascular regulation. The present results suggest that
excitatory mechanisms that arise from the NTS and CVLM are
important to activate RVLM and the sympathetic system. In
addition, they suggest that a balance between NTS and CVLM
excitatory and inhibitory mechanisms seems to be essential to
maintain baseline arterial pressure. Studies using different
methodologies are necessary to show more details and to
establish the role of the excitatory mechanisms proposed in the
present study in the control of sympathetic activity and arterial
pressure. An important mechanism still not understood is how
the excitatory projections from CVLM and NTS to RVLM are
activated under physiological conditions. Other questions for
further investigation include whether the pathway relaying
excitatory signals from the NTS to RVLM is also involved in
chemoreceptor signaling and whether baroreceptor signaling is
involved in the cardiovascular responses evoked from NTS
when the CVLM is blocked by muscimol.
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ABSTRACT 
In the present study we investigated the role of commissural nucleus of the solitary 
tract (commNTS) on the excitatory responses produced by CVLM deactivation. For that, 
we evaluated the effects on mean arterial pressure (MAP), heart rate (HR) and renal, 
mesenteric and hindquarter vascular resistances produced by either electrolytic lesion or 
blockade of glutamatergic mechanisms in the commNTS with kynurenic acid (kyn) 
combined with the deactivation of the caudal ventrolateral medulla (CVLM) mechanisms 
by injections of the GABAA agonist muscimol or kyn. Male Holtzman rats anesthetized 
with urethane/chloralose, iv, were used. Bilateral injections of muscimol (2 mM – 50 nL) 
into the CVLM alone increased MAP (181 ± 6 mmHg, vs. control: 104 ± 3 mmHg), HR 
(418 ± 16 bpm, vs. control:  322 ± 12 bpm) and vascular resistances. However, the 
combination of muscimol into the CVLM with acute commNTS lesions or kyn into the 
commNTS reduced MAP to 67 ± 5 and 75 ± 3 mmHg, respectively HR to 279 ± 8 and 303 
± 7 bpm, respectively and vascular resistances below to control baseline levels. Bilateral 
injections of kyn (50 mM – 50 nL) into the CVLM alone also increased MAP, HR and 
vascular resistances, while the combination of kyn into the CVLM with kyn into the NTS 
also reduced MAP (81 ± 7 mmHg), HR (306 ± 11 bpm) and vascular resistances below to 
control baseline levels. The results suggest that important glutamatergic excitatory 
mechanisms are activated in the commNTS and CVLM to control arterial pressure, HR and 
vascular resistance under the conditions of the present experiments. 
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INTRODUCTION 
The nucleus of the solitary tract (NTS) is the first synaptic integrative site for 
viscerosensory afferents in the brainstem including those related to respiratory and 
cardiovascular control and among them arterial baro and chemoreflexes (Ciriello et al., 
1994; Dampney, 1994; Guyenet, 2006).  
The central mechanisms related to baroreceptor reflexes includes GABAergic 
neurons in the caudal ventrolateral medulla (CVLM) that receive an excitatory projection 
from the NTS and in turn project to presympathetic neurons in the rostral ventrolateral 
medulla (RVLM) (Chan and Sawchenko, 1998; Gordon and Sved, 2002). Based upon 
numerous studies using anatomical, pharmacological and physiological approaches, 
baroreceptor-mediated decreases in sympathetic activity and blood pressure are believed to 
depend on activation of GABAergic CVLM neurons that project to presympathetic RVLM 
neurons. In parallel with the baroreceptor mechanisms, chemoreceptor afferents primarily 
innervate commissural NTS (commNTS) (Blessing et al., 1999). Most of the commNTS 
neurons that are activated by carotid body stimulation are not respiratory modulated and 
therefore are probably not part of the respiratory pattern generator (Koshiya and Guyenet, 
1996; Paton et al., 2001). Many of these carotid body-responsive neurons project to the 
ventrolateral medulla where one of their targets has long been assumed to be the arterial 
pressure-regulating C1 neurons (Aicher et al., 1996; Koshiya and Guyenet, 1996; Paton et 
al., 2001). The existence of pressor mechanisms in the commNTS is supported by the 
increase in arterial pressure produced by L-glutamate injections into the NTS in 
anesthetized rats after the inhibition of the CVLM with muscimol (Urbanski and Sapru, 
1988). This pressor response induced by L-glutamate into the commNTS in anesthetized 
rats is abolished by the blockade of excitatory amino acid (EAA) receptors in the RVLM 
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which suggests the existence of a pressor pathway from the commNTS to the RVLM, 
(Willette et al., 1987, Urbanski and Sapru, 1988). Electrolytic lesions in commNTS abolish 
the pressor response produced by stimulation of peripheral chemoreceptor with potassium 
cyanide without significant changes in baroreflex activity (Colombari et al., 1996; Sato et 
al., 2001). 
Besides the inhibitory projection, studies have suggested that CVLM also sends 
excitatory projections to the RVLM (Ito and Sved, 1997; Natarajan and Morrison, 2000; 
Moreira et al., 2005). In accordance with this suggestion, a previous study from our 
laboratory (Moreira et al., 2005) demonstrated that the blockade of the EAA receptors with 
bilateral injection of kyn into the NTS (postremal region) combined with the inhibition of 
the CVLM with muscimol reduced arterial pressure and vascular resistance to a level 
below the baseline levels, suggesting that important pressor mechanisms arising from the 
NTS and CVLM are involved in the control of cardiovascular functions. 
Although the medullary circuitry connecting baroreceptors and chemoreceptor 
inputs to sympathetic vasomotor outflow is well established (Guyenet, 2006), the 
excitatory inputs that activate presympathetic neurons in the RVLM are not completely 
understood. The increase in sympathetic activity and arterial pressure produced by the 
inhibition of the CVLM is suggested to be due to the disinhibition of the RVLM. However, 
besides inhibitory inputs from the CVLM, the RVLM may also receive excitatory 
projections from the CVLM and from the NTS (postremal region) that are important to 
control sympathetic activity and arterial pressure (Moreira et al., 2005). Therefore, the aim 
of the present study was to investigate the importance of excitatory mechanisms that arise 
from commNTS and CVLM for cardiovascular regulation. In addition, the possible 
activation by glutamatergic mechanisms of these excitatory pathways in the commNTS 
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and CVLM were also investigated. We also hypothesize that the postremal (Moreira et al., 
2005) and the commissural (present results) region of the NTS could contribute for 
excitatory influences to RVLM neurons after blockade of the CVLM. For this, we tested: 
1) the effects of electrolytic lesions of the commNTS on cardiovascular responses induced 
by bilateral inhibition of the CVLM with muscimol and, 2) the cardiovascular responses 
produced by bilateral deactivation of the CVLM mechanisms with muscimol or blockade 
of the EAA with kynurenic acid (kyn) combined with the blockade of EAA receptors 
within the commNTS with kyn. Some of these data have been published in abstract and 
presented at the 2006 Experimental Biology meeting. 
 
RESULTS 
Histological analysis  
As shown in Figure 1, lesions of the commNTS were located on the midline above 
the central canal and extended from the level of the obex to ~1 mm caudal to the obex. 
Lesions destroyed the commNTS keeping intact the area postrema and lateral regions of the 
NTS. Other tissues like the ventromedial portions of the gracile nucleus and medial 
portions of the dorsal motor nucleus of vagus that lay adjacent to the lesioned area, 
presented only minimal damage. The size of the lesions was similar to that of previous 
studies (Colombari et al., 1996; Sato et al., 1999; 2001; 2003). 
Figure 2A and 2B are photomicrographs showing the typical sites of the injections 
into the commissural region of the NTS and into the CVLM, respectively, in one rat 
representative of the rats used in the present study. Figure 2C and 2D are diagrammatic 
composites showing the injection sites in rats that received injections of kyn into the 
commNTS and muscimol into the CVLM. According to Paxinos and Watson (Paxinos and 
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Watson, 1988), Figure 2C represent slices of brain located approximately 14.08 mm and 
14.3 mm caudal to bregma level and 2D represent slices of brain located approximately 
13.3 mm and 13.6 mm caudal to bregma level. 
The injection of dye extended 210 ± 13 μm on each side of the injection center and 
therefore muscimol, which probably diffuses more than the dye has likely reached the 
respiratory neurons located in the pre-Bötzinger complex (dorsal to the CVLM 
cardiovascular neurons). To exclude eventual effects related to respiratory responses, 
animals that presented respiratory changes were not analyzed. 
  
Effects of bilateral injections of muscimol into the CVLM on MAP, HR and regional 
vascular resistances in rats with commNTS lesions. 
Acute (30 min) commNTS-lesions did not affect baseline MAP (103 ± 5 mmHg, vs. 
sham lesions: 106 ± 3 mmHg) and HR (320 ± 9 bpm, vs. sham lesions: 324 ± 14 bpm). 
Bilateral injections of the GABAA agonist muscimol (2 mM) into the CVLM in 
sham lesioned rats produced an intense increase in MAP (181 ± 6 mmHg), tachycardia (418 
± 16 bpm), and increase in renal (312 ± 24%), mesenteric (324 ± 39%) and hindquarter 
(350 ± 51%) vascular resistance, (Figure 3). However, in acute commNTS-lesioned rats, 
muscimol into the CVLM reduced MAP (67 ± 5 mmHg), HR (279 ± 8 bpm) and renal (-43 
± 12%), mesenteric (-55 ± 18%) and hindquarter (-58 ± 7%) vascular resistance below 
control baseline pre-injection level (Figure 3). The commNTS lesion performed in these 
series of experiments was the same as shown before that was capable to block the effect of 
peripheral chemoreflex activation and no effect on arterial baroreflex (Colombari et al., 
1996; Sato et al., 1999; 2001; 2003). 
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Changes in MAP, HR and regional vascular resistances induced by kynurenic acid into 
the commNTS combined with muscimol into the CVLM. 
The experiments described in the commNTS lesion experiments suggested that the 
commNTS neurons have an important role in the sympathoexcitatory effect produced by 
CVLM-inhibition, but we do not know exactly if this effect is due a destruction of fibers of 
passage or cell body located into the commNTS. In this next series of experiments, we 
injected kyn into the commNTS in animals with or without inhibition of the CVLM. 
Baseline pre-treatment levels of MAP (100 ± 2 mmHg, p>0.05) and HR (325 ± 3 
bpm, p>0.05) were similar in all experimental groups tested. 
Bilateral injections of muscimol (2 mM in 50 nL) alone into the CVLM again 
induced sustained (at least 30 min of duration) hypertension, tachycardia, increase in renal, 
mesenteric, and hindquarter vascular resistances, while injections of kyn (50 mM in 50 nL) 
alone into the commNTS produced no change in MAP, HR and renal, mesenteric and 
hindquarter vascular resistances (Figure 4 and 5). 
Differently from the responses after muscimol alone into the CVLM or kyn alone 
into the commNTS, the combination of muscimol into the CVLM with kyn into the 
commNTS immediately reduced MAP, HR and renal, mesenteric and hindquarter vascular 
resistances to a level below control pre-injection baseline levels independent if the 
injections of muscimol into the CVLM were performed before (Figure 4) or after kyn into 
the NTS (Figure 5). 
Changes in MAP, HR and regional vascular resistances induced by combining injections 
of kynurenic acid into the commNTS and into the CVLM. 
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The next series of experiments we injected kyn into the commNTS in animals with 
or without blockade of the EAA receptors in the CVLM. 
The pre-treatment baseline levels of MAP (108 ± 5 mmHg, p>0.05) and HR (324 ± 
4 bpm, p>0.05) were similar in all experimental groups tested. 
Bilateral injections of kyn (50 mM in 50 nL) alone into the CVLM increased MAP, 
HR and renal, mesenteric and hindquarter vascular resistances, while injections of kyn (50 
mM in 50 nL) into the commNTS again produced no change on MAP, HR and renal, 
mesenteric and hindquarter vascular resistances (Figure 6 and 7). 
Differently from the responses after kyn alone into the CVLM or into the 
commNTS, the combination of kyn into the CVLM with kyn into the commNTS 
immediately reduced MAP, HR and renal, mesenteric and hindquarter vascular resistances 
to a level below control pre-injection baseline levels independent if the injections of kyn 
into the CVLM were performed before (Figure 6) or after kyn into the commNTS (Figure 
7). 
 
Effects of muscimol and kynurenic acid injected outside the CVLM and commNTS on 
MAP, HR and regional vascular resistances 
Bilateral injections of muscimol outside the CVLM or injection of kyn outside the 
commNTS, respectively produced no significant changes in the baseline MAP, HR or renal, 
mesenteric and hindquarter vascular resistances. Injections of kyn outside the NTS after 
muscimol into the CVLM produced no additional changes in MAP (177 ± 13 mmHg, vs. 
vehicle: 174 ± 6 mmHg, p > 0.05), HR (414 ± 13 bpm, vs. vehicle: 406 ± 8 bpm, p > 0.05) 
or renal (315 ± 31%, vs. vehicle: 313 ± 32%, p > 0.05), mesenteric (326 ± 28%, vs. vehicle: 
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319 ± 15%, p > 0.05) and hindquarter (356 ± 43%, vs. vehicle: 349 ± 33%, p > 0.05) 
vascular resistances. 
The injections of kyn outside the commNTS or bilateral injection of muscimol 
outside the CVLM, respectively produced no significant changes in the baseline MAP, HR 
or renal, mesenteric and hindquarter vascular resistances. Injections of muscimol outside 
the CVLM after kyn into the commNTS produced no additional changes in MAP (104 ± 3 
mmHg, vs. vehicle: 106 ± 5 mmHg, p > 0.05), HR (326 ± 8 bpm, vs. vehicle: 323 ± 16 
bpm, p > 0.05) or renal (14 ± 36%, vs. vehicle: 15 ± 41%, p > 0.05), mesenteric (16 ± 25%, 
vs. vehicle: 16 ± 13%, p > 0.05) and hindquarter (15 ± 32%, vs. vehicle: 18 ± 19%, p > 
0.05) vascular resistances. 
 
Effects of kynurenic acid injected outside the CVLM and commNTS on MAP, HR and 
regional vascular resistances 
Bilateral injections of kyn outside the CVLM or injection of kyn outside the 
commNTS, respectively, produced no significant changes in the baseline MAP, HR or 
renal, mesenteric and hindquarter vascular resistances. Injections of kyn outside the NTS 
after kyn into the CVLM produced no additional changes in MAP (138 ± 6 mmHg, vs. 
vehicle: 144 ± 7 mmHg, p > 0.05), HR (372 ± 15 bpm, vs. vehicle: 368 ± 8 bpm, p > 0.05) 
or renal (112 ± 21%, vs. vehicle: 120 ± 32%, p > 0.05), mesenteric (126 ± 18%, vs. vehicle: 
129 ± 15%, p > 0.05) and hindquarter (124 ± 19%, vs. vehicle: 128 ± 25%, p > 0.05) 
vascular resistances. 
The injections of kyn outside the commNTS or outside the CVLM, respectively 
produced no significant changes in the baseline MAP, HR or renal, mesenteric and 
hindquarter vascular resistances. Injections of kyn outside the CVLM after kyn into the 
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commNTS produced no additional changes in MAP (117 ± 12 mmHg, vs. vehicle: 108 ± 9 
mmHg, p > 0.05), HR (326 ± 8 bpm, vs. vehicle: 323 ± 16 bpm, p > 0.05) or renal (14 ± 
36%, vs. vehicle: 15 ± 41%, p > 0.05), mesenteric (16 ± 25%, vs. vehicle: 16 ± 13%, p > 
0.05) and hindquarter (15 ± 32%, vs. vehicle: 18 ± 19%, p > 0.05) vascular resistances. 
 
DISCUSSION 
As shown by the present or previous studies (Natarajan and Morrison, 2000; 
Houriuchi et al., 2004; Schreihofer et al., 2005; Moreira et al., 2005; Moreira et al., 2006), 
inhibition of CVLM by muscimol or blockade of glutamatergic receptors of CVLM 
increases MAP, HR and renal, mesenteric and hindquarter vascular resistances. On the 
other hand, commNTS lesions or blockade of glutamatergic mechanisms in the commNTS 
produces no change of MAP, HR and vascular resistance. However, deactivation of CVLM 
mechanisms in rats with lesions of the commNTS or blockade of the glutamatergic 
receptors of the commNTS reduces MAP, HR and vascular resistances below control 
baseline levels. Misplaced injections of muscimol or kyn outside the CVLM or commNTS 
produce no significant changes in the baseline vascular resistances, MAP and HR. 
Therefore, the present results suggest that excitatory glutamatergic mechanisms arising 
from the commNTS and the CVLM are capable of maintaining arterial pressure, heart rate 
and vascular resistance under these experimental conditions.  
 
Relationship with prior study 
Besides the important pressor mechanisms arising from the postremal region of the 
NTS and from the CVLM (Moreira et al., 2005), the novelty in the present study is that the 
blockade of the glutamatergic receptors of the commNTS simultaneously with the 
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blockade of the CVLM reduces MAP, HR and vascular resistances below control 
preinjection baseline levels. Indeed, the present study confirms and extends the results 
from the previous study showing that excitatory mechanisms also arise from the 
commNTS and that these mechanisms depend on glutamatergic receptors. In our earliest 
study related to the postremal region of the NTS and CVLM (Moreira et al., 2005), we did 
encounter that after glutamatergic blockade of the NTS simultaneously with the CVLM 
inhibition reduced arterial pressure, mesenteric and hindquarter vascular resistance. 
However, in the previous study, we conclude that important excitatory mechanisms arising 
from the NTS (postremal) and CVLM control arterial pressure and vascular resistance. On 
the other hand, the present study have shown that the blockade of the commissural region 
of the NTS together with CVLM inhibition produced a much greater reduction in arterial 
pressure, heart rate and vascular resistance (renal, mesenteric and hindquarter). In view of 
the present results, we conclude and confirm the literature (Urbanski and Sapru, 1988; 
Colombari et al., 1996) that important excitatory mechanisms arise especially from 
commNTS to control and maintain cardiovascular functions. 
 
Possible pathways: relationship with chemoreceptors 
The tonic activity of RVLM sympathetic vasomotor neurons results from the 
combination of excitatory and inhibitory influences (Lipski et al., 1996; Sved et al., 2001; 
Dampney et al., 2003). The RVLM neurons also receive inputs from different medullary 
and pontine sources and part of them are GABAergic inputs from the CVLM that in turn 
are activated by excitatory baroreceptor-related inputs from the NTS (Chan and 
Sawchenko, 1998; Weston et al., 2003; Guyenet, 2006). Acute blockade of the CVLM 
neuron activity removes baroreceptor-mediated inhibition of presympathetic RVLM 
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neurons increasing their basal activity and the sympathetic vasomotor tone leading to 
increased arterial pressure (Koshiya and Guyenet, 1996; Horiuchi et al., 2004).  
The excitatory influence to the RVLM sympathetic vasomotor neurons is related to 
peripheral chemoreflex and this pathway might become tonically active under the 
condition of CVLM-inhibition. Alternatively, a mechanism not related to the chemoreflex 
seems to activate excitatory mechanisms in the commNTS causing sympathetic activation. 
The stimulation of peripheral chemoreceptors increases sympathetic activity through a 
pathway that connects the commNTS to sympathetic premotor neurons in the RVLM 
(Urbaski and Sapru, 1988; Colombari et al., 1996; Koshiya and Guyenet, 1996) or through 
brainstem pathways that involve neurons located in the ventrolateral pons (Koshiya and 
Guyenet, 1994). Several studies have shown that commNTS neurons have monosynaptic 
connections with the RVLM (Ross et al., 1985; Dampney et al., 1987; Hancock, 1988; 
Morilak et al., 1989; Otake et al., 1992), which, in turn, projects monosynaptically to 
preganglionic sympathetic neurons (Hancock, 1988; Otake et al., 1992). 
The deactivation of CVLM mechanisms increases vascular resistance, HR and 
MAP, while lesions of the commNTS or blockade of the EAA receptors with kyn into the 
commNTS do not affect MAP, HR and vascular resistance. However, the deactivation of 
CVLM mechanisms together with lesions of the commNTS or blockade of the EAA 
receptors with kyn into the commNTS reduces MAP, HR and vascular resistance to below 
control levels. These results suggest MAP, HR and vascular resistance increases produced 
by the inhibition of CVLM depend on facilitatory mechanisms arising from the commNTS. 
The commNTS may contain other types of neurons that up-regulate sympathetic tone 
besides those that convey peripheral chemoreceptor inputs as evidenced by: 1) the increase 
in arterial pressure elicited by microinjection of glutamate into commNTS (Urbaski et al., 
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1988) and, 2) inhibition of commNTS neurons block the increase in blood pressure evoked 
by inhibiting neurons located in the CVLM (Natarajan and Morrison, 1998; Moreira et al., 
2005). 
A sympathoexcitatory pathway from the commNTS to the RVLM is suggested to 
exist based on anatomical and imunohistochemical studies and these mechanisms are 
related to peripheral chemoreceptor signals (Koshiya et al., 1993; Koshiya and Guyenet, 
1996). The amino-acid L-glutamate is suggested to be the neurotransmitter released by the 
sympathoexcitatory pathway from commNTS to RVLM and by chemoreceptor afferent 
fibers in the commNTS (Vardhan et al., 1993; Chitravashi et al., 1994; 1995). Although 
kyn into the commNTS may block the chemoreflex, it is necessary to consider that 
chemoreceptors are usually silent in the absence of a proper stimulus and would not 
activate the pressor pathway from the commNTS to RVLM. But the present results 
demonstrate that the pressor responses to muscimol or kyn into the CVLM depend on a 
sympathoexcitatory mechanism that activates EAA receptors in the commNTS and 
probably involves the projections from commNTS to RVLM. We can not exclude the 
possibility of a pathway from commNTS to RVLM through the forebrain like PVN or the 
hypothalamus (Hardy, 2001). Excitation of the commNTS has been shown to increase 
MAP in both unanesthetized and urethane-anesthetized rats (Colombari et al., 1994; 
Urbanski et al., 1988). According to the present results, after the inhibition of the CVLM 
with muscimol, the EAA receptor activation in the commNTS is probably the mechanism 
that keeps arterial pressure, heart rate and vascular resistance above control levels. 
 
Excitatory mechanisms in the brainstem: NTS and CVLM 
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Many studies have suggested the participation of excitatory mechanisms arising 
from different central areas to activated RVLM neurons in resting conditions or 
hypertensive states (Guyenet et al., 1987; Ito and Sved, 1997; Ito et al., 2000). Ito and Sved 
(1997) have demonstrated that arterial pressure is reduced below control resting levels by 
the blockade of EAA receptors with kyn in the RVLM combined with a previous blockade 
of the CVLM with muscimol. These data suggest that the increase in arterial pressure 
produced by the blockade of the CVLM is dependent on the RVLM excitation produced by 
EAA release (Ito and Sved, 1997). Similarly, the present study suggests that the activation 
of excitatory mechanisms is essential for the pressor response to muscimol into the CVLM, 
i.e. the sympathetic activation during CVLM inhibition is not only due to reduction of 
RVLM gabaergic inhibition but also results from the activation of glutamatergic facilitatory 
mechanisms in the NTS. Therefore, the present results suggest that one important excitatory 
projection to the RVLM activated during CVLM inhibition arises from the commNTS and 
utilize L-glutamate as a neurotransmitter in the commNTS. 
Besides the blockade of the pressor response to muscimol into the CVLM, kyn into 
the RVLM also abolished the pressor response to muscimol into the NTS (Ito and Sved, 
1997), which suggests that the excitatory projection to the RVLM arises not only from the 
NTS. Again, similar to previous studies (Ito and Sved, 1997; Natrajan and Morrison, 2000; 
Moreira et al., 2005), the present results suggest that the CVLM sends excitatory 
projections to the RVLM that are capable of maintaining arterial pressure, heart rate and 
vascular resistance. The evidence for this suggestion is the reduction of MAP, HR and 
vascular resistance to below control baseline levels after the dual blockade of the 
commNTS and CVLM. The blockade of glutamatergic receptors in the commNTS with kyn 
alone produces no alteration of MAP, HR and vascular resistance. However if 
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glutamatergic receptors of the commNTS were already blocked, the additional blockade of 
CVLM mechanisms with muscimol or kyn results in reduction of MAP, HR and vascular 
resistance below control levels. These results suggest that the maintenance of MAP, HR 
and vascular resistance at baseline levels after the blockade of glutamatergic receptors of 
the commNTS alone depends on excitatory mechanisms that arise from the CVLM and that 
are activated by L-glutamate in this area. 
Neurons located into the caudal pressor area (CPA) may have a role as one of the 
sources of excitatory drive from the CVLM to the RVLM (Natarajan and Morrison, 2000). 
The paraventricular nucleus of the hypothalamus also sends a glutamatergic projection to 
the CVLM (Yang and Coote, 1999; Schreihofer, 2003). Other potential excitatory inputs to 
the CVLM may arise from respiratory-related pre-Bötzinger neurons, as evidenced by the 
effects of lesion of pre-Bötzinger neurons reducing the ability of the CVLM to change 
arterial pressure (Wang et al., 2002). Presympathetic RVLM neurons and sympathetic 
vasomotor nerves have respiratory-related activity (Haselton and Guyenet, 1989; Moreira et 
al., 2006) that may be conveyed by respiratory-related excitation of the CVLM. The spinal 
cord may be also another source of excitation to the CVLM because neurons in laminae I-
IV in spinal dorsal horn project directly to the region of the CVLM (Spike et al., 2003).  
 
Conclusion 
Overall the present results suggest that the pressor responses produced by the 
blockade of the inhibitory mechanism to the RVLM are strongly dependent on the 
sympathoexcitatory projections that arise from the CVLM and from commNTS and are 
activated by the release of L-glutamate in these areas. In addition, these excitatory 
mechanisms are also important to maintain baseline arterial pressure and vascular 
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resistance because the blockade of both mechanisms simultaneously reduced arterial 
pressure and vascular resistance below control resting levels. However, more studies are 
still necessary to find the sources of the inputs that tonically activate the neurons in the 
CVLM and commNTS. 
 
MATERIALS AND METHODS 
General procedures. All experiments were performed in accordance with the Brazilian 
National Health and Medical Research Council code of practice for the care and use of 
animals for scientific purposes and were approved by the Animal Experimentation Ethics 
Committee of the Federal University of São Paulo - School of Medicine.  
Male Holtzman rats weighing 300-350 g were used. One day before the experiment, 
the rats were anesthetized with ketamine (80 mg kg-1 of body weight) combined with 
xylazine (7 mg kg-1 of body weight) and the femoral artery and vein were cannulated for 
arterial pressure measurement and drug administration, respectively. The arterial and 
venous catheters (PE-10 connected to PE-50) were tunneled subcutaneously and fixed on 
the back of the rat with suture thread. On the next day, immediately before the experiments 
the animals were anesthetized with urethane (1.0 g kg-1, iv) combined with α-chloralose (60 
mg kg-1, iv). A midline laparotomy was performed and miniature pulsed Doppler flow 
probes were placed around the renal artery, superior mesenteric artery and low abdominal 
aorta for measurement of renal, mesenteric and hindquarter blood flows, respectively. The 
probes were fixed to the surrounding tissues with suture thread, and the animals were 
immediately place in a stereotaxic apparatus in a prone position with the incisor bar at 11 
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mm below the intra-aural line. A partial occipital craniotomy was perfomed to expose the 
dorsal surface of the brainstem. 
 
Arterial pressure, heart rate and regional blood flow recordings. The catheter inserted 
into the femoral artery was connected to a P23 Db pressure transducer (Statham Gould) 
coupled to a pre-amplifier (model ETH-200 Bridge Bio Amplifier, CB Sciences) connected 
to the Powerlab computer recording system (model Powerlab 16SP, ADInstruments) for 
measurement of pulsatile arterial pressure, mean arterial pressure (MAP) and heart rate 
(HR). The flow probes were connected to a Doppler flowmeter (Dept of Bioengineering, 
University of Iowa, Iowa City, IA, USA) also coupled to the Powerlab computer recording 
system. Details of the Doppler flow recording technique, including the reliability of the 
method for estimation of flow velocity, have been described previously (Haywood et al., 
1981). Relative renal, mesenteric and hindquarter vascular resistance changes were 
calculated as the ratio of MAP and Doppler shifts. Data from animals in which the probes 
moved during the experiment were not considered for analysis. 
The rectal temperature was maintained at 37°C with a thermostatically controlled 
heating pad. During the surgical procedure or recording period, if the animals were 
responsive to noxious toe pinch, a supplementary dose of urethane (0.1 g kg-1) combined 
with α-chloralose (20 mg kg-1) was administered iv. 
Eletrolytic commNTS lesions. A partial craniotomy of the occipital bone was performed, 
and the dorsal surface of the brainstem was exposed. A tungsten electrode was positioned 
in the commNTS (0.2 to 0.3 mm caudal to the calamus scriptorius, 0.5 mm below the 
dorsal surface of the brain stem and in the midline) and a 2-mA current was passed for 10 
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seconds, as previously described (Colombari et al., 1996; Sato et al., 1999; 2001; 2003). 
Sham-lesioned rats were submitted to the same procedures, but no electric current was 
passed. 
 
Central injections. Injections (50 nL, delivered over 5 s) of muscimol (2 mM) or saline into 
the CVLM and kynurenic acid (kyn, 50 mM) or vehicle into the commissural subnucleus of 
the NTS were performed using the same single-barrel glass pipette (20 µm tip diameter) 
coupled to a pressure injection apparatus (PicoSpritzer II). An injection was first performed 
in one side, the pipette was withdrawn from the brain and the contralateral injection was 
made; thus the two injections were made approximately 1 min apart, as the injection was 
performed bilaterally into the CVLM. The volume of each injection was estimated from the 
displacement of the fluid meniscus in the pipette using a calibrated reticule. Injections into 
the CVLM were made 0.5 mm rostral to the calamus scriptorius, 1.8 mm lateral to midline 
and 1.9 to 2.0 mm below the dorsal surface of the brainstem. Injections into the commNTS 
were made in the midline, 0.2 to 0.3 mm caudal to the calamus scriptorius and 0.5 mm 
below the dorsal surface of the brainstem.  
 
Drugs. Muscimol and kyn were purchased from Sigma Chemical Co., USA. Muscimol was 
dissolved in isotonic saline. Kyn was initially dissolved in 100 mM sodium bicarbonate (in 
a volume that corresponded to 10% of the final volume) and then diluted with isotonic 
saline until reaching the final volume. The pH of kyn solution was around 7.4. 
 
Histology. At the end of the experiments, a 2% solution of Evans blue was injected into the 
CVLM and commNTS (50 nL) using the same pipette that was previously used for drug 
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injection. Saline followed by 10% buffered formalin was perfused through the heart. The 
brains were removed, fixed in 10% formalin for at least 2 days, frozen, cut coronally into 
50 μm sections and stained with Giemsa. The sections were analyzed by light microscopy 
to confirm the sites of injections into the CVLM or into the commNTS and the lesions of 
commNTS. Section alignment between brains was done relative to a reference section. To 
align sections around CVLM level, the most rostral section containing an identifiable 
cluster of facial motor neurons was identified in each brain and assigned the level 11.6 mm 
caudal to Bregma (Bregma -11.6 mm) according to the atlas of Paxinos and Watson (1998).  
Levels rostral or caudal to this reference section were determined by adding a distance 
corresponding to the interval between sections multiplied by the number of intervening 
sections. In case of lesions or injection sites at commissural NTS level, the reference 
section used to align all others was the one closest to mid-area postrema level (Bregma -
13.8 mm). 
 
Statistical analysis. Statistical analysis was done with Sigma Stat version 3.0 (Jandel 
Corporation, Point Richmond, CA). Data are reported as means ± standard error of the 
mean. Two-way parametric ANOVA followed by the Newman-Keul multiple comparisons 
test were used as appropriate. Significance was set at P<0.05. 
Experimental protocols 
1) Effects of bilateral injections of muscimol into the CVLM on MAP, HR and regional 
vascular resistances in commNTS-lesioned rats.  
Blood flows, MAP and HR were continuously recorded during 80 minutes and were 
analyzed at every 10 minutes, starting the recording 10 minutes after the connections of the 
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arterial line to the pressure transducer. Control (baseline) values were recorded for 10 
minutes and were analyzed immediately before electrolytic commNTS or sham lesion. 
These values were used as reference to calculate the changes produced by the treatments. 
Thirty minutes after commNTS or sham lesion, muscimol or saline was bilaterally injected 
into the CVLM and the cardiovascular responses were evaluated during the next 40 
minutes. 
 Four groups of animals (n = 8 each group) were used to investigate the 
cardiovascular effects of bilateral injections of muscimol or saline into the CVLM in rats 
submitted to commNTS or sham lesions. In each rat, only one of the following 
combinations were tested: 
1) Sham lesion + saline into the CVLM (control);  
2) Sham lesion + muscimol into the CVLM; 
3) CommNTS lesion + saline into the CVLM;  
4) CommNTS lesion + muscimol into the CVLM. 
  
2) Effects of kynurenic acid into the commNTS combined with muscimol into the CVLM 
on MAP, HR and regional vascular resistances 
Muscimol or saline was injected into the CVLM before and after kyn or vehicle into 
the commNTS. 
Blood flows, MAP and HR were continuously recorded during 60 minutes and were 
analyzed at every 10 minutes, starting the recording 10 minutes after the connections of the 
arterial line to the pressure transducer. Control (baseline) values were recorded for 10 
minutes and were analyzed immediately before the first treatment. These values were used 
as reference to calculate the changes produced by the treatments. The second treatment was 
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performed 10 minutes later and the cardiovascular responses were evaluated during the next 
40 minutes. 
To test the first sequence of drug combinations, 4 groups of animals (n = 7 each 
group) were used and in each rats only one of the following combinations were tested: 
1) Saline into the CVLM + vehicle into the commNTS (control);  
2) Saline into the CVLM + kyn into the commNTS; 
3) Muscimol into the CVLM + vehicle into the commNTS;  
4) Muscimol into the CVLM + kyn into the commNTS. 
To test the second sequence of drug combinations, 4 groups of animals (n = 7 each 
group) were also used and in each rats only one of the following combinations were tested: 
1) Vehicle into the commNTS + saline into the CVLM (control);  
2) Kyn into the commNTS + saline into the CVLM; 
3) Vehicle into the commNTS + muscimol into the CVLM;  
4) Kyn into the commNTS + muscimol into the CVLM. 
 
3) Changes in MAP, HR and regional vascular resistances induced by combining 
injections of kynurenic acid into the commNTS and into the CVLM. 
The experimental design was similar to that described on item 2 above, except that 
kyn was injected into the CVLM, instead of muscimol. 
 Four groups of animals (n = 8 each group) were used to test the cardiovascular 
effects produced by the combination of kyn or vehicle into the CVLM followed by kyn or 
vehicle into the commNTS. Another 4 groups of animals (n = 7 each group) were used to 
investigate the cardiovascular effects produced by the combination of kyn into the 
commNTS followed by kyn into the CVLM.  
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4) Effects of muscimol and kynurenic acid injected in sites outside the CVLM and 
commNTS on MAP, HR and regional vascular resistances. 
To confirm the specificity of injection sites for the effects of muscimol and kyn on 
MAP, HR and regional vascular resistances, results from rats in which the injections did 
not reach the CVLM or the commNTS (misplaced injections) were also analyzed and 
presented in the Results section. 
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FIGURE LEGENDS 
 
Figure 1: Location of commissural nucleus of the solitary tract (commNTS) lesion. 
Photomicrograph of a coronal section of the brainstem showing the typical commNTS 
lesion (arrow). AP, area postrema; py, pyramidal tract; Sp5, spinal tract of trigeminal 
nerve; XII, hypoglossal nucleus. 
 
Figure 2: Location of commissural nucleus of the solitary tract (commNTS) and 
caudal ventrolateral medulla (CVLM) injections. 
Photomicrographs of a coronal sections of the brainstem showing the typical injections 
(arrow) into the (A) commissural region of the NTS and (B) CVLM and diagrammatic 
composite of a transverse sections of the rat medulla showing the sites where kyn and 
muscimol were injected approximately at the level (C) 14.08 mm - 14.3 mm, respectively 
and (D) 13.3 mm - 13.6 mm, respectively, caudal to bregma according to Paxinos and 
Watson, 1988. Filled circles indicate the centers of injection sites of kyn into the 
commNTS (n = 29) or muscimol (n = 22) or kyn (n = 15) into the CVLM, and open 
triangles indicate the centers of injection sites into the neighboring regions of the 
commNTS (n = 5) and CVLM (n = 6). Amb, nucleus ambiguous; cc, central canal; Gr, 
gracile nucleus; IO, inferior olive; LRt, Lateral reticular nucleus; NTS, nucleus of the 
solitary tract; for other abbreviations see Figure 1. Scale = 1 mm. 
 
Figure 3: Cardiovascular effects produced by bilateral injections of muscimol into the 
CVLM in commNTS-lesioned rats.  
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(A) typical recording showing changes in pulsatile arterial pressure (PAP), mean arterial 
pressure (MAP), heart rate (HR), renal (RBF), mesenteric (MBF) and hindquarter (HBF) 
blood flows produced by bilateral injections of muscimol (mus, 2 mM) into the CVLM 
after commNTS lesion. Arrows indicated the moment of the lesions and the injections. (B) 
Mean arterial pressure (MAP), (C) heart rate (HR) and changes in (D) renal (RVR), (E) 
mesenteric (MVR) and (F) hindquarter (HVR) vascular resistances produced by bilateral 
injections of mus (2 mM) or saline into the CVLM before and after commNTS lesions. The 
results are represented as means ± SEM. ANOVA showed significant differences among 
the treatments for MAP [F(3, 99) = 12.22, p<0.01], HR [F(3, 99) = 62.51, p<0.01], renal 
[F(3, 99) = 33.13, p<0.01], mesenteric, [F(3, 99) = 47.18, p<0.01] and hindquarter [F(3, 
99) = 29.17, p<0.01] vascular resistances. N = 8/group. *Different from sham commNTS + 
saline CVLM. 
 
Figure 4: Cardiovascular effects produced by bilateral injections of muscimol into the 
CVLM combined with kynurenic acid into the commNTS.  
(A) typical recording showing changes in pulsatile arterial pressure (PAP), mean arterial 
pressure (MAP), heart rate (HR), renal (RBF), mesenteric (MBF) and hindquarter (HBF) 
blood flows produced by bilateral injections of muscimol (mus, 2 mM) injected into the 
CVLM followed by injections of kynurenic acid (kyn, 50 mM) into the commNTS. Arrows 
indicated the moment of the injections. (B) Mean arterial pressure (MAP), (C) heart rate 
(HR) and changes in (D) renal (RVR), (E) mesenteric (MVR) and (F) hindquarter (HVR) 
vascular resistances produced by bilateral injections of mus (2 mM) or saline into the 
CVLM followed by injections of kyn (50 mM) or vehicle into the commNTS. The results 
are represented as means ± SEM. ANOVA showed significant differences among the 
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treatments for MAP [F(3, 113) = 22.04, p<0.01], HR [F(3, 113) = 113.74, p<0.01], renal 
[F(3, 115) = 62.66, p<0.01], mesenteric, [F(3, 113) = 52.13, p<0.01] and hindquarter [F(3, 
113) = 55.69, p<0.01] vascular resistances. N = 7/group. *Different from saline CVLM + 
vehicle commNTS. 
 
Figure 5: Cardiovascular effects produced by injection of kynurenic acid into the 
commNTS combined with muscimol into the CVLM.  
(A) typical recording showing changes in pulsatile arterial pressure (PAP), mean arterial 
pressure (MAP), heart rate (HR), renal (RBF), mesenteric (MBF) and hindquarter (HBF) 
blood flows produced by injections of kynurenic acid (kyn, 50 mM) into the commNTS 
followed by bilateral injections of muscimol (mus, 2 mM) into the CVLM. Arrows 
indicated the moment of the injections. (B) Mean arterial pressure (MAP), (C) heart rate 
(HR) and changes in (D) renal (RVR), (E) mesenteric (MVR) and (F) hindquarter (HVR) 
vascular resistances produced by injections of kyn (50 mM) or vehicle into the commNTS 
followed by bilateral injection of mus (2 mM) or saline into the CVLM. The results are 
represented as means ± SEM. ANOVA showed significant differences among the 
treatments for MAP [F(3, 113) = 15.84, p<0.01], HR [F(3, 113) = 29.37, p<0.01], renal 
[F(3, 113) = 95.67, p<0.01], mesenteric [F(3, 113) = 129.26, p<0.01] and hindquarter [F(3, 
113) = 56.92, p<0.01] vascular resistances. N = 7/group. *Different from vehicle 
commNTS + saline CVLM. 
 
Figure 6: Cardiovascular effects produced by bilateral injections of kynurenic acid 
into the CVLM combined with kynurenic acid into the commNTS.  
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(A) typical recording showing changes in pulsatile arterial pressure (PAP), mean arterial 
pressure (MAP), heart rate (HR), renal (RBF), mesenteric (MBF) and hindquarter (HBF) 
blood flows produced by bilateral injections of kynurenic acid (kyn, 50 mM) injected into 
the CVLM followed by injections of kyn (50 mM) into the commNTS. Arrows indicated 
the moment of the injections. (B) Mean arterial pressure (MAP), (C) heart rate (HR) and 
changes in (D) renal (RVR), (E) mesenteric (MVR) and (F) hindquarter (HVR) vascular 
resistances produced by bilateral injections of kyn (50 mM) or vehicle into the CVLM 
followed by injections of kyn (50 mM) or vehicle into the commNTS. The results are 
represented as means ± SEM. ANOVA showed significant differences among the 
treatments for MAP [F(3, 99) = 112.06, p<0.01], HR [F(3, 99) = 87.47, p<0.01], renal 
[F(3, 99) = 125.66, p<0.01], mesenteric, [F(3, 99) = 49.33, p<0.01] and hindquarter [F(3, 
99) = 113.77, p<0.01] vascular resistances. N = 8/group. *Different from vehicle CVLM + 
vehicle commNTS. 
 
Figure 7: Cardiovascular effects of kynurenic acid into the commNTS combined with 
kynurenic acid into the CVLM.  
(A) typical recording showing changes in pulsatile arterial pressure (PAP), mean arterial 
pressure (MAP), heart rate (HR), renal (RBF), mesenteric (MBF) and hindquarter (HBF) 
blood flows produced by injections of kynurenic acid (kyn, 50 mM) into the commNTS 
followed by bilateral injections of kyn (50 mM) into the CVLM. Arrows indicated the 
moment of the injections. (B) Mean arterial pressure (MAP), (C) heart rate (HR) and 
changes in (D) renal (RVR), (E) mesenteric (MVR) and (F) hindquarter (HVR) vascular 
resistances produced by injections of kyn (50 mM) or vehicle into the commNTS followed 
by bilateral injection of kyn (50 mM) or vehicle into the CVLM. The results are 
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represented as means ± SEM. ANOVA showed significant differences among the 
treatments for MAP [F(3, 113) = 39.12, p<0.01], HR [F(3, 113) = 44.27, p<0.01], renal 
[F(3, 113) = 111.13, p<0.01], mesenteric [F(3, 113) = 149.32, p<0.01] and hindquarter 
[F(3, 113) = 99.92, p<0.01] vascular resistances. N = 7/group. *Different from vehicle 
commNTS + vehicle CVLM. 
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Discussão e Conclusão 
A principal novidade da primeira parte dessa tese mostra que o bloqueio 
dos receptores glutamatérgicos do NTS (região postremal ou comissural), 
juntamente com a inibição bilateral da região do CVL, reduz a pressão arterial e a 
resistência vascular abaixo dos valores controles. Do mesmo modo, a lesão 
eletrolítica da região comissural do NTS, juntamente com a inibição bilateral do 
CVL produz redução da pressão arterial e a resistência vascular abaixo dos 
valores controles. Vale ressaltar que, diferente da injeção bilateral de ácido 
quinurênico no NTS postremal, a lesão eletrolítica ou o bloqueio glutamatérgico 
da região comissural do NTS não produz alterações nos valores basais da 
pressão arterial e resistência vascular. 
Portanto, os dois primeiros trabalhos sugerem que importantes 
mecanismos excitatórios existem no NTS (postremal e comissural) e também no 
CVL e estão envolvidos no controle das variáveis cardiovasculares. Vale ressaltar 
que esses mecanismos foram estudados numa determinada condição 
experimental, condição essa na qual realizamos inibição da região do CVL e 
bloqueios na região do NTS. Situações de inibição da região do CVL ou bloqueio 
da região do NTS são sinônimos de hipertensão. Quando realizamos a 
combinação de inibições (CVL e NTS), esperávamos que a hipertensão fosse 
ainda maior, o que relamente não aconteceu. Na sequência de inibições do NTS e 
do CVL, observamos uma redução e/ou manutenção dos níveis de pressão 
arterial próximo dos níveis basais. Portanto, nessa situação, quem estaria 
mantendo o tônus simpático? O NTS e CVL deixam de manter inibição sobre o 
RVL, e então, quais os mecanismos responsáveis para manter o controle 
excitação e inibição sobre o RVL? Certamente, nessa tese iremos tentar 
esclarecer alguns dos possíveis mecanismos responsáveis por esses efeitos, mas 
futuros experimentos serão necessários para completamente esclarecer esses 
fatos.   
Importantes mecanismos cardiovasculares envolvendo o NTS, CVL e RVL 
têm sido exaustivamente propostos na literatura (Dampney, 1994; Colombari e 
cols., 2001; Guyenet, 2006).  
Importantes mecanismos, envolvendo a região bulbar, estão relacionados a 
ativação de vários reflexos, como por exemplo o quimiorreflexo e o barorreflexo. 
Os quimiorreceptores periféricos promovem a ativação dos neurônios pré-motores 
simpáticos da região do RVL via, basicamente, 2 mecanismos excitatórios: um 
mecanismo excitatório direto entre o NTS e os neurônios do RVL (Urbanski e 
Sapru, 1988a; Colombari e cols., 1996; Koshiya e Guyenet, 1996) ou, 
indiretamente, via o grupamento noradrenérgico A5, localizado na ponte 
ventrolateral (Koshiya e Guyent, 1994; Guyenet, 2000). Por outro lado, os 
barorreceptores enviam aferências excitatórias para neurônios de segunda ordem, 
localizados na região postremal do NTS. Esses neurônios projetam-se para a 
região CVL, local da população de neurônios inibitórios (GABAérgicos), que por 
sua vez se projetam para a região do RVL (Dampney, 1994; Colombari e cols., 
2001; Gordon e Sved, 2002; Guyente, 2006). O aminoácido excitatório L-
glutamato parece ser o principal neurotransmissor liberado pelas aferências dos 
baro e quimiorreflexos (Talman e cols., 1980; Leone e Gordon, 1989; Ciriello e 
cols., 1994; Dampney, 1994; Gordon e Sved, 2002). O bloqueio do barorreflexo 
com a injeção bilateral do antagonista de receptores glutamatérgicos ionotrópicos, 
ácido quinurênico, no NTS promove uma desativação do mecanismo inibitório do 
CVL, resultando numa redução da inibição para os neurônios pré-motores 
simpáticos do RVL e, consequentemente, num aumento da atividade simpática e 
da pressão arterial. A injeção bilateral do agonista GABAérgico muscimol na 
região do CVL também promove uma redução da inibição para os neurônios do 
RVL, produzindo efeitos similares ao bloqueio glutamatérgicos na região do NTS 
(Willette e cols., 1987; Blessing, 1988; Cravo e cols., 1991; Moreira e cols., 2005; 
2006; 2007). Embora os sinais do barorreflexo sejam importantes para inibir os 
neurônios pré-motores simpáticos do RVL, vale ressaltar que parte da inibição 
para os neurônios do RVL parece ser não dependente do barorreflexo (Cravo e 
cols., 1991). Isso pode explicar por que, em nossos experimentos, o aumento de 
pressão arterial e resistência vascular é muito maior com a injeção bilateral de 
muscimol no CVL em relação a injeção bilateral de ácido quinurênico no NTS. 
Certamente, nossos resultados em adição aos da literatura, nos permite sugerir 
que os neurônios da região do CVL devem ser a fonte principal de inibição direta 
sobre o RVL, enquanto que a projeção do NTS para o RVL parece ser 
predominantemente excitatórias. 
Independentemente, a injeção bilateral de muscimol no CVL ou a injeção 
bilateral de ácido quinurênico no NTS promove uma desinibição para a região do 
RVL e, consequentemente, um aumento da atividade simpática, resistência 
vascular e pressão arterial. Entretanto, quando esses tratamentos são feitos 
simultaneamente, isto é, injeção bilateral de muscimol no CVL seguido da injeção 
bilateral de ácido quinurênico no NTS postremal, a resistência vascular e pressão 
arterial reduzem para valores abaixo dos valores basais (controles). O mesmo 
efeito é também observado quando são feitas injeções simultâneas de muscimol 
no CVL, juntamente com a injeção de ácido quinurênico ou lesão eletrolítica na 
região caudal e medial (comissural) do NTS. A única diferença é que o bloqueio ou 
a lesão do NTScom sozinho não produz alterações na pressão arterial ou 
resistência vascular basais. Este dado por si é muito importante no cenário da 
literatura que invariavelmente cita lesões ou inibições do NTS como fonte de 
hipertensão. Diferentes trabalhos do nosso laboratório mostram que lesões ou 
inibições da porção comissural do NTS não promovem modificações na 
resistência periférica e consequentemente na pressão arterial basal. Ademais, em 
situações de hipertensão, tal lesão ou inibição do NTS comissural promove uma 
redução de atividade simpática associada com redução de níveis pressóricos 
(Sato e cols., 2001; 2002). Esses resultados também sugerem que o aumento de 
pressão arterial e resistência vascular produzido pela inibição apenas do CVL 
depende de mecanismos excitatórios localizados no NTS intermediário e/ou 
comissural. Os efeitos de aumento de pressão arterial e resistência vascular 
produzido apenas pelo bloqueio do NTS intermediário (postremal) dependem de 
mecanismos excitatórios localizados no CVL, associados evidentemente com a 
remoção de projeções do NTS para o CVL dependente de barorreceptores que 
são inibitórios sobre o RVL. 
Esses resultados sugerem que o aumento de pressão arterial e resistência 
vascular produzido pela inibição apenas do CVL depende de mecanismos 
excitatórios localizados no NTS. Os efeitos de aumento de pressão arterial e 
resistência vascular produzido apenas pelo bloqueio do NTS depende de 
mecanismos excitatórios localizados no CVL. 
A existência de projeções excitatórias da região CVL para a região RVL do 
bulbo foi primeiramente proposta por Ito e Sved (Ito e Sved, 1997), como sendo 
parte de um modelo conceitual de interconexões entre os neurônios da região 
bulbar, os quais são responsáveis, em grande parte, pela manutenção das 
variáveis cardiovasculares. Esse modelo foi proposto considerando a observação 
que o nível de pressão arterial basal não foi alterado após o bloqueio dos 
receptores glutamatérgicos na região RVL do bulbo (Guyenet e cols., 1987; Kiely e 
cols., 1994; Sun, 1996; Ito e Sved , 1997). No mesmo trabalho, o bloqueio 
glutamatérgico da região RVL após a inibição da região CVL com muscimol 
reduziu a pressão arterial para níveis considerados espinais, sugerindo a 
eliminação do tônus simpático (Ito e Sved, 1997). Projeções excitatórias da região 
CVL para a região RVL do bulbo também foi proposto por Natarajan e Morisson 
(2000). Os autores sugerem que os neurônios localizados na área pressora caudal 
(APC) constituem uma das principais fontes de regulação da atividade dos 
neurônios excitatórios da região CVL do bulbo e que esses neurônios seria 
glutamatérgicos (Natarajan e Morisson, 2000). 
Um importante ponto a ser lembrado nessa discussão diz respeito à 
especificidade do antagonista de receptores  glutamatérgicos ionotrópicos ácido 
quinurênico. Devemos considerar que o ácido quinurênico antagoniza a maioria 
dos receptores glutamatérgicos ionotrópicos como o NMDA, kainato e AMPA 
(Collingridge e cols., 1989). A especificidade farmacológica da injeção de ácido 
quinurênico na dose utilizada nesse trabalho mostra os seguintes critérios de 
especificidade: 1) essa droga não produz efeito na transmissão GABAérgica e 
promove, principalmente o bloqueio dos receptores NMDA (Guyenet e cols., 1987; 
Glaum e cols., 1992; Koshiya e cols., 1993; Sun, 1996); 2) A atividade simpática 
não é afetada quando ocorre a injeção de ácido quinurênico na região RVL 
(Guyenet e cols., 1987; Koshiya e cols., 1993); 3) O análogo estrutural inativo 
ácido xanturênico não produz nenhum efeito cardiovascular quando injetado na 
região CVL e RVL (Guyenet e cols., 1987; Koshiya e cols., 1993). 
 Sabe-se que mecanismos excitatórios partem de diferentes áreas 
encefálicas e são importantes para a manutenção da atividade basal dos 
neurônios do RVL (Ito e Sved, 1997; Sato e cols., 2003). Embora o bloqueio de 
receptores glutamatérgicos no RVL não produza efeitos significantes na pressão 
arterial e atividade simpática (Guyenet e cols., 1987; Ito e Sved, 1997; Horiuchi e 
cols., 2004), sabe-se que esse bloqueio reduz a pressão arterial após a inibição 
dos neurônios da região do CVL (Ito e Sved, 1997). Esses resultados sugerem 
que o aumento de pressão arterial produzido pela inibição do CVL é dependente 
da liberação de aminoácidos excitatórios (o L-glutamato seria o principal 
candidato) na região do RVL. De uma maneira similar, os presentes resultados 
sugerem que importantes projeções excitatórias (glutamatérgicas) para a região 
do RVL, para o controle de pressão arterial e resistência vascular, originam-se no 
NTS, confirmando os dados da literatura (Ito e Sved., 1997; Natarajan e Morrison, 
1998; Heesch e cols., 2006). 
A presença de mecanismos excitatórios no NTS foi sugerido em vários 
modelos experimentais. Esses mecanismos são sugeridos pela resposta pressora 
produzida pela injeção de L-glutamato no NTS de ratos acordados ou pelo efeito 
anti-hipertensivo da lesão eletrolítica no NTS (comissural) em ratos 
espontaneamente hipertensos (Machado e Bonagamba, 1992; Colombari e cols., 
1994; Sato e cols., 1999; 2003). A injeção de L-glutamato no NTS, em ratos 
anestesiados, produz resposta depressora, mas a mesma injeção no NTS, após o 
bloqueio da região do CVL, produz resposta pressora, sugerindo que a injeção de 
L-glutamato no NTS pode ativar mecanismos excitatórios, mesmo em animais 
anestesiados (Urbanski e Sapru, 1988b). 
Estudos anatômicos, imunohistoquímicos e eletrofisiológicos têm sugerido a 
existência de mecanismos excitatórios do NTS para o RVL e que estariam 
envolvidos na via do quimiorreflexo (Urbanski e Sapru, 1988a; 1988b; Koshiya e 
cols., 1993; Koshiya e Guyenet, 1996a; Moreira e cols., 2006). 
A injeção de ácido quinurênico no NTS bloqueia as respostas do 
quimiorreflexo em animais anestesiados (Zhang e Mifflin, 1993; Vardhan e cols., 
1993; Chitravanshi e cols., 1994; Chitravanshi e Sapru, 1995), mas é necessário 
considerar que o quimiorreflexo necessita de um estímulo próprio para ser ativado. 
Nos nossos experimentos, durante o bloqueio da região do CVL com muscimol, 
um mecanismo não relacionado ao quimiorreflexo parece ativar os mecanismos 
excitatórios no NTS, causando aumento da resistência vascular e pressão arterial.  
Dados da literatura mostram que a injeção de ácido quinurênico no RVL 
aboliu a resposta pressora produzida pela injeção de muscimol na região do CVL, 
indicando que projeções excitatórias para a região do RVL são originadas em 
outras regiões do SNC e não somente no NTS (Ito e Sved, 1997). Parece claro 
que, no nosso modelo experimental (inibição da região do CVL), a pressão arterial 
e a resistência vascular são dependentes de mecanismos glutamatérgicos no 
NTS. Por outro lado, a resposta pressora produzida pelo bloqueio glutamatérgico 
no NTS é abolido pela injeção de muscimol no CVL, sugerindo que mecanismos 
excitatórios existentes na região do CVL (bloqueados pelo muscimol) estão 
envolvidos na resposta pressora produzida pelo bloqueio glutamatérgico no NTS. 
Vale ressaltar nesses experimentos também que independente da sequência de 
bloqueios farmacológicos no NTS e CVL, nós observamos as mesmas respostas 
de queda de pressão e de resistência vascular para valores abaixo do basal. 
Diante de tudo que foi discutido chegamos a conclusão de que um 
mecanismo ainda não muito bem elucidado é como os neurônios 
simpatoexcitatórios da região do RVL são ativados para promover a manutenção 
da pressão arterial e da atividade simpática. Parece existir um balanço entre vias 
inibitórias e vias excitatórias. Além dos mecanismos inibitórios para o controle dos 
neurônios do RVL, mais recentemente, tem-se discutido a presença e a 
importância dos mecanismos excitatórios no controle da atividade dos neurônios 
do RVL. Os resultados discutidos nessa primeira parte da tese mostram a possível 
existência de vias excitatórias da região do NTS (região postremal e comissural) 
bem como da região do CVL para o controle dos neurônios simpatoexcitatórios da 
região do RVL. Para melhor elucidar essas possibilidades, diferentes metodologias 
de eletrofisiologia e técnicas anatômicas serão necessárias para comprovar a 
existência desses mecanismos. Uma outra questão em aberto é como essas vias 
excitatórias estariam funcionando numa situação fisiológica normal. Estariam 
também essas vias envolvidas nos reflexos barorreceptor e quimioreceptor? Por 
exemplo, qual seria a condição fisiológica em que estas vias glutamatergicas 
simpatoexcitatórias estariam funcionando? Uma situação importante seria como 
ocorre a ativação da atividade simpática durante ativação do quimiorreflexo 
periférico e/ou central? Existiria uma integração entre a ativação do quimiorreflexo 
central e periférico? Logo, uma série de perguntas surgiram durante a finalização 
dessa primeira parte. A partir disso, eu procurei responder parte delas durante a 
realização do meu estágio de doutorado sanduíche e que serão discutidos na 
segunda parte desta tese.  
Portanto, com os nossos experimentos, nós podemos concluir e sugerir que 
a resposta pressora produzida pelo bloqueio do mecanismo inibitório para o RVL é 
dependente de projeções excitatórias provenientes da região do CVL e do NTS 
(região postremal e comissural). Esses mecanismos excitatórios são importantes 
para manutenção da pressão arterial e resistência vascular, pois o bloqueio 
simultâneo dos dois mecanismos resulta em queda da pressão arterial e 
resistência vascular abaixo dos valores basais. O esquema a seguir procura 
elucidar os possíveis mecanismos envolvidos no circuito bulbar responsáveis pelo 
controle das variáveis cardiovasculares. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Os esquemas acima procuram mostrar as possíveis interconexões entre 
NTS, região CVL e a região RVL. Neurônios do NTS enviam projeções 
excitatórias para a região CVL e RVL. Os neurônios da região CVL (CVL inibitório, 
vermelho) enviam projeções para a região RVL, promovendo a principal fonte de 
inibição dos neurônios dessa área. Por outro lado, a região CVL pode conter 
neurônios excitatórios (CVL exitatório, verde), os quais enviariam projeções para 
a região RVL e auxiliam na manutenção das variáveis cardiovasculares.  
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Introdução  
O SNC possui mecanismos refinados de defesa contra elevados valores de 
dióxido de carbono (CO2) e alteraçõs nos níveis de pH. Esses mecanismos são, 
basicamente, os mecanismos de controle da respiração, que promovem um ajuste 
no níveis de CO2 para valores considerados fisiológicos (Feldman e cols., 2003). 
Há mais de 40 anos atrás, Mitchell e colaboradores propuseram uma hipótese de 
que os neurônios sensíveis a variações de CO2 e pH estariam localizados na 
superfície ventral do bulbo (Mitchell e cols 1963a, 1963b). Essa hipótese 
rapidamente transformou-se em livro texto para as áreas de saúde. Embora um 
grande número de estudos foram realizados no campo da quimiossensibilidade, o 
verdadeiro papel dos quimiorreceptores centrais ainda é motivo de muitas 
controvérsias (Guyenet e col., 2005b; Richerson e cols., 2005). Atualmente, sabe-
se que neurônios quimiossensíveis foram identificados em várias regiões do SNC, 
mas ainda a verdadeira contribuição dessas regiões no controle da respiração, em 
relação a variações nos valores de CO2, ainda não foi completamente esclarecida. 
Recentemente, o campo da neurobiologia respiratória também tem entrado em 
diversas discussões a respeito do principal local no SNC responsável pelo controle 
da quimiorrecepção.         
 
Quimiorreflexo central e periférico: possível interação bulbar das vias 
glutamatérgicas. 
Situações de hipercapnia (aumento nas concentrações de CO2) promovem um 
aumento na atividade simpática, mesmo em situações de remoção cirúrgica dos 
quimiorreceptores periféricos e dos barorreceptores (Millhorn, 1986; Moreira e 
cols., 2006). Isso sugere que os quimiorreceptores centrais seriam os 
responsáveis pelos efeitos excitatórios da hipercapnia (Millhorn, 1986; Oikawa et 
al., 2005). Em situações de anestesia, a ativação simpática promovida pelos 
quimiorreceptores centrais parece ser mediada em grande escala pelos neurônios 
bulboespinais do RVL, pois esses neurônios respondem a variações nas 
concentrações de CO2 com um aumento na modulação respiratória sobre a 
atividade simpática. Essas respostas são semelhantes às observadas nos nervos 
simpáticos lombar e esplâncnico (McAllen, 1987; Haselton and Guyenet, 1989, 
Moreira e cols., 2006) (Figura 1).  
Como já citado anteriormente, a maioria dos quimiorreceptores centrais estão 
localizados na superfíce ventral do bulbo (Loeschcke, 1982). Portanto, os 
quimiorreceptores 
centrais estão, 
provavelmente, 
expostos a níveis de 
CO2 semelhantes aos 
níveis de CO2 arterial e 
venoso (Loeschcke, 
1982; Kiley et al., 
1985). Alguns dos 
quimiorreceptores 
centrais foram 
recentemente 
caracterizados no 
núcleo retrotrapezóide 
(NRT), uma estrutura 
localizada na porção 
rostral da coluna 
respiratória e embaixo 
da porção caudal do 
núcleo facial (Mulkey et 
al., 2004), (Figura 2).  
A 
quimiossensibilidade 
dessa região parece 
ser mediada pela 
expressão de canais de 
potássio sensíveis a variações de pH, que se fecham durante a acidificação dessa 
região, promovendo excitação celular e disparo de potenciais de ação. Sabe-se 
também que os neurônios quimiossensíveis do NRT são glutamatérgicos, são 
modulados pela respiração em altas concentrações de CO2 e projetam-se para a 
região ventrolateral do bulbo, incluindo a região do RVL (Mulkey et al., 2004).  
O mecanismo neural que os quimiorreceptores centrais fazem parte são de 
extrema importância, pois eles são responsáveis pelo controle químico da 
respiração (Feldman e cols., 2003; Feldman e Del Negro, 2006). Esses receptores 
conseguem detectar alterações na pressão parcial de CO2 do fluido extracelular, 
via mudanças no pH (Feldman e cols., 2003; Nattie, 2006). Sabe-se, também, que 
os quimiorreceptores periféricos, localizados no corpúsculo carotídeo, também 
auxiliam na manutenção dos 
níveis de CO2 (Scheid e cols., 
2001; Feldman e cols., 2003; 
Richerson, 2004; Putnam e 
cols., 2004; Prabhakar e 
Peng, 2004; Bin-Jaliah e cols., 
2004). A integração entre os 
quimiorreceptores centrais e 
periféricos ainda não está 
muito bem esclarecida, 
exceto por se saber que essa 
integração ocorre, 
praticamente, na região 
pontina e bulbar (Feldman e 
cols., 2003). 
Como já descrito 
anteriormente, a teoria mais aceita é que os quimiorreceptores centrais são 
sensíveis a alterações de pH (Loeschcke, 1982; Putnam e cols., 2004; Richerson 
e cols., 2005; Guyenet e cols., 2005b). A proporção de neurônios bulbares, in vitro, 
sensíveis a alterações de pH varia de 15% até mais de 90% dependendo da 
região estudada, da preparação experimental e dos critérios utilizados para se 
definir quimiossensibilidade (Dean e cols., 1989; Kawai e cols., 1996; Richerson, 
2004; Mulkey e cols., 2004; Ritucci e cols., 2005). Logo, pode-se concluir que os 
quimiorreceptores centrais são essenciais para o sistema respiratório (Nattie, 
2001; Feldman e cols., 2003; Nattie, 2006). 
O NRT contém características que definem essa região como sendo uma 
região, classicamente, quimiossensível (Smith e cols., 1989; Ellenberger e 
Feldman, 1990; Nattie e cols., 2001; Cream e cols., 2002; Mulkey e cols., 2004; 
Ritucci e cols., 2005; Guyenet e cols., 2005a; Takakura e cols., 2006). Os 
neurônios do NRT respondem a variações de CO2 mesmo na ausência dos 
quimiorreceptores periféricos, são classificados como células excitatórias 
(glutamatérgicas) e projetam-se para centros respiratórios (Mulkey e cols., 2004; 
Ritucci e cols., 2005; Guyenet e cols., 2005a). As respostas dos neurônios do NRT 
para as variações de CO2 são muito maiores do que as células vizinhas a essa 
região, como por exemplo os núcleos da rafe (Mulkey e cols., 2004; Ritucci e cols., 
2005; Guyenet e cols., 2005a).  
Os quimiorreceptores periféricos 
detectam principalmente situações de redução 
da pressão parcial de O2 (hipóxia). Eles também 
detectam alterações na pressão parcial de CO2 
ainda mais rápido do que os quimiorreceptores 
centrais (Nattie, 2006; Smith e cols., 2006). A 
estimulação dos quimiorreceptores periféricos 
produz bradicardia e 
ativação do sistema 
nervoso simpático 
(Paton e cols, 2001; 
Braga e cols., 2006; 
Moreira e cols., 2006). 
A presença da resposta vagal (bradicardia) indica que os neurônios 
cardiovagais são ativados pelo quimiorreceptores periféricos (Figura 3). Durante a 
ativação desse mecanismo, assume-se que tenha uma arritmia respiratória 
(aumento da inibição dos neurônios pré-ganglionares durante inspiração). Esse  
mecanismo pode não ser responsável pela hipóxia induzindo bradicardia, pois a 
estimulação dos quimiorreceptores periféricos aumentam a atividade inspiratória, 
que por sua vez inibiria os neurônios cardio-vagais, causando uma taquicardia, 
mas não uma bradicardia. Portanto, o mecanismo que os quimiorreceptores 
periféricos produzem bradicardia permanece ainda desconhecido.  
 A ativação simpática produzida pela estimulação dos quimiorreceptores 
periféricos ocorre em sincronia com a atividade do nervo frênico (Figura 4). Como 
e por que os quimiorreceptores periféricos produzem um aumento da atividade 
simpática? Seria a explicação clássica (via neural dos quimiorreceptores 
periféricos: NTS – RVL) ou então seria por causa da sua modulação respiratória. 
Em várias espécies, o padrão respiratório da atividade simpática, produzido pela 
ativação dos quimiorreceptores periféricos, parece ser praticamente o mesmo 
padrão observado quando se tem a ativação dos quimiorreceptores centrais e, 
possivelmente, envolveria os mesmos 
mecanismos neurais já conhecidos 
(Figura 4) (Sun, 1995).  
Sabe-se que os neurônios bulbo-
espinais do RVL não são ativados pelos 
quimiorreceptores periféricos após o 
bloqueio dos receptores glutamatérgicos 
da região do RVL (Sun e Reis, 1995), 
mas uma grande ativação persiste após a 
inibição da região do CVL, embora a 
ativação não ocorra mais em sincronia 
com a respiração (Koshiya e Guyente, 
1996b; Guyenet, 2000). 
Logo, essa evidência 
sugere que durante a 
ativação dos 
quimiorreceptores periféricos, a modulação respiratória dos neurônios do RVL seja 
mediada via região do CVL (Figura 4). Esse processo não é responsável pelo 
aumento total da atividade simpática que, provavelmente, é devido a uma via 
excitatória do NTS para a região do RVL (Figura 4). A via entre os 
quimiorreceptores periféricos e RVL envolve uma sinapse glutamatérgica 
localizada no NTScom (Koshiya e Guyenet, 1996a; Sun e Reis, 1995; Takakura e 
cols., 2006). Os neurônios do NTScom projetam-se diretamente para a região do 
RVL via uma projeção excitatória (Colombari e cols., 1996; Koshiya e Guyenet, 
1996a; Blessing, 1997; Paton, 1999). Possivelmente, interneurônios, localizados 
na região do NRT, podem fazer parte desse circuito (Takakura e cols., 2006; Rosin 
e cols., 2006) (Figura 4). 
A atividade simpática é ativada pela estimulação tanto dos 
quimiorreceptores centrais como periféricos (Koshiya e cols., 1993; Koshiya e 
Guyente, 1996a; 1996b; Guyenet, 2006; Moreira e cols., 2006). O modo pelo qual 
os quimiorreceptores centrais ativam a respiração e a atividade simpática ainda 
não está muito bem esclarecido, principalmente em termos celulares e 
moleculares. Entretanto, o que se sabe é que esse mecanismo envolve a ativação 
de uma rede de neurônios na região bulbar (Guyenet, 2000). Há uma teoria que 
defende a idéia de que a quimiorrecepção central parece estar amplamente 
distribuída no SNC, em especial no bulbo e ponte, resultando num efeito 
cumulativo do pH em vários neurônios (Feldman e cols., 2003; Richerson, 2004; 
Nattie, 2001; 2006; Nattie e Li, 2006). A existência de uma rede neuronal 
distribuída no SNC é sugerida por evidências in vivo, mostrando que a acidificação 
de várias partes do bulbo, incluindo o NTS, a coluna respiratória ventral, o NRT e 
os núcleos da rafe aumentam os padrões de atividade respiratória (Nattie, 2001; 
Richerson, 2004; Mulkey e cols., 2004; Mandel e Schreihofer, 2006). Em 
contrapartida, existe uma outra visão sobre os quimiorreceptores centrais, 
mostrando que, ao contrário da ampla distribuição dessas células no bulbo, um 
conjunto de neurônios localizados no NRT, ou NTS ou na rafe parece mediar os 
efeitos do pH no controle cardio-respiratório (Guyenet e cols., 2005a; 2005b; Li e 
Nattie, 2002; Richerson e cols., 2005; Takakura e cols., 2006).  
O fato de os quimiorreceptores centrais estarem localizados em várias 
partes do bulbo, com diferentes graus de sensibilidade, aumentam as 
possibilidades de que vários componentes do sistema nervoso simpático possam 
estar envolvidos na quimiorrecepção. A idéia clássica de que uma situação de 
hipercapnia promove um aumento da atividade simpática via quimiorreceptores 
localizados exclusivamente nos neurônios respiratórios não foi ainda demonstrada 
experimentalmente. A região do locus coeruleus é, visivelmente, sensível ao pH in 
vitro e in vivo (Pineda e Aghajanian, 1997). A literatura também mostra que os 
neurônios do RVL podem ser ativados por acidificação ou, ainda, que o CO2 
ativaria os neurônios do RVL via neurônios sensíveis ao pH, mas que 
tecnicamente não fazem parte da rede respiratória (Haselton e Guyenet, 1989; 
Moreira e cols., 2006).  
 Como já citado anteriormente, na ausência das aferências dos 
quimiorreceptores periféricos, uma situação de hipercapnia promove o aumento da 
atividade simpática para coração e vasos sanguíneos (Hanna e cols., 1988). O 
efeito do CO2 é normalmente atribuído a uma sequência de eventos. A 
acidificação do fluido extracelular promove a estimulação dos quimiorreceptores 
centrais; esses receptores ativam os neurônios que controlam o padrão 
respiratório que, por sua vez, enviam informações para os neurônios 
simpatoexcitatórios do RVL (Millhorn e Eldrige, 1986; Richter e Spyer, 1990; 
Moreira e cols., 2006). Essa teoria está fundamentada na evidência de que a 
ativação simpática promovida pelos quimiorreceptores centrais ocorre em 
sincronia com o ciclo respiratório (Millhorn, 1986; Millhorn e Eldrige, 1986; 
Guyenet e cols., 1990; Moreira e cols., 2006). Lesões químicas ou eletrolíticas na 
superfíce ventral do bulbo promove uma atenuação da atividade do nervo frênico e 
também na modulação respiratória na atividade simpática (Hanna e cols., 1979; 
Millhorn, 1986; Millhorn e Eldrige, 1986). Durante a estimulação dos 
quimiorreceptores periféricos, os neurônios simpatoexcitatórios do RVL exibem um 
padrão de atividade respiratória central. Essa atividade é similar aos neurônios 
pré-ganglionares simpáticos (McAllen, 1987; Haselton e Guyenet, 1989; Darnall e 
Guyenet, 1990; Guyenet e cols., 1990; Miyawaki e cols., 1995) (Figura 1).  
Sabe-se que a região pontina e bulbar contêm múltiplas regiões 
quimiossensíveis, como já descrito anteriormente (Nattie e Li, 1996; Feldman e 
cols.,  2003; Hodges e cols., 2004; Mulkey e cosl., 2004; Putnam e cols., 2004; 
Richerson e cols., 2005; Pineda e Aghajanian, 1997). A observação de que os 
neurônios simpatoexcitatórios do RVL são ritmicamente modulados pela 
respiração é insuficiente para concluir que esses neurônios promovem um 
aumento na atividade simpática durante a estimulação dos quimiorreceptores 
centrais. O fato de a atividade simpática e os neurônios simpatoexcitatórios do 
RVL serem ativados em sincronia com a respiração, durante a estimulação dos 
quimiorreceptores centrais, não se justifica que essa sincronia seja resultante de 
uma via excitatória para os neurônios do RVL.  
 Portanto, um dos objetivos da segunda parte dessa tese é tentar provar 
uma série de dúvidas existentes sobre o principal mecanismo pelo qual os 
quimiorreceptores centrais promovem um aumento na atividade simpática. Como 
se comportariam os neurônios simpatoexcitatórios do RVL durante a ativação dos 
quimiorreceptores centrais (aumento das concentrações de CO2: 5% até 10%) e 
se essa ativação envolve a participação de sinapses e vias glutamatérgicas. Um 
outro objetivo dessa tese será tentar esclarecer uma possível integração entre os 
quimiorreceptores periféricos e centrais. Nossa hipótese é que essa integração 
ocorra na região ventrolateral do bulbo, em especial no NRT e envolva a 
participação de vias excitatórias glutamatérgicas, uma vez que o NRT é um 
importante centro cardio-respiratório. Para a realização desses protocolos, 
procuramos abordar técnicas de eletrofisiologia e marcações neuronais.  
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Peripheral chemoreceptor inputs to retrotrapezoid nucleus
(RTN) CO2-sensitive neurons in rats
Ana Carolina Thomaz Takakura1,2, Thiago Santos Moreira1,2, Eduardo Colombari2, Gavin H. West1,
Ruth L. Stornetta1 and Patrice G. Guyenet1
1Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA
2Department of Physiology, UNIFESP-EPM, Sa˜o Paulo, SP, 04023-060, Brazil
The rat retrotrapezoid nucleus (RTN) contains pH-sensitive neurons that are putative central
chemoreceptors. Here, we examined whether these neurons respond to peripheral chemo-
receptor stimulation and whether the input is direct from the solitary tract nucleus (NTS)
or indirect via the respiratory network. A dense neuronal projection from commissural
NTS (commNTS) to RTN was revealed using the anterograde tracer biotinylated dextran
amine (BDA). Within RTN, 51% of BDA-labelled axonal varicosities contained detectable
levels of vesicular glutamate transporter-2 (VGLUT2) but only 5% contained glutamic acid
decarboxylase-67 (GAD67). Awake rats were exposed to hypoxia (n = 6) or normoxia (n = 5)
1 week after injection of the retrograde tracer cholera toxin B (CTB) into RTN. Hypoxia-activated
neurons were identified by the presence of Fos-immunoreactive nuclei. CommNTS neurons
immunoreactive for both Fos and CTB were found only in hypoxia-treated rats. VGLUT2 mRNA
was detected in 92 ± 13% of these neurons whereas only 12 ± 9% contained GAD67 mRNA.
In urethane–chloralose-anaesthetized rats, bilateral inhibition of the RTN with muscimol
eliminated the phrenic nerve discharge (PND) at rest, during hyperoxic hypercapnia (10% CO2),
and during peripheral chemoreceptor stimulation (hypoxia and/or I.V. sodium cyanide, NaCN).
RTN CO2-activated neurons were recorded extracellularly in anaesthetized intact or vagotomized
rats. These neurons were strongly activated by hypoxia (10–15% O2; 30 s) or by NaCN. Hypoxia
and NaCN were ineffective in rats with carotid chemoreceptor denervation. Bilateral injection
of muscimol into the ventral respiratory column 1.5 mm caudal to RTN eliminated PND and the
respiratory modulation of RTN neurons. Muscimol did not change the threshold and sensitivity
of RTN neurons to hyperoxic hypercapnia nor their activation by peripheral chemoreceptor
stimulation. In conclusion, RTN neurons respond to brain PCO2 presumably via their intrinsic
chemosensitivity and to carotid chemoreceptor activation via a direct glutamatergic pathway
from commNTS that bypasses the respiratory network. RTN neurons probably contribute a
portion of the chemical drive to breathe.
(Received 16 December 2005; accepted after revision 31 January 2006; first published online 2 February 2006)
Corresponding author P. G. Guyenet: Department of Pharmacology, University of Virginia Health System, PO Box
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The chemical drive to breathe relies on central chemo-
receptors that detect brain extracellular fluid PCO2 via
pH, and on carotid body chemoreceptors that respond
to arterial PCO2 in a PO2 - and glucose-dependent manner
(Scheid et al. 2001; Feldman et al. 2003; Richerson, 2004;
Putnam et al. 2004; Prabhakar & Peng, 2004; Bin-Jaliah
et al. 2004). The way in which central and peripheral
chemoreceptor information is integrated at the cellular
A. C. T. Takakura and T. S. Moreira contributed equally to this study.
and network levels is unclear except for the fact that
the process occurs within the pontomedullary region
(Feldman et al. 2003). The question is made even more
complex by current uncertainties regarding the very nature
of central chemoreceptors.
Although substances released from glia or non-neuronal
cells have repeatedly been invoked to account for the
sensitivity of brainstem neurons to extracellular fluid PCO2
(Erlichman et al. 1998; Gourine et al. 2005; Guyenet
et al. 2005b), the dominant theory is that neuronal pH-
sensitive conductances underlie central chemoreception
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(Loeschcke, 1982; Putnam et al. 2004; Richerson
et al. 2005; Guyenet et al. 2005b). The proportion of
brainstem neurons that respond to pH or PCO2 in vitro
varies from 15% to more than 90% depending on the brain
region, the preparation and the criteria that is applied
to define the cells as chemosensitive (Dean et al. 1989;
Kawai et al. 1996; Richerson et al. 2001; Mulkey et al.
2004; Ritucci et al. 2005). In light of this evidence, central
chemosensitivity could be viewed as an emergent property
of the respiratory network that cannot be assigned to
any particular component of the system. Yet, other
evidence suggests that central chemoreception does rely
on specialized neurons that drive a respiratory motor
pattern generator that has no or inadequate sensitivity
to pH on its own (Nattie, 2001; Feldman et al. 2003).
Congenital central hypoventilation syndrome, a disease in
which patients have absent or greatly diminished central
hypercapnic ventilatory chemosensitivity, argues in favour
of the existence of central neurons specialized for chemo-
reception (Spengler et al. 2001; Gaultier & Gallego, 2005).
The highly differentiated responsiveness of brainstem
neurons to hypercapnia in vivo provides further evidence
(Guyenet et al. 2005b).
The retrotrapezoid nucleus (RTN) contains very
superficial propriobulbar neurons that have properties
consistent with such specialized chemoreceptors (Smith
et al. 1989; Ellenberger & Feldman, 1990; Nattie et al.
1991; Cream et al. 2002; Mulkey et al. 2004; Ritucci et al.
2005; Guyenet et al. 2005a). Their response to PCO2 is far
greater than that of surrounding cells, in vivo and in slices
(Mulkey et al. 2004; Ritucci et al. 2005; Guyenet et al.
2005a). These CO2-responsive cells are glutamatergic and
have axonal projections that are anatomically appropriate
to be driving the respiratory network (Mulkey et al.
2004).
The present study is designed to test whether RTN
is an important site of integration between central and
peripheral chemoreception. Our working hypothesis is
that the intrinsic response of RTN neurons to pH is
enhanced by excitatory inputs from peripheral chemo-
receptors and that the resulting activity of these neurons
could be encoding some of the chemical drive to
breathe.
The results demonstrate that RTN neurons receive
a strong excitatory input from carotid chemoreceptor
afferents that bypasses the respiratory network and
probably involves a single intervening glutamatergic
neuron located in the nucleus of the solitary tract (NTS).
Based on this and prior evidence, we conclude that
RTN neurons have the capability of detecting brain PCO2
directly and that they also respond to arterial blood
gas composition via very direct neural inputs from
peripheral chemoreceptors. RTN neurons could therefore
be a source of integrated chemical drive to some aspect of
the respiratory circuitry.
Methods
Animals
The experiments were performed on a total of 64
male Sprague-Dawley rats (Taconic; Germantown, NY,
USA) weighing 250–350 g. Fifty rats were used in
electrophysiological experiments, the rest for anatomy.
Procedures were in accordance with NIH Animal Care and
Use Guidelines and were approved by the University of
Virginia’s Animal Care and Use Committee.
Surgery and anaesthesia
General anaesthesia was induced with 5% halothane in
100% oxygen. The rats received a tracheostomy and
artificial ventilation with 1.4–1.5% halothane in 100%
oxygen was maintained throughout surgery. All rats
were subjected to the following previously described
surgical procedures: femoral artery cannulation for arterial
pressure (AP) measurement, bladder cannulation to ease
urination, femoral vein cannulation for administration of
fluids and drugs, removal of the occipital plate to insert a
recording electrode into the medulla oblongata via a dorsal
transcerebellar approach, and skin incision over the lower
jaw for placement of a bipolar stimulating electrode next
to the mandibular branch of the facial nerve (Guyenet et al.
2005a). The phrenic nerve was accessed by a dorsolateral
approach after retraction of the right shoulder blade. A
bilateral vagotomy in the neck was performed in 11 rats. Six
intact rats were additionally subjected to bilateral carotid
body denervation.
Upon completion of surgical procedures, halothane
was replaced by a mixture of urethane (0.5 g kg−1) and
α-chloralose (60 mg kg−1) slowly administered i.v. All
rats were ventilated with 100% oxygen throughout the
experiment except during the hypoxia protocols. The O2
concentration of the breathing mixture was monitored
with a PO2 -sensitive electrode located at the intake of
the ventilator. Rectal temperature (maintained at 37◦C)
and end-tidal CO2 were monitored throughout the
experiment with a capnometer (Columbus Instruments,
Ohio, USA) that was calibrated twice per experiment
against a calibrated CO2–N2 mix. This instrument
provided a reading of < 0.1% CO2 during inspiration
in animals breathing 100% oxygen and an asymptotic,
nearly horizontal reading during expiration. We previously
showed that the capnometer readings closely approximate
arterial PCO2 (Guyenet et al. 2005a). After injection of
the intravenous anaesthetic mixture, the adequacy of
anaesthesia was monitored during a 20 min stabilization
period by testing for absence of withdrawal response, lack
of BP change and lack of change in PND rate or amplitude
to firm toe pinch. After these criteria were satisfied,
the muscle relaxant pancuronium was administered at
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the initial dose of 1 mg kg−1 i.v. and the adequacy of
anaesthesia was thereafter gauged solely by the lack of
increase in BP and PND rate or amplitude to firm toe
pinch. Approximately hourly supplements of one-third
of the initial dose of chloralose–urethane were needed to
satisfy these criteria during the course of the recording
period (3–4 h).
In vivo recordings of physiological variables
and neuronal activity
Arterial pressure (AP), the mass discharge of the phrenic
nerve (PND), tracheal CO2 and single units were recorded
as previously described (Guyenet et al. 2005a). Before
searching for RTN neurons, ventilation was adjusted
to lower end-expiratory CO2 to 4% at steady-state
(60–80 cycles s−1; tidal volume 1.2–1.4 ml (100 g)−1).
These conditions were selected because 4% end-expiratory
CO2 was below the firing threshold of both RTN units
and the PND. Variable amounts of pure CO2 were then
added to the breathing mixture to adjust end-expiratory
CO2 to the desired level. When searching for RTN units,
end-expiratory CO2 was set at 6.5–7% in order to insure
that both PND and the CO2-sensitive neurons of RTN
were active. RTN neurons were recorded exclusively under
the caudal end of the facial motor nucleus in a region
that matches the prior definition of RTN in rats (Cream
et al. 2002; Weston et al. 2004; Guyenet et al. 2005a).
As in prior work, the caudal and ventral boundaries of
the facial motor nucleus were identified in each rat by
the large (up to 5 mV) negative antidromic field potential
generated in the facial motor nucleus by stimulating the
mandibular branch of the facial nerve (for details see
Brown & Guyenet, 1985). RTN CO2-activated neurons
were encountered between 200 and 350 μm below the
lower edge of the facial motor nucleus, 1.6–1.9 mm lateral
to the midline and from 100 μm caudal to 400 μm rostral
to the caudal end of the facial field potential (Mulkey et al.
2004; Guyenet et al. 2005a). Prior single neuron labelling
experiments have indicated that this region lies between
coronal planes Bregma −11.7 and Bregma −11.2 mm of
the Paxinos and Watson atlas (Paxinos & Watson, 1998;
Mulkey et al. 2004; Guyenet et al. 2005a). Most recordings
were made on the left side of the brain. The RTN also
contains presympathetic barosensitive neurons located
on average dorso-medial to the CO2-sensitive neurons
(Mulkey et al. 2004). These neurons cannot be silenced by
hypocapnia and their discharge rate increases by at most
80% between 4 and 10% end-expiratory CO2. These cells
were ignored in the present study.
All analog data (end-expiratory CO2, PND, unit
activity, AP) were stored on a microcomputer via
a micro1401 digitizer from Cambridge Electronics
Design (CED, Cambridge, UK) and were processed
off-line using version 5 of the Spike 2 software (CED).
Processing included action potential discrimination and
binning, neuronal discharge rate measurement, and
PND ‘integration’ (iPND) consisting of rectification
and smoothing (τ , 0.015 s). Neural minute × volume
(mvPND, a measure of the total phrenic nerve discharge
per unit of time) was determined by averaging iPND over
50 s (vagotomized rats) or during 20 respiratory cycles
(rats with intact vagus nerves) and normalizing the result
by assigning a value of 0 to the dependent variable recorded
at low levels of end-expiratory CO2 (below threshold)
and a value of 1 at the highest level of PCO2 investigated
(between 9.5 and 10%). The CED software was also
used for acquisition of peri-event histograms of neuronal
activity and peri-event averages of iPND or tracheal CO2.
The peri-event histograms of neuronal single-unit activity
were triggered either on iPND or on the tracheal CO2 trace
and represented the summation of at least 100 respiratory
cycles (350–800 action potentials per histogram).
The steady-state relationship between RTN neuronal
activity and end-expiratory CO2 was obtained by stepping
the inspired CO2 level to various values for a minimum
of 3 min and up to 5 min. The mean discharge rate of
the neuron was measured during the last 30 s of each
step at which time end-expiratory CO2 and the discharge
of the neuron appeared to have reached equilibrium.
End-expiratory CO2 was measured by averaging the
maximum values recorded from 10 consecutive breaths
at the midpoint of the time interval sampled.
Stimulation of carotid chemoreceptor was done with
bolus injections of NaCN (50 μg kg−1, i.v.) or by switching
the breathing mixture from 100% O2 to 10–15% O2
balanced with N2 for 30 s using an electronic valve.
Evidence that the hypoxic stimulus activated neurons
via stimulation of carotid chemoreceptors was obtained
by demonstrating that denervation of these receptors
eliminated the excitatory effect of the hypoxic stimulus on
PND and the activity of hypoxia-responsive RTN neurons.
Intraparenchymal injections
Muscimol (Sigma Chemicals Co.; 1.75 mm in sterile
saline pH 7.4) was pressure injected (30 nl in 5 s)
bilaterally through single-barrelled glass pipettes (20 μm
tip diameter). The muscimol solution contained a 5%
dilution of fluorescent latex microbeads (Lumafluor, New
City, NY, USA) for later histological identification of the
injection sites (Guyenet et al. 1990). These glass pipettes
also allowed recordings of field potentials and multiunit
brain activity, properties that were used to direct the
electrode tip to the desired sites. Injections into RTN
were thus guided by recording the facial field potential
and were placed 200 μm below the lower edge of the
field, 1.6–1.9 mm lateral to the midline and 200–300 μm
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rostral to the caudal end of the field. Injections into
the midline raphe were done bilaterally 300 μm lateral
to the midline at the same coronal level and depth
as RTN. Injections into the rostral ventral respiratory
group (rVRG) were guided by locating inspiratory-related
multiunit activity. The target region was found 400 μm
rostral to the calamus scriptorius, 1.8 mm lateral to
midline and 1.9–2.2 mm below the dorsal surface of
the brainstem using electrodes angled 20 deg forward.
The electrophysiological recordings were made on one side
only and the second injection was placed 1–2 min later
in the symmetric brain location based on the stereotaxic
coordinates of the first one. The classification of respiratory
neurons was based on the timing of their discharge in
relation to that of the phrenic nerve using accepted
nomenclature (Feldman & McCrimmon, 1999).
Tracer injections
Tracer injections were made while the rats were
anaesthetized with a mixture of ketamine (75 mg kg−1),
xylazine (5 mg kg−1), and acepromazine (1 mg kg−1)
administered i.m. Surgery used standard aseptic methods,
and after surgery, the rats were treated with the
antibiotic ampicillin (100 mg kg−1) and the analgesic
ketorolac (0.6 mg kg−1, s.c.).
A group of seven rats received iontophoretic injections
of the anterograde tracer biotinylated dextran amine
(BDA-lysine fixable, MW 10000; 10% w/v in 10 mm
phosphate buffer, pH 7.4; Molecular Probes) into the
commissural part of the nucleus of the solitary tract
(commNTS) (20 μm tip diameter glass pipettes; 2 μA
positive current pulses, 5 s duration every 10 s for 10 min).
These injections were made 0.4 mm caudal to the calamus
scriptorius, in the midline and 0.3–0.5 mm below the
dorsal surface of the brainstem. These rats were allowed to
survive 7–10 days following which they were anaesthetized
with pentobarbital (60 mg kg−1, i.p.) and perfused
transcardially with fixative as described below.
Another group of 11 rats received an iontophoretic
injection of cholera toxin B (1% CTB in 0.2 m phosphate
buffer, pH 7.35; List Biological Laboratories, Campbell,
CA, USA; 20 μm tip diameter glass pipettes; 2 μA positive
current pulses, 5 s duration every 10 s for 10 min) into the
left RTN in order to retrogradely label commNTS neurons
that innervate RTN. These injections were made below the
facial motor nucleus under electrophysiological guidance
as described above (200 μm below the ventral boundary
of the facial nucleus, 1.6–2.0 mm lateral to the midline,
between Bregma −11.6 and −11.2 mm). Seven to ten days
following the CTB deposits, six of the rats were exposed for
3 h to a hypoxic breathing mixture (8% O2, balanced with
N2) in a small flow-through environmental chamber. The
rest of the rats were exposed to room air under the same
conditions. Except in one case, the experiments were run
in pairs consisting of one rat exposed to hypoxia and the
other to normoxia. The pair of animals were anaesthetized
with pentobarbital and perfusion fixed immediately after
the 3 h of exposure to hypoxia or normoxia.
Histology
The rats were deeply anaesthetized with 60 mg kg−1
pentobarbital i.p. then injected with heparin (500 units,
intracardially) and finally perfused through the ascending
aorta with 150 ml of phosphate-buffered saline (pH 7.4)
followed by 4% phosphate-buffered (0.1 m; pH 7.4)
paraformaldehyde (Electron Microscopy Sciences, Fort
Washington, PA, USA). The brain was removed and
stored in the perfusion fixative for 24–48 h at 4◦C. Series
of coronal sections (30 μm) from the brain were cut
using a vibrating microtome and stored in cryoprotectant
solution (20% glycerol plus 30% ethylene glycol in 50 mm
phosphate buffer, pH 7.4) at −20◦C for up to 2 weeks
awaiting histological processing.
All histochemical procedures were done using
free-floating sections according to previously described
protocols. BDA was detected using either streptavidin-Cy3
(1 : 200; 60 min; Jackson ImmunoResearch Laboratories,
West Grove, PA, USA) or avidin–Alexa 488 (1 : 200;
60 min; Molecular Probes) (Stocker et al. 2006). Vesicular
glutamate transporter 2 (VGLUT2) and glutamic acid
decarboxylase 67 (GAD67) were detected by immuno-
fluorescence using a guinea-pig anti-VGLUT2 antibody
(AB 5907; Chemicon International, Temecula, CA, USA;
dilution 1 : 2500 dilution) or a rabbit anti-GAD67
antibody (AB5992; Chemicon International; 1 : 2500
dilution; 24–48 h incubation in Tris-buffered saline with
10% horse serum and 0.1% Triton X-100) (Stocker
et al. 2006). The VGLUT2 antibody was revealed
with Alexa-488-tagged goat anti-guinea-pig IgG (1 : 200,
Molecular Probes; 60 min). The GAD67 antibody was
revealed with Alexa 488-tagged goat anti-rabbit IgG
(1 : 200, Molecular Probes; 60 min).
Fos immunoreactivity was detected using a rabbit
anti-c-Fos antibody (sc-52, Santa Cruz Biotechnology,
Santa Cruz, CA, USA; 1 : 1500) followed by a
Cy-3-conjugated goat anti-rabbit IgG (Jackson; 1 : 200).
CTB was detected with a goat anti-CTB antibody (List
Biological Laboratories, Campbell, CA, USA; 1 : 2000)
followed by Alexa 488-conjugated donkey anti-goat IgG
(Molecular Probes; 1 : 250).
GAD67 mRNA was detected using a 3.2 kb
digoxigenin-labelled cRNA probe exactly as previously
described (Stornetta & Guyenet, 1999). VGLUT2 mRNA
was detected using a 3.4 kb probe, also according
to previously described methods (Stornetta et al.
2003a). Digoxigenin was revealed with a sheep
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polyclonal anti-digoxigenin antibody conjugated to
alkaline phosphatase (Roche Molecular Biochemicals,
Indianapolis, IN, USA) and alkaline phosphatase
was reacted with nitro-blue tetrazolium (NBT) and
5-bromo-4-chloro-3-indolyl-phosphate, 4-toluidine salt
(BCIP). Previous testing has established the specificity of
our probes (Stornetta et al. 2002). Absence of labelling
in facial, hypoglossal and nucleus ambiguus motor
neurons was taken as the quality standard since these cells
are the most prone to exhibit non-specific NBT/BCIP
reaction product under suboptimal conditions. Probe
hybridization was always carried out before any
immunohistochemistry, i.e. before detection of Fos
immunoreactivity and or CTB. Following hybridization,
all primary antibodies were applied, then the alkaline
phosphatase colourimetric reaction was performed
and, finally, fluorescent secondary antibodies were
applied. Finally, the sections were mounted in sequential
rostrocaudal order onto slides, dried and covered with
Vectashield (Vector Laboratories, Burlingame, CA, USA).
Coverslips were affixed with nail polish.
Antibody specificity
No labelling was observed when the primary antibodies
were omitted. The VGLUT2 antibody was raised against
a peptide which, when preincubated with the primary
antibody, eliminated immunoreactivity (Stocker et al.
2006). This antibody labelled terminals only. The GAD67
antibody also labelled nerve terminals exclusively. The
antigen used to raise this antibody was derived from a
cloned feline DNA expressed in E. coli and has been
characterized previously (Kaufman et al. 1991). The
anti-digoxigenin antibody produced no reaction product
in the absence of digoxigenin-labelled RNA probes.
Riboprobe immunolabelling was confined to neuronal cell
bodies exclusive of nuclei.
Cell mapping, cell counting and imaging
A conventional multifunction microscope (brightfield,
darkfield and epifluorescence) was used for all
observations except when indicated. The computer-
assisted mapping technique made use of a motor-driven
microscope stage controlled by the Neurolucida software
and has been described in detail previously (Stornetta &
Guyenet, 1999). The Neurolucida files were exported to
NeuroExplorer software (MicroBrightfield, Colchester,
VT, USA) to count the various types of neuronal profiles
within a defined area of the reticular formation.
Section alignment between brains was done relative to
a reference section. To align sections around RTN level,
the most caudal section containing an identifiable cluster
of facial motor neurons was identified in each brain and
assigned the level 11.6 mm caudal to Bregma (Bregma
−11.6 mm) according to the atlas of Paxinos & Watson
(1998). Levels rostral or caudal to this reference section
were determined by adding a distance corresponding to
the interval between sections multiplied by the number
of intervening sections. The same method was also used
to identify the Bregma level of the muscimol injections
targeted to the rVRG. When the object of the experiment
was to locate neurons or injection sites at commissural
NTS level, the reference section used to align all others
was the one closest to mid-area postrema level (Bregma
−13.8 mm).
To count the number of BDA-labelled varicosities
located in RTN following tracer injection into commNTS,
a 200 μm-wide rectangle extending from the medial edge
of the trigeminal tract to the lateral edge of the pyramidal
tract was placed tangentially to the ventral medullary
surface. BDA-labelled axonal varicosities were counted
within this rectangle at four levels of the RTN.
The Neurolucida files were exported to the Canvas 9
software drawing program for final modifications.
Photographs were taken with a 12-bit colour CCD camera
(CoolSnap, Roper Scientific, Tuscon, AZ, USA; resolution
1392 pixels × 1042 pixels).
An Olympus IX81 DSU spinning disk confocal
microscope (Olympus America, Inc., Melville, NY,
USA) was used to test for colocalization of BDA and
either VGLUT2 or GAD67 immunoreactivity in axonal
varicosities located in the RTN region. Images were
captured with a SensiCam QE 12-bit CCD camera
(resolution 1376 pixels × 1040 pixels, Cooke Corp.,
Auburn Hills, MI, USA). IPLab software (Scanalytics,
Rockville, MD, USA) was used for merging of colour
channels in photographs of dual labelling experiments.
The neuroanatomical nomenclature is after Paxinos &
Watson (1998).
Statistics
Statistical analysis was done with Sigma Stat version 3.0
(Jandel Corporation, Point Richmond, CA, USA). Data
are reported as means ± standard error of the mean. A
t test, (paired or unpaired) and one- or two-way
parametric ANOVA followed by the Newman-Keul
multiple comparisons test were used as appropriate.
Significance was set at P < 0.05.
Results
Hypoxia activates commNTS glutamatergic neurons
that innervate RTN
Carotid chemoreceptor afferents terminate predominantly
in commNTS. To test whether commNTS innervates RTN,
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the anterograde tracer BDA was injected by iontophoresis
into commNTS in seven rats. Five BDA injections out of
seven were correctly placed (Fig. 1A). In each of these
five cases, the BDA injection was centred at the level
of the calamus scriptorius and labelled neurons were
confined to the commNTS. One week after injection,
numerous BDA-labelled axonal varicosities or terminals
(putative synapses) were present in the RTN, defined
here as the region where the cell bodies and dendrites of
previously identified CO2-activated neurons are located.
Figure 1B is a computer-assisted plot of the BDA-labelled
varicosities that were detected in a representative coronal
section located close to Bregma −11.4 mm (200 μm
rostral to the caudal end of the facial motor nucleus).
The plotting was limited to the ventral third of the
brain. BDA-labelled varicosities were found throughout
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Figure 1. Projections from commissural NTS to RTN
A, computer-assisted plot of 5 iontophoretic injections of biotinylated dextran amine (BDA) that were confined to
commNTS. All injection sites were within 200 μm of the level represented (Bregma −13.8 mm according to the
atlas of Paxinos and Watson). This plane corresponds to the caudal edge of the area postrema. B, representative
coronal section at Bregma −11.4 mm (200 μm rostral to the posterior edge of the facial motor nucleus (7). Each dot
represents an axonal varicosity assumed to be a synapse or a release site. Plotting was confined to the lower third
of the section below the dotted line. The enlarged inset is the area that was selected for counting the number of
varicosities. C, mean number of varicosities present in the box defined in B at four levels of the RTN region (∗P < 0.05
from other levels represented; ANOVA for repeated measures; 5 rats). D, proportion of BDA-immunoreactive
varicosities that contained VGLUT2 or GAD67 immunoreactivity. The terminals were examined by confocal
microscopy selectively within the marginal layer of RTN. IO, inferior olive; NTS, nucleus of the solitary tract; py,
pyramidal tract; sp5, spinal tract of trigeminal nerve; 12, hypoglossal nucleus.
the ventral medulla albeit at variable densities. As seen in
the inset, these putative synapses were especially numerous
under the medial half of the facial motor nucleus in
very close proximity to the ventral medullary surface.
The number of BDA-labelled axonal varicosities present
within RTN (defined by the rectangle shown in Fig. 1B;
see Methods for details) were counted in four equidistant
sections per rat and the resulting distribution histogram
is shown in Fig. 1C. The number of BDA-labelled
varicosities within the defined area was greatest (P < 0.05
by repeated measure ANOVA) close to the caudal end
of the facial motor nucleus and dropped considerably
caudal to that level (Fig. 1C). The area with the maximum
density of varicosities approximates the region where
we find the greatest concentration of CO2-responsive
neurons.
C© 2006 The Authors. Journal compilation C© 2006 The Physiological Society
 at UNIV OF VIRGINIA on October 5, 2006 jp.physoc.orgDownloaded from 
J Physiol 572.2 RTN and chemoreception 509
The next experiments were designed to test whether
the projection from commNTS to RTN neurons is
predominantly glutamatergic or GABAergic. Sections
from the same five brains were reacted for simultaneous
detection of BDA and either VGLUT2 or GAD67 immuno-
reactivity and the material was examined by confocal
microscopy. We focused our observations on the marginal
layer of RTN, a readily identified 50 μm-thick region
of the ventral medulla that lies closest to the ventral
medullary surface under the spinocerebellar tract. This
choice was made because the marginal layer contains
an especially dense input from commNTS (Fig. 1B) and
because the CO2-activated neurons of RTN have profuse
dendrites within the marginal layer regardless of whether
their cell bodies reside within or dorsal to this region
(Mulkey et al. 2004; Weston et al. 2004). The BDA-labelled
varicosities present within this region of RTN were rarely
immunoreactive for GAD67 but they were commonly
VGLUT2-immunoreactive (Fig. 2). An estimate of the
percentage of excitatory (VGLUT2-ir) versus inhibitory
(GAD67-ir) BDA-labelled varicosities was obtained by
sampling the marginal layer with a confocal microscope
in each of the five rats. Four equidistant sections between
Bregma −11.3 and Bregma −12.2 mm were selected.
Within this region an average of 51% of the total number of
BDA-labelled varicosities sampled were immunoreactive
for VGLUT2 (243 varicosities) whereas only 5% of 212
sampled varicosities were GAD67-ir. The proportion
of BDA-positive varicosities containing VGLUT2- versus
GAD67-immunoreactivity was approximately the same
at the four levels investigated (Fig. 1D). Each level also
contained numerous BDA-labelled axonal varicosities in
which no other immunoreactivity could be detected.
Figure 2. BDA-labelled varicosities within the marginal layer of RTN are predominantly glutamatergic
A–C, example of BDA-labelled axonal varicosities (red) that were not immunoreactive for GAD67 (still red, i.e. not
double-labelled in the merged panel). D–F, example of BDA-labelled axonal varicosities that were immunoreactive
for VGLUT2 (green in E, orange in the overlay). Scale bar, 50 μm, in A, applies to all panels.
The next series of experiments was designed to test
whether the glutamatergic projection from commNTS
to RTN includes neurons that are activated by systemic
hypoxia. CommNTS with projections to RTN were
prelabelled with CTB 1 week before the rats were exposed
to hypoxia (8% O2, 6 rats) or to normal air (5 rats). Fos
immunoreactivity was used to identify commNTS neurons
that were activated by hypoxia. CommNTS neurons were
classified as glutamatergic or GABAergic based on whether
they contained VGLUT2 mRNA or GAD67 mRNA.
The CTB injections, placed with electrophysiological
guidance under the caudal end of the facial motor nucleus,
were centred 100–300 μm dorsal to the ventral medullary
surface 2–400 μm rostral to the caudal end of the facial
motor nucleus. Figure 3A depicts the location of the CTB
injections in the six rats that were exposed to hypoxia.
Fos immunoreactivity was absent in the NTS of the five
control rats exposed to room air and these rats were
not examined further. One series of 30 μm-thick coronal
sections (180 μm apart) was selected from the brain of
each hypoxia-treated rat and reacted for simultaneous
detection of Fos immunoreactivity, VGLUT2 mRNA and
CTB immunoreactivity. An adjacent series of sections
from the same six brains was reacted for detection of
Fos immunoreactivity, GAD67 mRNA and CTB immuno-
reactivity. As illustrated in Fig. 4, neurons immuno-
reactive for both Fos and CTB commonly contained
VGLUT2 mRNA (Fig. 4A–C) whereas they typically did
not contain GAD67 mRNA (Fig. 4D–F). For quantification
purposes, the coronal sections located at mid-area
postrema level and 180, 360, 540 and 720 μm caudal to that
plane were selected and commNTS neurons containing
pertinent combinations of Fos immunoreactivity, CTB
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immunoreactivity and VGLUT2 mRNA were mapped
and counted. CommNTS neurons with the same marker
combination were summed across the five coronal sections
in each rat and the single resulting number was averaged
across the six rats. As shown in Fig. 3B and C, the vast
majority of the commNTS neurons that were immuno-
reactive for both Fos and CTB contained VGLUT2 mRNA
(92 ± 13%) whereas only a small proportion of the
same class of neurons (Fos- and CTB-positive) contained
GAD67 mRNA (12 ± 9%; Fig. 3D).
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Figure 3. Hypoxia-activated commNTS neurons with RTN projections are predominantly glutamatergic
A, computer-assisted plots of cholera toxin B injection sites in six rats. The deposits were placed below the caudal end
of the facial motor nucleus (7) under electrophysiological guidance. Each deposit was found within 200 μm of the
coronal plane represented (Bregma −11.4 mm). B, computer-assisted plot of three pertinent marker combinations
detected in commNTS neurons (Bregma level −14.08 mm). C, total number of commNTS neurons (mean ± S.E.M. of
6 rats) detected in four sections per brain (Fos, all Fos-ir neurons irrespective of other markers; CTB, all CTB-ir neurons
irrespective of other markers). Most hypoxia-sensitive neurons with RTN projections contained VGLUT2 mRNA.
D, total number of commNTS neurons (mean ± S.E.M. of 6 rats) detected in four sections per brain (Fos-ir, all Fos-ir
neurons irrespective of other markers; CTB, all CTB-ir neurons irrespective of other markers). Few hypoxia-sensitive
neurons with RTN projections contained GAD67 mRNA. RPa, raphe pallidus; for other abbreviations see Fig. 1.
Carotid chemoreceptor stimulation
activates RTN neurons
As in prior work, RTN neurons were defined by their
location (2–350 μm below the inferior margin of the
antidromic facial field potential) and by the fact that
they were silent below a threshold level of CO2 and
increasingly active at higher levels of CO2. An example
of one cell recorded in a rat with intact vagus nerves is
shown in Fig. 5A. As under halothane anaesthesia, RTN
cells became respiratory modulated only at higher levels
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of central respiratory drive (Fig. 5A, insets) but their
firing probability did not reach zero at any period of
the cycle even at 10% end-expiratory CO2, the highest
level examined (Fig. 5B). The particular cell shown in
Fig. 5B displayed one of several respiratory patterns
that we previously observed in halothane-anaesthetized
rats (Guyenet et al. 2005a). This particular pattern was
interpreted previously as the result of inhibitory volleys
during post-inspiration and late expiration (Guyenet
et al. 2005a). The full range of respiratory patterns
previously identified under halothane was present under
chloralose–urethane anaesthesia including the common
pattern consisting of early inspiratory and post-inspiratory
inhibition, an example of which is shown in Fig. 9B1.
However, the respiratory modulation of RTN units was
generally less pronounced under chloralose–urethane
anaesthesia than under halothane judging by the fact
that in a high proportion of the neurons (46%; 13
of 28 sampled neurons) less than 15% difference was
observed between the presumed nadir and apex of the
PND-triggered histograms even when the CO2 level was
above 9%.
At steady state, the discharge rate of RTN neurons
was a linear function of end-expiratory CO2 at first and
then exhibited incomplete saturation at higher levels of
CO2 (Figs 5C and 6). PND also exhibited a somewhat
curvilinear relationship to CO2 (Figs 5C and 6) although
the saturation was less marked than under halothane.
On average, the discharge rate of RTN units increased
by 2.2 ± 0.4 Hz for each 1% increase in end-expiratory
CO2 during the linear portion of the relationship and
reached a mean level close to 10 Hz at 10% end-expiratory
Figure 4. Hypoxia-activated commNTS neurons with RTN projections contain VGLUT mRNA
A–C, example of a neuron retrogradely labelled from RTN (CTB-immunoreactive) and located in commNTS that
was activated by hypoxia (Fos-ir) and contained VGLUT2 mRNA. D–F, example of a CTB-labelled neuron located in
commNTS that was activated by hypoxia (Fos-ir) but lacked GAD67 mRNA, unlike many of the surrounding cells.
Scale bar, 20 μm in A, applies to all panels.
CO2 (Fig. 6B). The CO2 threshold of RTN neurons was
not statistically different in vagotomized versus intact rats
(Fig. 6B) unlike that of the PND, which was significantly
lower in vagotomized rats (Fig. 6). Consequently, the CO2
threshold of RTN neurons was lower than that of PND in
intact rats (mean threshold of 41 RTN neurons in 23 rats:
5.1 ± 0.2%; mean PND threshold: 6.4 ± 0.3%; P < 0.05)
whereas these threshold values were closer in vagotomized
rats (mean CO2 threshold of 20 RTN neurons in 11 rats:
5.0 ± 0.3%; mean PND threshold: 5.3 ± 0.5%; P > 0.05)
(Fig. 6).
Stimulation of carotid chemoreceptors with brief
periods of hypoxia (30 s of 10–13% O2) or intravenous
injection of NaCN (50 μg kg−1) was performed in 16 rats
with intact vagus nerves, 10 of which had intact carotid
nerves and the rest were denervated bilaterally. In rats
with intact peripheral chemoreceptors, hypoxia or cyanide
increased PND activity and activated every RTN neuron
sampled (hypoxia and NaCN: 41 neurons; Fig. 7A and C).
During these tests, the CO2 level was set slightly above the
PND threshold, i.e. close to 6.5% CO2. The stimulatory
effects of hypoxia and cyanide on both PND and RTN
neurons was absent in rats with carotid body denervation
(Fig. 7B and D). The sensitivity of RTN neurons to CO2
was unaffected by carotid body denervation (control rats:
2.3 ± 0.3 Hz per 1% rise in end-expiratory CO2; chemo-
denervated rats: 2.2 ± 0.4 Hz; n.s.). On average, carotid
body denervation had no effect on the CO2 threshold
measured under steady-state conditions (control rats:
4.7 ± 0.3%; chemodenervated rats: 5.2 ± 0.2%; n.s.).
To determine more precisely how peripheral chemo-
receptor inputs and central chemosensitivity are integrated
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Figure 5. General electrophysiological characteristics of RTN neurons
A, example of one RTN neuron exposed to various levels of end-expiratory CO2 in a rat with intact vagus
nerves. The large upward deflections in the iPND trace represent augmented breaths commonly observed under
chloralose–urethane anaesthesia. The insets illustrate the regularity of the cell discharge at low CO2 level (left
inset) and its respiratory entrainment at higher levels of CO2 when the phrenic nerve was active (right inset).
B, PND-triggered activity histogram showing that the RTN neuron is respiratory modulated but not respiratory
phasic at high levels of CO2. C, relationship between neuronal discharge rate and end-expiratory CO2 at steady
state for the neuron represented in A. The same graph also shows the relationship between mvPND (neural
minute × volume) and end-expiratory CO2. The high PND CO2 threshold was characteristic or rats with intact
vagus nerves.
Figure 6. General electrophysiological
characteristics of RTN neurons: group data
A, relationship between mvPND (neural
minute × volume) and end-expiratory CO2 at steady
state in intact (8 rats) and in vagotomized rats (6 rats).
∗Significantly different from intact rats (P < 0.05;
two-way ANOVA). B, relationship between neuronal
discharge rate and end-expiratory CO2 at steady state
in 8 rats with intact vagus nerves (21 neurons) and in 6
vagotomized rats (11 neurons). There was no difference.
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Figure 7. RTN neurons are activated by hypoxia and cyanide
A, response of one RTN neuron to I.V. injection of 50 μg kg−1 of cyanide and to hypoxia (12% O2) in a rat with
intact carotid chemoreceptors. B, lack of effect of the same stimuli on PND and an RTN neuron in a rat subjected
to carotid chemoreceptor denervation. C, group data for rats with intact carotid chemoreceptors (15 neurons from
10 rats). In these tests, the resting discharge rate of RTN neurons was kept at 2–5 Hz by adjusting end-expiratory
CO2. ∗Significant difference from discharge at rest (P < 0.05; paired t test). D, group data for rats subjected to
carotid chemoreceptor denervation (13 neurons from 6 rats). Carotid body stimulation produced no effect.
at RTN level, we measured the steady-state relationship
between RTN neuron discharge rate and end-expiratory
CO2 during long exposures to three levels of oxygen (100%,
15% and 21% O2 balanced with N2; 20 min per O2 level).
Figure 8. Effect of steady-state hypoxia on the
CO2-responsiveness of RTN neurons
Single RTN neurons were exposed to various
steady-state levels of CO2 under hyperoxia according to
the protocol shown in Fig. 5A. The procedure was then
repeated while oxygen in the breathing mixture was
reduced to 15%. The test was repeated a second and
final time while oxygen in the breathing mixture was set
at 21%. A, relationship between firing rate at
steady-state and end-expiratory CO2 for 5 RTN neurons
subjected to this protocol. ∗P < 0.05 from the
corresponding 15% O2 data points by two-way ANOVA
for repeated measures. B, maximum firing rate of the
cells ∗P < 0.05 from the 15% group by one-way
repeated measure ANOVA. C, slope of the linear part of
the relationship between firing rate and end-expiratory
CO2 (n.s.). D, CO2 threshold of RTN neurons. ∗P < 0.05
from the 15% group by one-way repeated measure
ANOVA.
These measurements were made sequentially in the order
indicated in six cells from five rats with intact vagus nerves
(Fig. 8). The effects of more severe hypoxia could not
be tested because excessive hypotension occurred with
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Figure 9. Bilateral injections of muscimol into the ventral respiratory column do not change the response
of RTN neurons to central and peripheral chemoreceptor stimulation
A, a single RTN neuron (cell 1) was exposed to various concentrations of CO2 under hyperoxia, then tested for
its response to 12% hypoxia and cyanide (vagotomized rat). Muscimol was then injected into the ventrolateral
medulla on both sides causing a gradual disappearance of PND. The mechanical disturbance caused by the injections
typically caused the loss of the first RTN neuron and the search was resumed for another active neuron in the
immediate vicinity of the first (cell 2). Muscimol eliminated PND at rest and during stimulation of peripheral or
central chemoreceptors but cell 2 responded normally to these stimuli. The insets show that cell 2, recorded after
muscimol, had a very regular discharge rate even at high levels of CO2 whereas cell 1 was respiratory modulated.
B1, peri-event histogram of the discharge of cell 1 at high CO2. PND served as trigger. This neuron was inhibited
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long duration exposure to hypoxia below 15% O2. In the
presence of 15% O2, the CO2 threshold of RTN neurons
was significantly reduced (hypoxia: 4.5 ± 0.6% CO2;
hyperoxia: 5.3 ± 0.3% CO2; P < 0.05) but the sensitivity
of the cells to CO2 was not changed (hypoxia: 3.3 ± 1.1 Hz
per 1% rise in end-expiratory CO2; hyperoxia: 2.3 ± 0.5;
n.s.; Fig. 8). ‘Normoxia’ (21% O2) had no effect on the
CO2 threshold of RTN neurons (normoxia: 5.2 ± 0.4%
CO2; hyperoxia: 5.3 ± 0.3% CO2; n.s.) nor on their
CO2 sensitivity (normoxia: 2.1 ± 0.2 Hz per 1% rise
in end-expiratory CO2; hyperoxia: 2.3 ± 0.5 Hz; NS;
Fig. 8).
Injection of muscimol in the rostral ventral respiratory
group does not change the sensitivity of RTN neurons
to central or peripheral chemoreceptor stimulation
The anatomical experiments described in the first
paragraph of the Results section suggested that the
activation of RTN neurons by peripheral chemoreceptor
stimulation could be due to a direct excitatory input
from commNTS. Our prior work on RTN neurons is
consistent with the notion that their response to CO2 under
hyperoxia is due to their intrinsic chemosensitivity
(Mulkey et al. 2004; Guyenet et al. 2005a). If both
hypotheses are correct, the response of RTN neurons to
hyperoxic hypercapnia and to peripheral chemoreceptor
stimulation should persist after inactivation of the central
respiratory pattern generator. The GABAA receptor agonist
muscimol was selected for this purpose. In six vagotomized
rats, bilateral injections of muscimol (1.75 mm, 30 nl per
side) were placed under electrophysiological guidance into
a region of the VRG from where strong inspiratory-related
multiunit activity could be recorded. Muscimol injection
into this region eliminated the PND for up to 2 h (Fig. 9A
and B). Upon histological examination, the centres of the
injection sites were found close to 1.5 mm posterior to
the caudal end of the facial motor nucleus (Fig. 10C).
By our previous estimates, these sites correspond to the
rVRG (Stornetta et al. 2003b). The fluorescent microbeads
extended 270 ± 15 μm on each side of the injection centre
and therefore muscimol, which probably diffuses more
freely that microbeads, is likely to have also reached the
respiratory neurons located in the pre-Bo¨tzinger complex.
One or two RTN neurons were fully characterized in
each of the six rats before muscimol injection. Attempts to
hold the same neuron before and after muscimol injection
into the ventrolateral medulla were not successful because
of the mechanical disturbance created by moving the
during early inspiration and again during post-inspiration. B2, peri-event histogram of the discharge of cell 2 at
high CO2. End-expiratory CO2 served as trigger. C1, interspike interval distribution histogram of cell 1 at high CO2.
The histogram is asymmetric and skewed towards longer intervals. C2, interspike interval distribution histogram
of cell 2 at high CO2. The histogram is very symmetric due to the loss of entrainment by the respiratory network.
muscimol injection pipette. The example shown in Fig. 9
illustrates an experiment in which an RTN neuron was
characterized before muscimol and a second RTN neuron
was found just after the second muscimol injection in the
immediate vicinity of the first one. As shown in Fig. 9A,
muscimol eliminated PND but the RTN neuron recorded
after muscimol responded to hyperoxic hypercapnia and
to peripheral chemoreceptor stimulation in the same way
as the cell recorded before muscimol. Consistent with the
loss of central respiratory network activity (i.e. PND), the
CO2-activated neuron recorded after muscimol injection
had no detectable respiratory-like modulation, in other
words the cell discharged much more regularly (Fig. 9B
versus C).
On average, the properties of RTN neurons recorded
before muscimol (9 neurons in 6 rats) were the same
as those recorded after muscimol before any recovery
of PND occurred (1 neuron per rat in the same 6 rats)
(Fig. 10A and B). Specifically, under hyperoxia, the CO2
threshold and the CO2 sensitivity of the cells were the
same (Fig. 10A) and the responses of the cells to hypoxia
or cyanide were also indistinguishable (Fig. 10B). The only
difference was that every neuron recorded after muscimol
lacked respiratory modulation and discharged much more
regularly (Table 1).
Bilateral injections of muscimol into RTN eliminate
PND at rest and during chemoreceptor stimulation
RTN is believed to contribute an important source
of excitatory drive to the respiratory network under
anaesthesia. The final experiments were designed to
determine whether bilateral inhibition of RTN is capable
of suppressing the stimulatory effect of both central and
peripheral chemoreceptor activation on PND. Muscimol
(1.75 mm, 30 nl) was injected bilaterally under electro-
physiological guidance 200 μm below the facial motor
nucleus and 200 μm rostral to the caudal end of this
nucleus to target the region that contains the highest
density of CO2-sensitive RTN neurons according to our
prior experience (Mulkey et al. 2004; Guyenet et al. 2005a).
The centre of the injection sites were in the desired location
as shown by histological mapping of fluorescent micro-
beads included in the injectate (Fig. 11C). The beads were
found to have spread approximately 260 μm on each side
of the injection centre.
As illustrated in Fig. 11A, muscimol eliminated
PND and no activity, even tonic, could be restored
by combined central (10% CO2) and peripheral
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Figure 10. Bilateral injections of muscimol into the ventral
respiratory column do not change the response of RTN neurons
to central and peripheral chemoreceptor stimulation: group
data
A, relationship between firing rate at steady-state and end-expiratory
CO2 measured under hyperoxic conditions. The relationship was the
same before (9 cells in 6 rats) and after bilateral injection of muscimol
(1.75 mM, 30 nl on each side) into the ventrolateral medulla (6 cells in
6 rats; n.s. by two-way repeated measure ANOVA). B, effect of
cyanide and transient hypoxia on the discharge rate of RTN neurons
before and after muscimol (∗P < 0.05 from control by unpaired t test).
C, computer-assisted plots of the centre of the muscimol injection sites
revealed by the presence of fluorescent microbeads included in the
injectate. The centre of all injections were within 200 μm of the
coronal level indicated. This level corresponds to the rVRG.
chemoreceptor stimulation (10–13% O2 or i.v. injection
of NaCN). Complete recovery from the effect of muscimol
occurred within 2 h (Fig. 11B). Muscimol produced the
same complete PND inhibition in each of eight rats.
These muscimol injections also reduced blood pressure
from 121 ± 5 to 97 ± 6 mmHg (P < 0.01), consistent
with muscimol having inhibited some of the blood
pressure-regulating neurons that reside in the ventrolateral
medulla at and caudal to RTN level.
Bilateral injections of the same amount of muscimol
into the midline raphe at the same coronal plane as RTN
(two 30 nl injections; 6 rats) produced no effect on resting
mvPND measured at an end-expiratory CO2 of 7–8%
(96 ± 12% of pre-drug mvPND after muscimol; n.s.).
Muscimol injection into the raphe had no effect on blood
pressure (from 122 ± 5 to 123 ± 5 mmHg; n.s.).
Discussion
The present study indicates that RTN neurons respond
both to central PCO2 and to signals from carotid
chemoreceptors. The pathway between carotid chemo-
receptor afferents and RTN neurons is excitatory and
may involve a single intervening glutamatergic neuron
located within commNTS (Fig. 12). We conclude that RTN
neurons integrate central and peripheral chemoreceptor
information and may drive diaphragmatic activity and/or
other aspects of the cardiorespiratory network.
Properties of RTN neurons under chloralose–urethane
anaesthesia
RTN neurons recorded under chloralose–urethane
anaesthesia had similar properties as under halothane,
the anaesthetic used in our previous experiments. The
sensitivity of RTN neurons to CO2 under hyperoxic
conditions presumably reflects their intrinsic response to
extracellular pH (Mulkey et al. 2004; Guyenet et al. 2005a).
This CO2 sensitivity was the same under both anaesthetics
(2.2 Hz per 1% change in end-expiratory CO2). This
fact is noteworthy since halothane opens TWIK-related
acid-sensitive channels (TASK), which are expressed by
many brainstem respiratory neurons and are candidate
molecular substrates of central chemosensitivity (Bayliss
et al. 2001; Washburn et al. 2003). The present results do
not exclude a contribution of TASK channels to central
chemosensitivity but they demonstrate that 1% halothane
does not affect the pH sensitivity of RTN neurons any more
than chloralose–urethane anaesthesia used at a dose that
produces a comparable depth of anaesthesia.
There were a few minor differences between the
two anaesthetics, however. The CO2 threshold of
RTN neurons under hyperoxia was slightly higher
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Table 1. Interspike interval distribution of RTN neurons before
and after injection of muscimol into the ventral respiratory
column caudal to RTN
Inter-spike Inter-spike Number
interval (mean) interval (S.D.) of neurons
Before muscimol 0.115 ± 0.009 0.052 ± 0.08 9
After muscimol 0.096 ± 0.008 0.022 ± 0.03 6
P (paired t test) n.s. < 0.05
Interspike interval distribution histograms (ISH) of RTN neurons
were made during periods when the rats were exposed to high
levels of end-expiratory CO2 (9–10%) as shown in Fig. 9C1 and 2.
The table shows the mean interspike interval and the standard
deviation of these ISH distributions. The average discharge
rate of the cells was no different after muscimol was injected
bilaterally into the rVRG but the standard deviation of the ISH
was significantly smaller indicating that the discharge of the
neurons was on average more regular after muscimol injection.
under chloralose–urethane (5% versus 4.2%) and the
relationship between RTN neuron activity and CO2
exhibited a somewhat less pronounced saturation at high
levels of hypercapnia. PND had a similar CO2 threshold
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Figure 11. Bilateral injections of muscimol into RTN eliminate PND
A, effect of bilateral injections of muscimol (30 nl, 52 pmol) placed under the caudal end of the facial motor nucleus
using antidromic field potentials as guide for pipette placement. PND disappeared and could not be restored by
extreme chemoreceptor stimulation (10% end-expiratory CO2 + hypoxia). B, relationship between mvPND and
end-expiratory CO2 at steady-state before muscimol, 30 min after and 2 h after injection (full recovery). Data are
from the case shown in A (recovery period not shown in A). PND was normalized to the maximum value observed
before muscimol. C, computer-assisted plots of the muscimol injection sites targeted to RTN projected on a single
coronal section located 200 μm rostral to the caudal end of the facial motor nucleus (open circles; 8 rats). The plot
also shows the location of muscimol injections that were placed in the midline raphe at the same level as RTN in
6 rats. These injections produced no effect on resting PND or blood pressure.
as under halothane but, like RTN neurons, PND also
exhibited a less pronounced saturation at high levels of
hypercapnia. As shown previously, the intrinsic response
of RTN neurons to PCO2 is linear and the saturation of their
discharge rate at high levels of CO2 is caused by inhibitory
inputs from the CPG that increase in intensity along with
the central inspiratory drive (Guyenet et al. 2005a). This
input is somewhat weaker under chloralose–urethane as
suggested by a generally more modest central respiratory
modulation of RTN neurons than under halothane. A
weaker input should produce a more linear relationship
between RTN activity and CO2, as was observed.
RTN neurons receive oligo-synaptic excitatory inputs
from carotid chemoreceptors
All RTN neurons were vigorously activated by brief
periods of hypoxia and by intravenous cyanide. Since these
responses were observed only in rats with intact carotid
chemoreceptors, they depended entirely on afferent inputs
from these organs. These results are congruent with prior
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experimentation in rats and cats (Bodineau et al. 2000b;
Mulkey et al. 2004).
Carotid chemoreceptor afferents primarily innervate
commNTS (Blessing et al. 1999). Most of the commNTS
neurons that are activated by carotid body stimulation
are not respiratory modulated and therefore are probably
not part of the respiratory pattern generator (Koshiya
& Guyenet, 1996; Paton et al. 2001). Many of these
carotid body-responsive neurons project to the ventro-
lateral medulla where one of their targets has long been
assumed to be the blood pressure-regulating C1 neurons
(Aicher et al. 1996; Koshiya & Guyenet, 1996; Paton et al.
2001). According to the present study, the commNTS
neurons that are activated by carotid body stimulation
innervate the RTN neurons and this projection is
predominantly glutamatergic. These NTS neurons could
also innervate other ventrolateral medullary neurons
including the blood pressure-regulating C1 neurons
(Aicher et al. 1996; Sun & Reis, 1996) but this issue is
not addressed by the present experiments.
The presumption that commNTS neurons innervate the
CO2-sensitive neurons is based on the observation that
many BDA-labelled axonal varicosities were found in the
marginal layer of RTN where the CO2-sensitive cells have
extensive dendrites (Mulkey et al. 2004; Guyenet et al.
2005a). The Fos-expression experiments also indicated
that the projection from commNTS to RTN contains many
neurons that are activated by hypoxia. We assume that the
vast majority of the NTS neurons that express Fos following
hypoxia respond to activation of the carotid bodies rather
Hypoxaemia/
Figure 12. Possible role of RTN in chemosensory integration
We propose that RTN neurons function as integrators of central and peripheral chemoreceptor information. The
exact targets of RTN neurons are still undefined and probably include elements of the various respiratory pattern
generators located within the ventrolateral medulla (CPGs), possibly premotor neurons (Dobbins & Feldman, 1994).
Other potential targets of RTN neurons include the ventrolateral medullary neurons that drive sympathetic cardio-
vascular efferents (not represented). RTN neurons are subject to inhibition from the CPG (Guyenet et al. 2005a),
a mechanism that could conceivably be related to the need to down-regulate this structure when the pattern
generators are activated by other inputs. commNTS, commissural nucleus of the solitary tract; CPG, respiratory
pattern generator; RTN, retrotrapezoid nucleus.
than to secondary effects of hypoxia on blood pressure.
In any event, the present results are consistent with prior
electrophysiological evidence that commNTS cells with
carotid chemoreceptor input innervate the rostral ventro-
lateral medulla in rats and the RTN region of cats (Koshiya
& Guyenet, 1996; Bodineau et al. 2000a).
In addition, the present study shows that the
hypoxia-activated pathway between commNTS and RTN
is predominantly glutamatergic since an average of 92%
of these neurons contained detectable levels of VGLUT2
mRNA. A smaller percentage of BDA-labelled varicosities
were found to contain VGLUT2 immunoreactivity in the
anterograde tracing experiments (51%) but this method
may underestimate the proportion of terminals that
are glutamatergic for two reasons. First, dual labelling
for BDA and VGLUT2 may not reveal each marker
equally, especially in the depth of the tissue because of
incomplete antibody penetration. It is also conceivable
that a portion of the BDA-labelled structures that look like
axonal varicosities may lack VGLUT2 immunoreactivity
simply because they are not synapses. This second inter-
pretation is less likely because, where investigated, the
vast majority of BDA axonal varicosities seen at the
light microscopic level correspond to synaptic sites seen
by electron microscopy of thin sections (Kincaid et al.
1998). Therefore, it is more instructive to contrast the
high percentage of putative VGLUT2-immunoreactive
synapses identified in the projection from commNTS
to RTN (around 51% of the BDA-labelled varicosities)
with the low percentage of terminals identified as
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GAD67-immunoreactive (5%). In summary, the vast
majority of hypoxia-sensitive commNTS neurons with
RTN projections are glutamatergic but a small fraction
of this pathway may be inhibitory since around 12% of
neurons containing Fos and CTB also contained GAD67
mRNA in rats exposed to hypoxia. This conclusion is
also compatible with the fact that RTN contained a small
number of BDA-labelled terminals that were immuno-
reactive for GAD67 after injection of the tracer into
commNTS. This inhibitory projection may not target the
CO2-activated neurons of RTN but may contact more
medially located neurons that regulate sympathetic tone
to the skin and the brown adipose tissue, outflows that are
inhibited by hypoxia (Madden & Morrison, 2005).
The present results do not prove that the
hypoxia-activated glutamatergic neurons of commNTS
that innervate RTN are second-order neurons, i.e.
receive monosynaptic inputs from carotid chemoreceptor
afferents. However, this possibility is likely given that, in
slices, low-jitter, presumably monosynaptic, EPSCs can
be elicited by stimulating the solitary tract in most of
the NTS neurons that project towards the ventrolateral
medulla (Bailey et al. 2004).
In summary, the present study demonstrates that the
RTN region receives glutamatergic inputs from commNTS
neurons that are activated by peripheral chemoreceptor
stimulation. These glutamatergic neurons could well be the
sole central neurons interposed between carotid chemo-
receptor afferents and the chemosensitive neurons of RTN
though the existence of interneurons within the NTS or
the RTN is not ruled out by the present evidence. In any
case, the main pathway between carotid chemoreceptor
afferents and RTN neurons almost certainly bypasses the
respiratory rhythm and pattern-generating network since
injections of muscimol into the ventral respiratory column
caudal to RTN eliminated PND but did not affect the
response of RTN neurons to hypoxia or cyanide.
RTN neurons respond both to brain extracellular fluid
PCO2 and to blood gas composition as detected
by peripheral chemoreceptors
At present, the theory that a pH-sensitive resting potassium
conductance underlies the chemosensitivity of RTN
neurons accounts satisfactorily for prior observations
in slices (Mulkey et al. 2004; Putnam et al. 2004).
However, ATP release, possibly from nearby non-neuronal
cells, may also contribute to the CO2 responsiveness of
RTN neurons or other nearby chemoreceptors in vivo
(Gourine et al. 2005). Whether it is intrinsic, paracrine
or both, the response of RTN neurons to brain PCO2
in vivo does not seem secondary to the activation of
the respiratory network, at least under anaesthesia. This
notion is supported by prior evidence that the response of
RTN neurons to hyperoxic hypercapnia is unaffected by
high concentrations of a glutamate receptor antagonist in
vivo and that RTN neurons have a comparable response
to pH in coronal slices (Mulkey et al. 2004; Guyenet
et al. 2005a). Consistent with this interpretation, in
the present study the response of RTN neurons to
hyperoxic hypercapnia was unaffected by inhibiting the
ventral respiratory column with muscimol at sites caudal
to the RTN. The sole effect of muscimol was to regularize
the discharge of RTN neurons as expected from the loss
of the respiratory-phasic inputs that these neurons receive
from the central respiratory pattern generator (Guyenet
et al. 2005a).
Steady-state peripheral chemoreceptor stimulation
increased the discharge rate of RTN neurons by a fixed
amount regardless of the level of end-expiratory PCO2 . In
other words, extracellular fluid pH and peripheral chemo-
receptor stimulation seem to have roughly additive effects
on RTN neuron activity, at least at the mild level of
hypoxia that could be reliably investigated without
causing hypotension (15% O2). Interestingly, the effect of
peripheral chemoreceptor stimulation and the central
action of CO2 on PND are also typically additive under
anaesthesia (Nattie et al. 1991). At RTN level, this
summation had the effect of lowering the end-expiratory
CO2 threshold of the neurons, i.e. the CO2 level at which
they started to discharge. If the molecular substrate of
central chemosensitivity is nothing more than a set of
pH-sensitive neuronal conductances, it is logical to expect
that the CO2 response of central chemoreceptor neurons
would vary according to the synaptic inputs that they
receive. However, to our knowledge, RTN neurons are the
first documented example where this convergence involves
an excitatory input from peripheral chemoreceptors.
In summary, under anaesthesia, RTN neurons detect
brain extracellular fluid pH, probably directly, and they
encode this variable in a manner that depends on the
strength of the input that they simultaneously receive from
carotid chemoreceptors. The CO2 threshold of the cells is
therefore not fixed but dependent on the synaptic inputs
that these cells receive.
RTN and the chemical drive to breathe
Injections of muscimol into RTN eliminated PND at rest
and during activation of central and peripheral chemo-
receptors. These injections were centred below the caudal
pole of the facial motor nucleus where the presumed RTN
chemoreceptor neurons are most concentrated based on
present and prior recordings (Mulkey et al. 2004; Guyenet
et al. 2005a,b). At face value, these results are congruent
with many other lines of evidence which suggest that RTN
is a chemosensitive region that drives inspiration (Nattie
et al. 1991; Feldman et al. 2003; Onimaru & Homma, 2003)
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and with anatomical evidence that some RTN neurons
may be directly antecedent to phrenic premotor neurons
(Dobbins & Feldman, 1994). The contribution of the RTN
region to breathing is not limited to the anaesthetized state.
Even unilateral lesion of this bilateral structure produces
notable chronic deficits in the hypercapnic ventilatory
response of awake rats (−39%; Akilesh et al. 1997). The fact
that muscimol also eliminated the effect of carotid chemo-
receptor stimulation on PND could also be viewed as
evidence that RTN encodes the chemical drive to breathe,
at least under anaesthesia.
Although the macrophysiological data (RTN lesions,
stimulations, etc.) are generally consistent with the
electrophysiological characteristics and projection pattern
of RTN neurons, both lines of supporting evidence
have inherent limitations. First, regarding the electro-
physiological evidence, the discharge and projection
pattern of RTN neurons provide necessary but not
sufficient evidence of their role in respiratory control
since the exact targets of these neurons are still unknown.
Second, the exact boundaries of the tissue affected by
procedures like muscimol injection, ventral medullary
surface cooling, and chemical or electrolytic lesions are
difficult to assess accurately (Millhorn, 1986; Fukuda et al.
1993; Nattie & Li, 1994; Forster et al. 1995).
The fluorescent microbeads that were co-injected with
muscimol migrated up to 300 μm from the injection
centre. Respiratory and other ventrolateral medullary
formation neurons in rat typically have dendrites that
spread no farther than 200 μm from their cell bodies
in the rostrocaudal direction but exceptions (up to
500 μm spread) are not uncommon (Pilowsky et al. 1990;
Schreihofer & Guyenet, 1997). Therefore it is conceivable
that neurons located from 500 μm up to 800 μm caudal
to the centre of the injection sites (3–600 μm caudal to the
posterior edge of the facial motor nucleus) could have been
inhibited to various degrees by injecting muscimol into
RTN. Our estimates of the effective spread of muscimol
are much smaller than the 1.7–2 mm chemical spread
measured autoradiographically by Edeline et al. (2002).
This difference can be explained in part by the fact that
we administered smaller volumes and eight times less drug
than the minimum dose administered by these authors (30
versus 50 nl, 50 versus 440 pmol). In addition, chemical
spread and effective spread are loosely related since the
first depends on the sensitivity of the detection method
whereas the second depends on a threshold concentration
being achieved for meaningful receptor occupancy. Our
estimate of the effective spread (at most 800 μm from
the centre and probably much less) is consistent with
the fact that injections into the raphe 1.5 mm lateral
to the centre of RTN produced no respiratory effect at
all. They are also consistent with the fact that muscimol
injection into the rVRG did not decrease blood pressure.
Decreases of 50–60 mmHg would have been expected
if the drug had inhibited a significant fraction of the
blood-pressure regulating neurons whose cell bodies are
largely confined to the Bo¨tzinger level of the ventral
respiratory column therefore well within 1 mm of the
rVRG (Kanjhan et al. 1995; Schreihofer et al. 1999b).
Judging the spread of muscimol from these physiological
criteria, injections placed into RTN could have inhibited
respiratory neurons located at the Bo¨tzinger level of the
VRC but most probably not caudal to that level. The
Bo¨tzinger region contains expiratory augmenting neurons
and other respiratory neurons (including pre-inspiratory
neurons identified in vitro) that could play an essential role
in generating inspiratory activity (Onimaru et al. 1992;
Kanjhan et al. 1995; Sun & Reis, 1996; Schreihofer et al.
1999a; Mellen et al. 2003). In short, we cannot exclude that
muscimol injection into RTN could have eliminated PND
in part or even in totality by silencing neurons located
caudal to the CO2-activated neurons that are the focus
of the present study. Consequently, alternate functions of
RTN neurons should also be considered, particularly the
possibility that these neurons could be regulating selected
autonomic efferents or respiratory outflows other than to
the diaphragm.
Some experiments suggest that the RTN region may
preferentially regulate the activity of expiratory muscles
(Forster et al. 1995; Janczewski & Feldman, 2006). The
theory that RTN neurons are part of an expiratory
rhythm generator (Janczewski & Feldman, 2006) is not
at odds with the present observations. Since the activity
of expiratory muscles is increased by central and peri-
pheral chemoreceptor stimulation, RTN neurons could
be a, or the, source of chemical drive for this part of the
respiratory network. The small respiratory modulation of
RTN neurons that we observed could be a consequence of
the anaesthesia. On the other hand, the greater sensitivity
of expiratory than inspiratory muscle activity to RTN
inhibition (Forster et al. 1995; Onimaru & Homma, 2003)
does not exclude the possibility that RTN could drive both
outflows; the differential susceptibility of these outflows to
RTN inhibition could simply be due to a higher threshold
for activation of the downstream expiratory network. This
interpretation is consistent with the fact that inspiratory
activity is much more strongly inhibited by RTN lesions
in models in which inspiratory drive is reduced by cold or
anaesthesia (Nattie & Li, 2000; and present results) than in
awake animals in which synaptic activity would certainly
be more robust (Li & Nattie, 1997). It is also consistent
with the fact that RTN acidification, which is less likely
to affect neurons distant from RTN than muscimol, does
increase inspiratory activity (Li & Nattie, 1997). Finally, the
possibility that RTN neurons drive numerous targets is also
consistent with the variety of central respiratory patterns
exhibited by these neurons (Guyenet et al. 2005a). In fact,
based on their location, anatomical connections or central
respiratory discharge pattern, RTN neurons could also be
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regulating other respiratory efferents (airway muscles) or a
selection of sympathetic (e.g. to heart, kidney or muscles)
or parasympathetic outflows (e.g. to tracheal muscles)
(Millhorn & Eldridge, 1986; Perez Fontan & Velloff, 1997;
Guyenet et al. 2005a).
Raphe and breathing
The midline raphe contains serotonergic neurons and
perhaps other neurons that regulate breathing and change
the response of the respiratory network to CO2 (Hodges
et al. 2004; Nattie et al. 2004; Richerson et al. 2005).
Under our experimental conditions, muscimol injection
into the midline raphe at the same rostrocaudal level as
RTN produced no effect on either PND or blood pressure.
Interestingly, muscimol injection into approximately the
same region of the medullary raphe in awake rats does
not reduce the effect of hypercapnia on ventilation either
(Taylor et al. 2005). Although this portion of the medullary
raphe contains very large numbers of serotonergic neurons
(Stornetta et al. 2005), these particular serotonergic
neurons may not regulate breathing. Alternatively, the
raphe neurons that are relevant to breathing could
have been inactive in our experiments because of the
anaesthesia, or the fraction of the raphe that was impaired
by muscimol could have been too small to produce
detectable effects on breathing (Hodges et al. 2004). The
first alternative is more likely because muscimol injection
into the rostral medullary raphe of awake rats does produce
effects on respiration (Taylor et al. 2005). However, these
effects are difficult to reconcile with the notion that
the rostral medullary raphe contains respiratory chemo-
receptors since muscimol potentiates the increase in
ventilation produced by hypercapnia (Taylor et al. 2005).
Furthermore, injection of dl-homocysteic acid into the
same region of the raphe produces apnoea and powerful
inhibition of the PND under anaesthesia (Verner et al.
2004), which also suggests that this region of the raphe
inhibits breathing when it is activated. In any event, our
data indicate that the midline raphe at RVL level does not
contribute detectably to central chemosensitivity under
our experimental conditions.
Conclusion: RTN as common central
chemoreceptor pathway
Millhorn & Eldridge (1986) have suggested the possibility
that afferents from carotid and medullary chemoreceptors
may converge on neurons situated upstream of the
respiratory centre pattern generators. The dysfunction
of a medullary centre that integrates central and
peripheral chemoreceptor inputs provides the most
plausible explanation of the spectrum of respiratory
deficits experienced by central congenital hypoventilation
syndrome (CCHS) patients (Shea et al. 1993). The
present experiments indicate that RTN neurons have the
physiological properties and anatomical location that are
required of such a chemoreceptor integrating centre. Based
on our prior work, we postulate that the so-called central
chemoreceptor input to RTN neurons may be nothing
more than their intrinsic sensitivity to pH. The present
work does not exclude the possibility that integration
between intrinsic chemosensitivity and inputs from
peripheral chemoreceptors could also be occurring at
other brainstem sites, including in regions that are capable
of influencing the respiratory network.
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Central chemoreceptors and sympathetic vasomotor
outflow
Thiago S. Moreira1,2, Ana C. Takakura1,2, Eduardo Colombari2 and Patrice G. Guyenet1
1Department of Pharmacology, University of Virginia, Charlottesville, VA, 22908, USA
2Department of Physiology, UNIFESP-EPM, Sa˜o Paulo, SP, 04023-060, Brazil
The present study explores how elevations in brain PCO2 increase the sympathetic nerve discharge
(SND). SND, phrenic nerve discharge (PND) and putative sympathoexcitatory vasomotor
neurons of the rostral ventrolateral medulla (RVLM) were recorded in anaesthetized sino-aortic
denervated and vagotomized rats. Hypercapnia (end-expiratory CO2 from 5% to 10%) increased
SND (97 ± 6%) and the activity of RVLM neurons (67 ± 4%). Injection of kynurenic acid (Kyn,
ionotropic glutamate receptor antagonist) into RVLM or the retrotrapezoid nucleus (RTN)
eliminated or reduced PND, respectively, but did not change the effect of CO2 on SND. Bilateral
injection of Kyn or muscimol into the rostral ventral respiratory group (rVRG-pre-Bo¨tzinger
region, also called CVLM) eliminated PND while increasing the stimulatory effect of CO2 on
SND. Muscimol injection into commissural part of the solitary tract nucleus (commNTS) had no
effect on PND or SND activation by CO2. As expected, injection of Kyn into RVLM or muscimol
into commNTS virtually blocked the effect of carotid body stimulation on SND in rats with intact
carotid sinus nerves. In conclusion, CO2 increases SND by activating RVLM sympathoexcitatory
neurons. The relevant central chemoreceptors are probably located within or close to RVLM
and not in the NTS or in the rVRG-pre-Bo¨tzinger/CVLM region. RVLM sympathoexcitatory
neurons may be intrinsically pH-sensitive and/or receive excitatory synaptic inputs from RTN
chemoreceptors. Activation of the central respiratory network reduces the overall sympathetic
response to CO2, presumably by activating barosensitive CVLM neurons and inhibiting RTN
chemoreceptors.
(Received 19 June 2006; accepted after revision 7 August 2006; first published online 10 August 2006)
Corresponding author P. G. Guyenet: Department of Pharmacology, University of Virginia Health System,
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In the absence of input from carotid bodies and
cardiopulmonary receptors hypercapnia markedly
increases sympathetic nerve discharge (SND) to the
heart and blood vessels (Hanna et al. 1988). The
effect of CO2 is generally attributed to the following
chain of events: brain extracellular fluid acidification
stimulates central ‘respiratory’ chemoreceptors, these
chemoreceptors activate the respiratory pattern
generator (CPG) and the CPG ultimately drives the
sympathetic generating network by phasically exciting the
sympathoexcitatory neurons of the rostral ventrolateral
medulla (RVLM) (Millhorn & Eldridge, 1986; Richter &
Spyer, 1990; Guyenet & Koshiya, 1992). This theory relies
on the following evidence. SND activation by central
chemoreceptors occurs in bursts that are synchronized
with the central respiratory cycle (Millhorn, 1986;
Millhorn & Eldridge, 1986; Guyenet et al. 1990; Habler
T. S. Moreira and A. C. Takakura contributed equally to this study.
et al. 1994). Damage to the ventrolateral medullary surface
via cooling, lesions or chemicals typically attenuates PND
and the respiratory oscillations of SND in roughly
proportional manner (Hanna et al. 1979; Millhorn,
1986; Millhorn & Eldridge, 1986). During central
chemoreceptor stimulation, RVLM sympathoexcitatory
neurons exhibit patterns of central respiratory-related
activity that are similar to those of barosensitive
sympathetic ganglionic neurons (McAllen, 1987;
Haselton & Guyenet, 1989; Darnall & Guyenet, 1990;
Guyenet et al. 1990; Miyawaki et al. 1995).
However, a number of assumptions underlying the
currently accepted view on how CO2 affects SND have
not been tested. For example, the proposed circuit
presumes that the sympathetic generating network does
not contain pH-responsive elements. Already challenged
25 years ago (Trzebski & Kubin, 1981), this premise is
even less persuasive at present given recent evidence that
the pontomedullary region may contain multiple sites
for respiratory chemoreception (nucleus of the solitary
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tract (NTS), retrotrapezoid nucleus (RTN), pre-Bo¨tzinger
complex, raphe) (Nattie & Li, 1996; Feldman et al. 2003;
Hodges et al. 2004; Mulkey et al. 2004; Putnam et al.
2004; Richerson et al. 2005). Noradrenergic neurons are
pH-sensitive (Pineda & Aghajanian, 1997) and RVLM
sympathoexcitatory neurons may also have this property
given that they express high levels of TASK channels,
have close relationships with capillaries and possess
dendrites that reach the ventral medullary surface (Milner
et al. 1987, 1989; Washburn et al. 2003). Second,
the observation that RVLM vasomotor neurons are
respiratory rhythmic is insufficient to conclude that these
cells cause the increased SND associated with central
chemoreceptor stimulation. Only one study has examined
whether the overall activity of these neurons is actually
increased by central chemoreceptor stimulation (Haselton
& Guyenet, 1989) and none has examined whether their
degree of activation is commensurate with the rise in
sympathetic vasomotor tone. Third, the fact that SND
or RVLM neurons are activated in bursts during central
chemoreceptor stimulation does not mean that such bursts
are caused by respiratory rhythmic excitatory volleys
to the RVLM neurons. Respiratory synchronous bursts
can be sculpted by periodic inhibitory inputs from a
background of tonic excitation. Many ventral respiratory
group (VRG) expiratory neurons and the chemosensitive
neurons of RTN derive their respiratory modulation in
this fashion during central chemoreceptor stimulation
(Sun et al. 2001; Guyenet et al. 2005a). The same
type of synaptic mechanism could also account for the
central respiratory modulation of RVLM neurons since
their principal tonically active GABAergic input from
caudal ventrolateral medulla (CVLM) neurons is strongly
respiratory modulated (Schreihofer & Guyenet, 2003;
Mandel & Schreihofer, 2006).
The goal of the present experiments is to test
several of the unproven assumptions that underlie our
present understanding of how central chemoreceptors
activate vasomotor SND. The main objectives are to test
rigorously the role of RVLM neurons in this reflex, to
determine whether the activation of these cells relies on
glutamate-mediated excitatory inputs and to circumscribe
the region of the medulla oblongata which contains the
pH-sensitive elements that are primarily responsible for
elevating sympathetic vasomotor tone.
Methods
Animals
The experiments were performed on 68 male
Sprague-Dawley rats (Taconic; Germantown, NY,
USA) weighing 270–350 g. Procedures were in accordance
with NIH Animal Care and Use Guidelines and were
approved by the University of Virginia Animal Care and
Use Committee.
Surgery and anaesthesia
General anaesthesia was induced with 5% halothane
in 100% oxygen. The rats received a tracheostomy
and surgery was done under artificial ventilation with
1.4–1.5% halothane in 100% oxygen. All rats were
subjected to the following previously described surgical
procedures: femoral artery cannulation for arterial
pressure (AP) measurement, femoral vein cannulation
for administration of fluids and drugs, removal of the
occipital plate for insertion of a pipette for microinjection
or insertion of a recording electrode into the medulla
oblongata via a dorsal transcerebellar approach, and skin
incision over the lower jaw for placement of a bipolar
stimulating electrode next to the mandibular branch of
the facial nerve (Guyenet et al. 2005a). The phrenic nerve
was accessed by a dorsolateral approach after retraction
of the right shoulder blade. All animals were bilaterally
vagotomized to prevent entrainment of the phrenic nerve
discharge to the ventilator. In most rats a complete
baro- and peripheral chemoreceptor deafferentation was
performed by sectioning the vagosympathetic trunks,
the superior laryngeal nerves and the glossopharyngeal
nerves (proximal to the junction with the carotid sinus
nerves). In the others (baro- and chemo-receptor intact
group), the vagus nerves were carefully separated from
the vagosympathetic trunk and selectively transected
bilaterally. We presume that this procedure left the aortic
depressor nerves intact but these very fine nerves were not
identified.
Splanchnic sympathetic nerve discharge (sSND) was
recorded as previously described (Schreihofer & Guyenet,
2000a,b; Schreihofer et al. 2000). The right splanchnic
nerve was isolated via a retroperitoneal approach, and
the segment distal to the suprarenal ganglion was placed
on a pair of Teflon-coated silver wires that had been
bared at the tip (250 μm bare diameter; A-M Systems,
www.a-msystems.com). In some experiments, lumbar
sympathetic nerve discharge (lSND) was also recorded
as previously described (Haselton & Guyenet, 1989;
Guyenet et al. 1990). In this case a ventral approach
to the sympathetic chain was used. The nerves and
wires were embedded in dental impression material
(polyvinylsiloxane; Darby.Spencer.Mead Dental Supply,
www.darbyspencermead.com), and the incision site was
closed around the exiting recording wires.
Upon completion of surgical procedures, halothane
concentration was adjusted (0.9–1%) for each animal
to a level sufficient to abolish the corneal reflex and
the retraction of distal phalanges to strong nociceptive
stimulation of the hindpaw. Since halothane has a marked
depressant effect on carotid body function, urethane
was used in experiments requiring preservation of the
peripheral chemoreflex. Thus, in the rats with intact
baro- and chemoreceptors, after completion of surgical
procedures, halothane was replaced by urethane
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(1.2–1.5 g kg−1) administered slowly i.v. All rats were
ventilated with 100% oxygen throughout the experiment.
Rectal temperature (maintained at 37◦C) and end
tidal-CO2 were monitored throughout the experiment
with a capnometer (Columbus Instruments, Ohio,
USA) that was calibrated twice per experiment against
a calibrated CO2–N2 mix. This instrument provided a
reading of < 0.1% CO2 during inspiration in animals
breathing 100% oxygen and an asymptotic, nearly
horizontal reading during expiration. We previously
showed that the capnometer readings closely approximate
arterial PCO2 (Guyenet et al. 2005a). Regardless of
the anaesthetic used, the adequacy of anaesthesia was
monitored during a 20 min stabilization period by
testing for absence of withdrawal response, lack of AP
change and lack of change in PND rate or amplitude
to firm toe pinch. After these criteria were satisfied, the
neuromuscular blocker pancuronium was administered
at the initial dose of 1 mg kg−1 i.v. and the adequacy of
anaesthesia was thereafter gauged solely by the lack of
increase in AP and PND rate or amplitude to firm toe
pinch. No adjustment of the halothane concentration was
needed. However, approximately hourly supplements of
one-third of the initial dose of urethane were needed to
satisfy these criteria during the course of the recording
period (4 h).
In vivo recordings of physiological variables
and neuronal activity
Arterial pressure (AP), the mass discharge of the phrenic
(PND), splanchnic (sSND) and lumbar (lSND) nerves,
tracheal CO2 and single units were recorded as previously
described (Guyenet et al. 2005a).
As in prior work, the caudal and ventral boundaries
of the facial motor nucleus were identified in each
rat by the large (up to 5 mV) negative antidromic
field potential generated in the facial motor nucleus
by stimulating the mandibular branch of the facial
nerve (for details see Brown & Guyenet, 1985). Before
starting the experiments, ventilation was adjusted to lower
end-expiratory CO2 – 4% at steady state (60–80 cycles s−1;
tidal volume 1–1.2 ml (100 g)−1). These conditions were
selected because 4% end-expiratory CO2 was below the
threshold of the PND. Variable amounts of pure CO2
were then added to the breathing mixture to adjust
end-expiratory CO2 to the desired level.
All analog data (end-expiratory CO2, sSND, lSND, PND,
AP and unit activity) were stored on a microcomputer
via a micro1401 digitizer from Cambridge Electronics
Design (CED, Cambridge, UK) and were processed
off-line using version 5 of the Spike 2 software (CED).
Processing included action potential discrimination and
binning, neuronal discharge rate measurement, and
PND ‘integration’ (iPND) consisting of rectification
and smoothing (τ , 0.015 s). Neural minute × volume
(mvPND, a measure of the total phrenic nerve discharge
per unit of time) was determined by averaging iPND
over 50 s and normalizing the result by assigning a value
of 0 to the dependent variable recorded at low levels of
end-expiratory CO2 (below threshold) and a value of 1
at the highest level of PCO2 investigated (between 9.5 and
10%). The CED software was also used for acquisition
of peri-event histograms of neuronal activity and
peri-event averages of iPND. The peri-event histograms of
neuronal single-unit activity were triggered on iPND trace
and represented the summation of at least 100 respiratory
cycles (350–800 action potentials per histogram).
The steady-state relationship between RVLM neuronal
activity and end-expiratory CO2 was obtained by stepping
the inspired CO2 level to various values for a minimum
of 3 min and up to 5 min. The mean discharge rate of
the neuron was measured during the last 30 s of each
step at which time end-expiratory CO2 and the discharge
of the neuron appeared to have reached equilibrium.
End-expiratory CO2 was measured by averaging the
maximum values recorded from 10 consecutive breaths
at the midpoint of the time interval sampled.
Stimulation of carotid chemoreceptors was done with
bolus injections of sodium cyanide (NaCN) (50 μg kg−1,
i.v.). Evidence that the stimulus activated brainstem
neurons via stimulation of carotid chemoreceptors was
obtained by demonstrating that denervation of these
receptors eliminated the excitatory effect of the stimulus
on PND.
Extracellular recording and juxtacellular labelling
of neurons in the RVLM
Single-unit recording experiments were performed in
seven baroreceptor-denervated halothane-anaesthetized
rats, artificially ventilated rats. A concentric bipolar
stimulating electrode was placed in the dorsolateral
funiculus of the spinal cord at T2 for antidromic activation
of RVLM neurons (Brown & Guyenet, 1985). The exposed
surface of the spinal cord was immersed in warm
mineral oil. The discharges of barosensitive neurons in
the RVLM were recorded extracellularly as previously
described (Schreihofer & Guyenet, 1997) using glass
electrodes filled with 1.5% biotinamide (Molecular Probes,
www.molecularprobes.com) in 0.5 m sodium acetate.
Optimal electrode resistance for recording and labelling
cells was 20–40 M measured in vivo. Recordings were
made with an intracellular amplifier in bridge mode
(Axoclamp 2A, Axon Instruments, www.axon.com) to
allow monitoring of action potentials during injection
of current through the electrode. The RVLM was
located using stereotaxic coordinates: 0–500 μm caudal to
the caudal end of the facial nucleus (identified by the
antidromic field potential), 1.6–2.0 mm lateral to the
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midline, and 0–200 μm below the ventral extent of
the facial field potential. The RVLM neurons selected
for labelling had the following characteristics: proper
location relative to the facial motor nucleus, spontaneous
activity (18–20 Hz at rest) and antidromic activation
from the spinal cord. As RVLM neurons generally
exhibit a high level of spontaneous activity and are
frequently subjected to medium-latency orthodromic
excitation (> 8–10 ms), spontaneous collisions prevented
identification of spinal-projecting axons except in neurons
with fast-conducting spinal axons (latency < 8 ms). After
electrophysiological characterization, RVLM bulbospinal
neurons were filled with biotinamide using the previously
described juxtacellular labelling method (200 ms pulses of
1.0–4.0 nA at 2.5 Hz for 1–3 min) (Schreihofer & Guyenet,
1997).
Intraparenchymal injections
Muscimol (Sigma; 1.75 mm in sterile saline pH 7.4)
or kynurenic acid (Kyn) (Sigma; 50, 100 or 200 mm
first dissolved in 1 n NaOH and then diluted in
phosphate-buffered saline pH 7.4) was pressure injected
(30–50 nl in 5 s) bilaterally through single-barrel glass
pipettes (20 μm tip diameter). The solutions contained
a 5% dilution of fluorescent latex microbeads (Lumafluor,
New City, NY, USA) for later histological identification of
the injection sites (Guyenet et al. 1990). The glass pipettes
containing the drug–microbeads mixture also allowed
recordings of field potentials and multiunit brain activity,
properties that were used to help direct the electrode tip to
the desired sites. Injections into RVLM were thus guided by
recording the facial field potential and were placed 200 μm
below the level corresponding to the lower edge of the
field, 0–400 μm caudal to the caudal end of the field and
1.6–2.0 mm lateral to the midline. Injections into the RTN
were also guided by recording the facial field potential and
were placed 200 μm below the lower edge of the field,
1.6–1.9 mm lateral to the midline and 200–400 μm rostral
to the caudal end of the field. Injections into the rostral
ventral respiratory group (rVRG) were guided by locating
inspiratory-related multiunit activity. The target region
was found 500 μm rostral to the calamus scriptorius,
1.8 mm lateral to midline and 1.9–2.2 mm below the dorsal
surface of the brainstem using electrodes angled 20 deg
forward. The electrophysiological recordings were made
on one side only and the second injection was placed
1–2 min later in the symmetric brain location (3.6 mm
away) based on the stereotaxic coordinates of the first
one. The classification of respiratory neurons was based
on the timing of their discharge in relation to that of
the phrenic nerve using accepted nomenclature (Feldman
& McCrimmon, 1999). Injections into the commissural
part of the nucleus of the solitary tract (commNTS) were
made 400 mm caudal to the calamus scriptorius, in the
midline and 0.3–0.5 mm below the dorsal surface of the
brainstem.
Histology
At the end of the experiment the rat was deeply
anaesthetized with halothane and perfused transcardially
with PBS (pH 7.4) followed by paraformaldehyde (4% in
0.1 m phosphate buffer, pH 7.4). The brain was removed
and stored in fixative for 24 h at 4◦C. Using a vibrating
microtome (Leica VT 1000S, Nussloch, Germany), 30 μm
coronal sections were cut through the medulla and
stored in a cryoprotectant solution at 20◦C (Schreihofer
& Guyenet, 1997). All histochemical procedures were
done using free-floating sections according to previously
described protocols. The sections were later processed
for visualization of biotinamide and phenylethanolamine
N-methyl transferase (PNMT) (Schreihofer & Guyenet,
1997). Biotinamide was revealed by incubating the
sections in streptavidin conjugated with Alexa 488 (1 : 200;
3 h; Jackson Immunoresearch Laboratories, West Grove,
PA, USA). This method was combined with immuno-
fluorescent detection of PNMT using an already described
rabbit polyclonal antibody (provided by M. C. Bohn)
used at 1 : 2000 dilution and revealed with a Cy3-tagged
anti-rabbit IgG (1 : 200; Jackson). Finally, the sections were
mounted in sequential rostrocaudal order onto slides,
dehydrated through a graded series of alcohol and xylene
and covered with Krystalon (EMD Chemicals Inc, NJ,
USA).
A conventional Zeiss Axioskop 2 multifunction
microscope (brightfield, darkfield and epifluorescence)
was used for all observations. Injection sites (fluorescent
microbeads) and biotinamide-labelled neurons were
plotted using a previously described computer-assisted
mapping technique based on the use of a motor-driven
microscope stage controlled by the Neurolucida
software (Stornetta & Guyenet, 1999). The Neurolucida
files were exported to the NeuroExplorer software
(MicroBrightfield, Colchester, VT, USA) to count the
various types of neuronal profiles within a defined area of
the reticular formation.
Section alignment between brains was done relative to a
reference section. To align sections around RVLM or RTN
level, the most caudal section containing an identifiable
cluster of facial motor neurons was identified in each brain
and assigned the level 11.6 mm caudal to Bregma (Bregma
−11.6 mm) according to the atlas of Paxinos & Watson
(1998). Levels rostral or caudal to this reference section
were determined by adding a distance corresponding to
the interval between sections multiplied by the number
of intervening sections. The same method was also used
to identify the Bregma level of the muscimol injections
targeted to the rVRG. When the object of the experiment
was to locate injection sites at commissural NTS level, the
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reference section used to align all others was the one closest
to mid-area postrema level (Bregma −13.8 mm).
The Neurolucida files were exported to the Canvas 9
software drawing program for final modifications. Images
were captured with a SensiCam QE 12-bit CCD camera
(resolution 1376 × 1040 pixels, Cooke Corp., Auburn
Hills, MI, USA). The neuroanatomical nomenclature is
after Paxinos & Watson (1998).
Statistics
Statistical analysis was done with Sigma Stat version 3.0
(Jandel Corporation, Point Richmond, CA, USA). Data are
reported as means ± standard error of the mean (s.e.m.).
t test, paired t test and one-way parametric ANOVA
followed by the Newman-Keul multiple comparisons test
were used as appropriate. Significance was set at P < 0.05.
A
B
C
D
Figure 1. Effect of hypercapnia on SND
and PND in vago-sino-aortic
denervated rats
A, effect produced by step-wise increases
in end-expiratory CO2 on splanchnic SND
(sSND) and PND in one rat. The ganglionic
blocker hexamethonium (Hex) was used to
define baseline SND. Inset shows the
peri-event average of sSND triggered on
the ascending phase of iPND. B, steady-
state relationship between sSND and
end-expiratory CO2 under halothane (11
rats) or urethane anaesthesia (8 rats). sSND
recorded at 3.3–3.8% CO2 was defined as
100 units. The noise (0 unit) was defined
by the hexamethonium method. C,
steady-state relationship between mvPND
(1 normalized unit equals the maximum
value of the signal) and end-expiratory
CO2 for the rats shown in B. D, evidence
that the animals were completely
barodenervated (Phe, phenylephrine,
5 μg kg−1 I.V.; SNP, sodium nitroprusside
30 μg kg−1 I.V.).
Results
Effect of central chemoreceptor stimulation
on SND and PND
These experiments were performed in vagotomized,
baro- and chemo-denervated rats (henceforth called
completely denervated rats). PND and splanchnic SND
(sSND) increased as a function of end-expiratory CO2
and steady-state values were reached after about 3 min
(Fig. 1A). Splanchnic SND exhibited its characteristic
early inspiratory modulation (inset in Fig. 1A). The
relationship between sSND and end-expiratory CO2 at
steady state was curvilinear suggesting the probable
existence of a threshold around 4% CO2 (Fig. 1B).
The sSND response to CO2 was anaesthetic-dependent
and somewhat larger under halothane than urethane
anaesthesia (Fig. 1B; steady-state SND increase from
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Table 1. Effect of Kyn injection into RVLM on lumbar SND
Low CO2 (5%) High CO2 (10%) Number of
animals
Before Kyn 100 191 ± 3∗ 4
After Kyn 102 ± 4 193 ± 3∗ 4
Recovery 101 ± 2 189 ± 5∗ 4
Values are mean ± S.E.M. ∗Significantly different from rest (low
CO2). Kyn, kynurenic acid; SND, sympathetic nerve discharge.
3–3.5% to 9.5–10% CO2: 388 ± 4% under halothane versus
250 ± 2% under urethane; P < 0.05). After normalization,
the PND response to CO2 was the same under both
anaesthetics (Fig. 1C). The lack of response in sSND to
acute changes in AP (Fig. 1D) and the absence of pulse
synchrony in the sSND (data not shown) demonstrated
that the preparation was baro-denervated. All animals
showed complete denervation as indicated by one or both
of these tests.
A
D E
F G
B
C
s a
Figure 2. Effect of hypercapnia on the
discharge rate of putative bulbospinal
vasomotor neurons of the rostral
ventrolateral medulla (RVLM) in
vagotomized and sino-aortic
deafferented rats
A, effect produced by stepping
end-expiratory CO2 from 5 to 10% on the
discharge of a putative bulbospinal
vasomotor neuron. B, time-controlled
collision test showing that the neuron
shown in A sends an axon to or through
spinal segment T3 (∗ indicates two sweeps
when collision occurred. Collisions
(absence of the antidromic spike, a, were
caused by decreasing the interval between
a spontaneous spike, s, and the stimulus
delivered to the spinal cord (arrow).
C, procedure used to label the cell
juxtacellularly with biotinamide (upper
trace: unit; lower trace current monitor;
3.4 nA). D, mean effect of stepping CO2
from 5 to 10% on 11 bulbospinal RVLM
neurons (∗P < 0.05 from both control and
recovery values). E, location of the
biotinamide-labelled neurons. The two
coronal sections represent from top to
bottom Bregma −11.6 and −11.8 mm
after Paxinos & Watson (1998).
F, PND-triggered activity histogram of the
RVLM bulbospinal neuron shown in A–C
reveals a respiratory pattern reminiscent of
that of the splanchnic nerve. G, different
RVLM neuron exhibiting a respiratory
pattern reminiscent of that of the lumbar
nerve. Amb, ambiguus nucleus; IO, inferior
olive; py, pyramidal tract; RPa, raphe
pallidus; sp5, spinal tract of trigeminal
nerve; VII, facial motor nucleus.
Lumbar SND (lSND) was recorded instead of splanchnic
SND in four halothane-anaesthetized denervated rats.
As expected, the respiratory modulation of lSND
consisted of an early inspiratory depression, followed
by a post-inspiratory peak (not illustrated; Haselton &
Guyenet, 1989). Increasing end-expired CO2 from 5% to
10% caused a 93% rise in lSND (Table 1). This increase
was the same as that of the sSND when the latter was also
measured while stepping end-expiratory CO2 between 5
to 10% (97 ± 6%).
Effect of central chemoreceptor stimulation on the
discharge rate of RVLM vasomotor neurons
Under anaesthesia, the baro-regulated class of sympathetic
efferents is mainly controlled through sympathoexcitatory
neurons located in the RVLM (Guyenet, 2006). The next
experiments were designed to determine whether the
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sympathoexcitatory response to CO2 is also associated
with an increased activity of these RVLM neurons. Since
the experiments had to be conducted in completely
denervated rats, the identification of the bulbospinal
sympathoexcitatory neurons located in the RVLM relied
on criteria other than their barosensitivity namely
location, spontaneous activity, axonal projection to the
thoracic cord and respiratory modulation typical of
lumbar or splanchnic SND. Cell location and cell
phenotype (adrenergic or not) was determined following
juxtacellular labelling (3.4 ± 0.2 nA for an average of
2 min). Eleven units with these characteristics were
identified, labelled with biotinamide and recovered
histologically (1–2 neurons per rat in 7 rats). Complete
barodenervation was demonstrated by the lack of effects
of raising or lowering AP on unit activity and the absence
of a pulse modulation in the discharge of the cells (data not
shown). Figure 2A shows the slowly developing activation
of a putative sympathoexcitatory neuron. The collision
test used to demonstrate that this cell had an axon at
thoracic level is shown in Fig. 2B. The entrainment of
the cell by extracellularly applied current (3.4 nA), which
produces the uptake of biotinamide by the stimulated cell,
is shown in Fig. 2C (upper trace, neuron; lower trace,
juxtacellularly applied current). Every bulbospinal RVLM
neuron tested was activated by hypercapnia. The average
antidromic latency was 3.8 ± 0.6 ms (range: 3.1–7.8 ms).
On average, increasing end-expired CO2 from 5 to 10%
raised the discharge rate of these cells from 18.2 ± 1.5
to 30 ± 3 spikes s−1 (67% increase; P < 0.05; Fig. 2D;
range 20–130%). The increase in mean discharge rate
was associated with an increase in AP of 25 ± 5 mmHg
(P < 0.05; comparison between mean AP at rest and at
Figure 3. Phenotype of the recorded rostral
ventrolateral medulla (RVLM) neurons
A and B, example of a biotinamide-labelled neuron
that was immunoreactive for phenylethanolamine
N-methyl transferase (PNMT, C1 adrenergic
neuron). C and D, example of a recorded neuron
that was negative for PNMT though located next to
a cluster of C1 cells (calibration, 50 μm).
the end of the hypercapnic episode). The unit shown in
Fig. 2A had a respiratory modulation that was of central
origin as indicated by the fact that ventilation and PND
were asynchronous (flat PND-triggered end-expiratory
CO2 average, Fig. 2F). The peri-event activity histogram
of this unit had an early inspiratory peak characteristic
of splanchnic SND (Fig. 2F ; compare with Fig. 1A, inset).
This pattern was found in 4 of 11 units. Five units had the
typical lumbar SND pattern (decreased firing probability
during early inspiration and increased discharge during
post-inspiration; Fig. 2G). The remaining two units had
no obvious respiratory modulation. The location of the
11 biotinamide-labelled cells is shown in Fig. 2E. Seven
neurons were PNMT-immunoreactive (Figs 2E, and 3A
and B) and four were not (Figs 2E, and 3C and D). All the
cells were found within the cluster of PNMT-ir neurons
that defines the pressor region of the RVLM.
Effects of kynurenic acid injection into the rostral
ventrolateral medulla on respiratory and sympathetic
outflows
Most sympathoexcitatory reflexes are severely attenuated
by blocking ionotropic excitatory amino acid (EAA)
receptors in the RVLM (Guyenet, 2006). In order to test
whether the sympathoactivation caused by stimulation
of central chemoreceptors conforms to this general rule
we injected the broad spectrum ionotropic EAA receptor
antagonist kynurenic acid (Kyn) into the RVLM and tested
the effect of this treatment on the rise in sSND and
PND caused by stepping end-expiratory CO2 from 5%
to 10% for 5 min. Hypercapnia produced an immediate
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hypotension of −12 ± 8 mmHg followed 30 s later by a
gradual return of AP to or slightly above control level.
Immediately after return to 5% CO2, AP increased by
23 ± 2 mmHg and returned to control values after 5 min.
Injections of Kyn (50 nl, concentration varying from
50 to 200 mm) were placed bilaterally in the RVLM of 18
totally denervated animals (50 mm in 6 rats, 100 mm in
5 rats and 200 mm in 7 rats). Kyn produced no effect on
resting AP and sSND at any of the three doses. At 50 and
100 mm, Kyn reduced PND amplitude measured at 10%
CO2 by 54 and 72%, respectively, and increased the rate
of the phrenic discharge (data not illustrated). At 200 mm,
Kyn almost completely eliminated PND (Fig. 4A and D).
Half-recovery time of PND ranged from 20 to 40 min
and complete recovery from the effect of Kyn on PND
occurred within 60 min (Fig. 4D). Kyn did not change the
increase in sSND caused by hypercapnia at any of the three
concentrations tested. The results produced by the highest
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Figure 4. Kynurenic acid (Kyn) injection into
the rostral ventrolateral medulla (RVLM) does
not change the effect of hypercapnia on sSND
in vagotomized sino-aortic deafferented rats
A, effect produced by stepping end-expiratory CO2
from 5 to 10% on sSND and PND in one rat before
and 5 min after bilateral microinjection of Kyn into
RVLM (200 mM, 50 nl). B, average results from 7
rats. Resting sSND during the control period (5%
CO2) was defined as 100 units (∗significant
difference between 10 and 5% CO2). Rec, recovery
period (> 60 min after Kyn injection). C, effect
produced by stepping end-expiratory CO2 from 5 to
10% on sSND before, during and after Kyn (n.s.).
D, effect of Kyn on mvPND elicited by stepping
end-expiratory CO2 from 5 to 10% (∗P < 0.05).
E, injection sites. The three coronal sections
represent from top to bottom Bregma −11.8,
−11.96 and −12.3 mm after Paxinos & Watson
(1998).
dose of Kyn (200 mm) are illustrated in Fig. 4. Note that the
drug changed neither the baseline value of sSND nor the
level of sSND reached at steady state during hypercapnia
(Fig. 4A and B). The hypercapnia-induced change in SND
is replotted in Fig. 4C for clarity. The Kyn injection sites
at the 200 mm dose (N = 7) are shown in Fig. 4E. These
sites were centred on the region that contains the bulk of
the bulbospinal sympathoexcitatory neurons of the RVLM
(compare Figs 2E and 4E).
The surprising lack of effect of even the highest dose
of Kyn on sSND response to CO2 prompted us to verify
that identical injections of Kyn could block the effect
of peripheral chemoreceptor stimulation on sSND as
described before (Koshiya et al. 1993; Sun & Reis, 1995).
Bilateral injection of Kyn (50 nl, 200 mm into RVLM) in
eight vagotomized urethane-anaesthetized rats with intact
carotid sinus nerves did not change AP (118 ± 2.5 mmHg
versus control, 121 ± 3 mmHg) or sSND at rest but these
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injections virtually eliminated resting PND and reduced
by 86 ± 7% the increase in AP and sSND produced by i.v.
injection of NaCN (Fig. 5A for representive case; Fig. 5B
and C for average results).
Effects of bilateral injection of kynurenic acid into
the retrotrapezoid nucleus on respiratory
and sympathetic outflows
The RTN region contains chemosensitive neurons that
probably provide an important source of excitatory drive
to the respiratory network, especially under anaesthesia
(Feldman et al. 2003). EAA receptor blockade in the RTN
region has also been described as capable of decreasing
the activity of the central respiratory pattern generator
(Nattie & Li, 1995). The next experiments were therefore
designed to determine whether bilateral blockade of EAA
receptors in RTN can suppress the stimulatory effect of
central chemoreceptor activation on PND and sSND. Kyn
(200 mm, 50 nl) was injected bilaterally under electro-
physiological guidance 200 μm below the facial motor
nucleus and 200 μm rostral to the caudal end of this
nucleus to target the region that contains the highest
density of CO2-sensitive RTN neurons according to our
prior data (Mulkey et al. 2004; Guyenet et al. 2005a).
Kyn reduced PND amplitude during hypercapnia by an
average of 49% (Fig. 6A and D). Kyn also increased PND
rate. However, the drug had no effect on the increase in
sSND caused by increasing end-expiratory CO2 from 5
to 10% (Fig. 6B and C). The effect of Kyn on PND was
fully reversible within 60 min (Fig. 6D). Kyn injections
did not change resting AP (control, 98 ± 4 mmHg; Kyn,
99 ± 5 mmHg). The Kyn injection sites were located below
the caudal and medial edge of the facial motor nucleus
(Fig. 6E). The fluorescent beads used to track the injection
sites had spread approximately 240 μm on each side of the
injection centre.
In brief, Kyn did not reduce the central stimulatory
effect of hypercapnia on sSND, regardless of whether the
injections were placed at the very rostral end of the RVLM,
the region that includes the RTN (Fig. 6E), or slightly more
caudally within the classically defined pressor region of
RVLM (Fig. 4E). However, PND inhibition by Kyn was
much greater when the drug was injected in the classically
defined RVLM than when it was placed more rostrally into
RTN (compare Figs 4D and 6D). This difference suggests
that the VLM site at which Kyn inhibits respiration in our
preparation is probably not the RTN but a region located
caudal to it. This result is consistent with prior evidence
that the discharge of RTN neurons is not affected by Kyn
in our preparation (Mulkey et al. 2004). The difference
between our results and those of Nattie & Li (1995) could
be due to the fact that the carotid sinus nerves were cut
in our preparation, thereby eliminating the glutamatergic
excitatory input to the chemosensitive neurons of RTN
(Takakura et al. 2006).
Effects of muscimol injection into the commissural
portion of the solitary tract nucleus (commNTS)
on respiratory and sympathetic chemoreflexes
The presence of acid-responsive neurons in the NTS and
the fact that NTS acidification in vivo alters respiration has
been interpreted as evidence that this structure contains
central respiratory chemoreceptors (Nattie & Li, 2002;
Feldman et al. 2003). The next experiments were designed
to test the role played by commNTS in the activation
of sSND and PND by increases in brain PCO2 . This
was accomplished by measuring the effects produced by
microinjecting the GABAA receptor agonist muscimol
(single 30 nl midline injection of 1.75 mm muscimol)
into the commNTS of seven completely denervated
halothane-anaesthetized rats. In order to verify our under-
lying assumption that muscimol did inhibit commNTS
neurons we also examined the effect of similar injections
on peripheral chemoreflexes. The latter experiments were
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Figure 5. Kynurenic acid (Kyn) injection into rostral
ventrolateral medulla (RVLM) greatly attenuate the peripheral
chemoreflex in vagotomized rats
A, response of the splanchnic and phrenic nerves to peripheral
chemoreceptor stimulation with I.V. cyanide (NaCN: 50 μg kg−1) in a
urethane-anaesthetized rat, before (left panel) and 5 min after bilateral
injection of Kyn (200 mM, 50 nl: right panel) into RVLM. B, effect of
Kyn on the cyanide-induced rise in MAP (∗P < 0.05; 8 rats). C, effect
of Kyn on the cyanide-induced rise in sSND (∗P < 0.05; 8 rats).
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conducted in eight vagotomized urethane-anaesthetized
rats with intact carotid sinus nerves.
Muscimol had no effect on the sympathetic or
the phrenic component of the central chemoreflex
(representative example in Fig. 7A; summary data in
Fig. 7B and C; histologically verified injection sites in
Fig. 7E).
In vagotomized rats with intact carotid sinus nerves,
muscimol injection into commNTS (7 rats) did not
change resting PND but eliminated the activation of
the sympathetic and respiratory outflows produced by
stimulating the carotid bodies with NaCN (representative
example in Fig. 8A; summary data in Fig. 8B and C).
The muscimol injection sites (not illustrated) were
indistinguishable from those shown in Fig. 7E.
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Figure 6. Kynurenic acid (Kyn) injection into the
retrotrapezoid nucleus (RTN) does not change the
effect of hypercapnia on sSND in vagotomized
sino-aortic deafferented rats
A, effect produced by stepping end-expiratory CO2
from 5 to 10% on sSND and PND in one rat before and
after bilateral microinjection of Kyn into RTN (200 mM,
50 nl). B, average results from 8 rats. sSND at rest during
the control period was defined as 100 units (∗P < 0.05,
significant difference between 10 and 5% CO2).
C, effect produced by stepping end-expiratory CO2
from 5 to 10% on the CO2-induced change in sSND
before and 5 min after injection of Kyn (n.s.). D, effect
of Kyn on mvPND elicited by stepping end-expiratory
CO2 from 5 to 10% (∗P < 0.05 relative to control and
recovery). E, injection sites. The three coronal sections
represent from top to bottom Bregma −11.0, −11.3
and −11.6 mm after Paxinos & Watson (1998).
Role of the caudal ventrolateral medulla
in the central sympathetic chemoreflex
The rise in sympathetic vasomotor outflow elicited by
central chemoreceptor stimulation is usually considered
to be driven synaptically by the activation of the central
respiratory pattern generator (Richter & Spyer, 1990). To
test the validity of this assumption we examined whether
pharmacological blockade of the central respiratory
pattern generator alters the sympathetic response to
hypercapnia in completely denervated rats.
Pharmacological blockade of the respiratory network was
performed by injecting drugs into the ventral respiratory
columm caudal to the RVLM (also called CVLM). Kyn
(200 mm, 50 nl per side) was used in a group of six
completely denervated rats and muscimol (1.75 mm,
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30 nl per side) was used in a second group of rats (n = 9).
The injections were placed under electrophysiological
guidance into a region of the rVRG/CVLM where strong
inspiratory-related multiunit activity could be recorded
from the injection pipette. The effects of these injections
on the respiratory system were gauged by their effect on
PND.
Kyn injection into the CVLM eliminated PND for up
to 60 min and prevented its activation by CO2 (Fig. 9A
and D). The injection centres were located close to
1.5 mm posterior to the caudal end of the facial motor
nucleus (Fig. 9E). By our previous estimates, these sites
correspond to the CVLM and the rostral end of the
rVRG (Stornetta et al. 2003). The fluorescent microbeads
extended 250 ± 12 μm on each side of the injection centre
and therefore Kyn, which diffuses more freely that micro-
beads, is likely to have also reached the respiratory neurons
located in the pre-Bo¨tzinger complex. Bilateral injection of
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Figure 7. Muscimol injection into the commissural
part of the solitary tract nucleus (commNTS) does
not change the effect of hypercapnia on sSND or
PND in vagotomized sino-aortic denervated rats
A, effect produced by stepping end-expiratory CO2
from 5 to 10% on sSND and PND in one rat before and
after a single midline microinjection of muscimol into
commNTS (1.75 mM, 30 nl). B, average results from
7 rats. sSND at rest during the control period was
defined as 100 units (∗P < 0.05 between 10 and 5%
CO2). C, effect produced of stepping end-expiratory
CO2 from 5 to 10% on the CO2-induced increase in
sSND before and 5 min after injection of muscimol
(n.s.). D, effect of muscimol on mvPND elicited by
stepping end-expiratory CO2 from 5 to 10% (n.s.).
E, injection sites. The two coronal sections represent
from top to bottom Bregma −14.08 and −14.3 mm
after Paxinos & Watson (1998). AP, area postrema;
cc, central canal; Gr, gracile nucleus; XII, hypoglossal
nucleus; for other abbreviations see Fig. 2.
Kyn increased resting AP from 100 ± 3 to 132 ± 5 mmHg
(P < 0.05) and resting sSND from 100 to 125% (P < 0.05).
Kyn also significantly increased the effect of hypercapnia
on sSND (Fig. 9B and C).
Virtually identical results were obtained when muscimol
instead of Kyn was injected into CVLM (8 rats; example
in Fig. 10A; summary data in Fig. 10B–D; injection sites
in Fig. 10E). Note that muscimol increased resting AP
from 103 ± 2 to 139 ± 5 mmHg (P < 0.05), eliminated
PND, increased resting sSND to 148 ± 9% of control level
(P < 0.05) and increased the magnitude of the sympathetic
nerve response to central chemoreceptor stimulation
(Fig. 10C).
Discussion
The present study indicates that the sympathoactivation
caused by rises in brain PCO2 is predominantly mediated
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by the activation of C1 and other sympathoexcitatory
neurons of the RVLM. We also show that the activation
of these neurons does not rely on chemoreceptors located
within the commNTS or the rVRG-pre-Bo¨tzinger region
(CVLM). Finally, we also show that hypercapnia activates
an inhibitory input to RVLM neurons, which reduces the
overall effect of CO2 on the sympathetic outflow. These
results and the pertinent literature are discussed in the
context of the largely novel scheme depicted in Fig. 11.
An essential aspect of the proposed scheme is that the
excitatory effect of CO2 on RVLM sympathoexcitatory
neurons results either from the intrinsic chemosensitivity
of these cells or from the activation of the pH-sensitive
interneurons located in RTN. The second essential feature
of the scheme is that the respiratory modulation of
SND is attributed to two processes: active inhibition by
GABAergic neurons located in CVLM and disfacilitation
of the RTN neurons. The respiratory modulation of the
sympathoexcitatory neurons is viewed as attenuating the
overall activation of the sympathetic outflow caused by
elevations of central nervous system (CNS) PCO2 .
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Figure 8. Muscimol injection into commissural part of the
solitary tract nucleus (commNTS) blocks peripheral
chemoreflexes in vagotomized rats
A, response of the splanchnic and phrenic nerves to peripheral
chemoreceptor stimulation with I.V. cyanide (50 μg kg−1) in a
urethane-anaesthetized rat before (left panel) and 5 min after a single
midline injection of muscimol (1.75 mM, 30 nl: right panel) into
commNTS. B, effect of muscimol on the cyanide-induced rise in MAP
(∗P < 0.05 when comparing effect of NaCN before and after
muscimol; 7 rats). C, effect of muscimol on the cyanide-induced rise in
sSND (∗P < 0.05; 7 rats).
RVLM sympathoexcitatory neurons contribute
to the sympathoactivation caused by central
chemoreceptor stimulation
Under anaesthesia, hypercapnia markedly increases
sympathetic efferent activity in vagotomized and
sino-aortic denervated preparations (Preiss & Polosa,
1977; Hanna et al. 1981; Millhorn & Eldridge, 1986).
In agreement with this well-established phenomenon,
the mass activity of the splanchnic or lumbar nerves
almost doubled at steady state in our preparation when
end-expiratory CO2 was raised from 5 to 10% and
SND more than tripled relative to the baseline recorded
at 3.5% CO2. The type of respiratory entrainment
observed in these sympathetic nerves during central
chemoreceptor stimulation (early inspiratory peak in
splanchnic and post-inspiratory peak in lumbar) also
conformed to prior observations in rats (Numao et al.
1987; Darnall & Guyenet, 1990; Guyenet et al. 1990;
Pilowsky et al. 1996). As shown before, the magnitude
of the respiratory modulation of SND (difference between
apex and nadir) is less pronounced in rats than in other
species and its pattern is also different. In our experimental
preparation, virtually all the activity recorded in these
nerves is silenced by stimulating arterial baroreceptors
(Haselton & Guyenet, 1989) therefore the recorded activity
consists overwhelmingly of baroregulated vasoconstrictor
efferents (Guyenet, 2006).
In our experiments hypercapnia produced an almost
immediate hypotension, which most probably results
from a direct (i.e. not sympathetically mediated) effect
of CO2 on the vasculature and, possibly, on cardiac
contractility. Blood pressure gradually came back up
during hypercapnia to reach about control level at the end
of the episode. Then, just after the hypercapnia episode, BP
tended to overshoot briefly. We assume that this overshoot
reflects the increase in sympathetic activity at a time when
the direct depressant effect of CO2 on the vasculature was
rapidly waning.
The effect of central chemoreceptor stimulation on the
activity of RVLM vasomotor neurons has rarely been
examined before, presumably because of the difficulty in
identifying these neurons in a preparation in which arterial
baroreceptors have been cut. The only prior attempt
(Haselton & Guyenet, 1989) reported a mean increase in
discharge of 36 ± 8% between 5 and 10% end-expiratory
CO2. The present result is 67 ± 4%. The difference is
probably due to the fact that we measured the effect
of CO2 at steady state (3–5 min equilibration) in the
present experiments whereas the cells were exposed to
shorter periods of hypercapnia in our prior study. As
shown by the kinetics of the phrenic response, several
minutes are required for equilibration. This delay is
required to establish a steady state in brain pH and
medullary blood flow (Sato et al. 1992). The difference may
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also be related to the selection of neurons. In the present
study, our sample consisted exclusively of neurons with
fast-conducting axons in which the collision test could
be performed. Medium latency (8–25 ms) orthodromic
spikes evoked by spinal cord stimulation collide
systematically with antidromic spikes in slow-conducting
bulbospinal sympathoexcitatory RVLM neurons,
preventing the identification of their spinal axon. Seven of
the 11 recorded cells were PNMT-immunoreactive, which
is consistent with the previously described properties
of fast-conducting barosensitive sympathoexcitatory
neurons of the RVLM (Schreihofer & Guyenet, 1997). In
the present case we do not know with certainty that the
presumed sympathoexcitatory neurons that we recorded
would have been regulated by arterial baroreceptors but
this is very likely because, in our previous experience,
all spontaneously active bulbospinal neurons located
in the rostral C1 region are inhibited by raising AP in
animals with intact baroreceptor afferents. In any event,
the essential point in the present context is that the
recorded neurons were identified as sympathoexcitatory
neurons. This is unquestionably the case for the seven
bulbospinal adrenergic cells that were recorded because
such C1 cells are known to innervate sympathetic
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Figure 9. Kynurenic acid (Kyn) injection into the
caudal ventrolateral medulla (CVLM) increases the
effect of hypercapnia on sSND in vagotomized
sino-aortic deafferented rats
A, effect produced by stepping end-expiratory CO2
from 5 to 10% on sSND and PND in one rat before and
after bilateral microinjection of Kyn into CVLM
(200 mM, 50 nl). B, average results from 6 rats. sSND at
rest during the control period was defined as 100 units
(∗P < 0.05 between 10 and 5% CO2). C, effect
produced by stepping end-expiratory CO2 from 5 to
10% on sSND before and after injection of Kyn into
CVLM (∗P < 0.05). D, effect of Kyn on mvPND elicited
by stepping end-expiratory CO2 from 5 to 10%
(∗P < 0.05 between control and drug). E, injection sites.
The two coronal sections represent from top to bottom
Bregma −13.3 and −13.6 mm after Paxinos & Watson
(1998). NTS, nucleus of the solitary tract; for other
abbreviations see Fig. 2.
preganglionic neurons and probably the case of the other
four bulbospinal neurons although the level of evidence is
less persuasive in this case (for review see Guyenet, 2006).
It is of course impossible to be sure that a 67% increase
in the activity of RVLM neurons fully accounts for a
97% increase in vasomotor SND. This uncertainty is
compounded by the fact that we could not identify neurons
with slowly conducting axon velocity in the present study.
In other words, the present data do not exclude the
possibility that other neurons (e.g. A5) might contribute
to the SND increase caused by central chemoreceptor
stimulation.
In preparations with intact baroreceptors and carotid
bodies, the activation of RVLM vasomotor neurons by
hypercapnia is of more modest amplitude (Haselton &
Guyenet, 1989). In some cases, no significant change
has been reported at the population level (McAllen,
1987; Mulkey et al. 2004). Possible explanations include
the heterogeneity of the bulbospinal sympathoexcitatory
neurons and, again, the fact that the hypercapnic stimulus
might have been of too short duration. The more likely
explanation perhaps is that the changes in RVLM neuron
activity produced by increasing central PCO2 are attenuated
by baroreceptor feedback due to the rise in AP, especially
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in those neurons that have the most powerful input
from these receptors and are thus the easiest to identify.
This attenuation may be further accentuated by the fact
that the baroreceptor feedback to the vasomotor SND is
more potent under conditions that increase the activity of
the central respiratory pattern generator (Chruscielewski
et al. 1975; Trzebski & Kubin, 1981; Miyawaki et al.
1995). This potentiation can probably be explained by the
integrative properties of the CVLM neurons that mediate
the baroreflex as will be discussed below and is illustrated
in Fig. 11.
The chemoreceptors located in the solitary tract
and the rVRG-pre-Bo¨tzinger region do not contribute
to the sympathoactivation caused by increasing
brain PCO2
Central respiratory chemoreceptors are neurons that
directly or indirectly detect changes in CNS interstitial
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Figure 10. Muscimol injection into the caudal
ventrolateral medulla (CVLM) increases the effect
of hypercapnia on sSND in vagotomized
sino-aortic deafferented rats
A, effect produced by stepping end-expiratory CO2
from 5 to 10% on sSND and PND in one rat before and
after bilateral microinjection of muscimol into CVLM
(1.75 mM, 30 nl). B, average results from 9 rats. sSND at
rest during the control period was defined as 100 units
(∗P < 0.05 for effect of hypercapnia relative to
baseline). C, effect produced of stepping end-expiratory
CO2 from 5 to 10% on sSND before and 5 min after
injection of muscimol into CVLM (∗P < 0.05 for effect
of muscimol). D, effect of muscimol on mvPND elicited
by stepping end-expiratory CO2 from 5 to 10%
(∗P < 0.05). E, injection sites. The two coronal sections
represent from top to bottom Bregma −13.3 and
−13.6 mm after Paxinos & Watson (1998).
fluid pH and ultimately influence the respiratory
network. Such neurons have been tentatively identified
in many lower brainstem regions, including the NTS, the
medullary raphe and several regions of the ventrolateral
medulla including the pre-Bo¨tzinger region and the
retrotrapezoid nucleus (Guyenet et al. 2005b; Nattie & Li,
2006). Whether the same or different chemoreceptors are
implicated in the central effect of CO2 on the sympathetic
outflow is an unsettled question. The lack of effect
of muscimol injection into commNTS indicates that
the caudal cardiorespiratory portion of the NTS plays
no role in the sympathoexcitatory response to central
chemoreceptor stimulation under the anaesthetic
conditions that we selected. The elimination of the
peripheral chemoreflex caused by such injections in
rats with intact carotid nerves demonstrated how
effective muscimol was at inhibiting commNTS neurons.
Yet, acidification of commNTS via microdialysis of
CO2-enriched fluid does increase respiration in awake
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Figure 11. Working model of the sympathetic chemoreflexes
A, peripheral chemoreflex. The increased SND is mediated primarily by
activation of the bulbospinal sympathoexcitatory neurons of the
RVLM. The excitatory drive of RVLM neurons operates via a direct
glutamatergic input from commNTS neurons and via a di-synaptic
input that relays via the intrinsically chemosensitive neurons of RTN.
The latter pathway is therefore modulated by the degree of central
chemoreceptor stimulation. The respiratory modulation of SND and
RVLM neurons is seen as deriving from two mechanisms,
respiratory-phasic activation by the CPG (respiratory rhythm and
pattern-generating network, in blue) of the GABAergic neurons that
mediate the sympathetic baroreflex (neuron in red) and
respiratory-phasic inhibition of RTN neurons (red arrow, transmitter
unidentified). The first mechanism causes an active inhibition of RVLM
neurons and the second causes a disfacilitation of RVLM neurons via
reduction in RTN discharges. In combination, these two processes
attenuate the activation of RVLM neurons during chemoreceptor
stimulation and cause the respiratory modulation of SND. B, central
chemoreflex. The increased SND caused by raising CNS PCO2 is driven
via activation of the bulbospinal sympathoexcitatory neurons of the
RVLM. The relevant chemoreceptors are located in the RVLM region.
The activation of RVLM neurons by extracellular fluid acidification is
mediated synaptically via the chemosensitive neurons of RTN and,
possibly, by the intrinsic chemosensitivity of the RVLM
sympathoexcitatory neurons. The respiratory modulation of RVLM
neurons and SND has the same mechanism as in the case of the
peripheral chemoreflex (CPG-mediated activation of the CVLM
neurons and CPG-mediated inhibition of the RTN). CNS acidification
activates the CPG via chemoreceptors located in the RTN and/or the
rVRG-pre-Bo¨tzinger region but not in the NTS. The integrative
properties of the CVLM GABAergic neurons that relay the sympathetic
baroreflex (in red) account for the well-documented potentiation of
the baroreflex caused by increasing CPG activity. The scheme only
applies to the effect of chemoreceptors on the baroregulated
sympathetic efferents that control the heart and resistance vessels. The
rats (Nattie & Li, 2002). The discrepancy can be explained
three ways. The first explanation, improbable perhaps
but impossible to exclude, is that artificial acidification
via microdialysis of CO2 or with acetazolamide does
not mimic the effect of systemic hypercapnia. Second,
anaesthesia may eliminate the effect produced by
acidifying the NTS. Third, the pH-sensitive cells of the NTS
(central chemoreceptors) reside in a different location than
the second-order cells involved in the peripheral chemo-
reflex. In support of this view, the NTS region acidified by
Nattie & Li (2002) with resulting stimulation of breathing
was slightly more rostral and lateral than that which we
targeted with muscimol in the present study.
The rVRG-pre-Bo¨tzinger region of the ventral
respiratory column also contains putative respiratory
chemoreceptors (Solomon et al. 2000; Nattie & Li,
2006). These receptors are apparently not involved in the
sympathoexcitation caused by hypercapnia since bilateral
injection of muscimol or Kyn into this region did not
decrease the effect of CO2 on SND. Kyn, which only blocks
EAA transmission, could conceivably have spared the
chemoreceptors responsible for activating RVLM neurons
but this explanation does not hold in the case of muscimol,
a GABAA receptor agonist that silences all neurons. The
neuronal inhibition caused by muscimol was profound
given the hours-long disappearance of the PND at rest and
during hypercapnia. Inhibition of the rVRG-pre-Bo¨tzinger
region with either Kyn or muscimol actually increased
the sympathoexcitation caused by hypercapnia, suggesting
that this region contains an inhibitory input to RVLM
neurons that is activated by CNS acidification.
Putative organization of the medullary network
responsible for peripheral and central sympathetic
chemoreflexes
The following discussion is an attempt to fit the results
of the present study and the pertinent literature into
a novel and more comprehensive theory of how the
sympathetic vasomotor outflow is regulated by central and
peripheral chemoreceptors. In this scheme, the increase
in SND caused by central or peripheral chemoreceptor
stimulation is seen as resulting from excitatory drives
to RVLM neurons. The scheme incorporates the already
established notion that RVLM neurons are excited by
scheme is not applicable to other sympathetic efferents (e.g. to skin or
brown adipose fat). Excitatory neurons in green (large circles, cell
bodies; small circles, ionotropic glutamatergic synapses; green arrows,
neurochemically uncharacterized excitatory connections). In red,
GABAergic CVLM neurons involved in the sympathetic baroreflex. Red
arrow, neurochemically unidentified inhibitory input from the CPG to
RTN neurons. CPG, central pattern generator; CVLM, caudal
ventrolateral medulla; LRN, lateral reticular nucleus; RTN,
retrotrapezoid nucleus; RVLM, rostral ventrolateral nucleus; for other
abbreviations see Fig. 2.
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peripheral chemoreceptors via a direct glutamatergic input
from commNTS (for review and references see Guyenet,
2000). To this notion, we add the concept that this
glutamatergic projection also activates RVLM neurons
via a di-synaptic excitatory pathway from commNTS
to RVLM that relays via the chemosensitive neurons
of the retrotrapezoid nucleus (RTN; secondary input)
(Fig. 11A) (Takakura et al. 2006). In the case of the
central chemoreflex (Fig. 11B) the primary excitatory
input to RVLM neurons is seen as originating from the
chemosensitive neurons of RTN although the possibility
that the RVLM sympathoexcitatory neurons might be
intrinsically sensitive to pH is also considered (Fig. 11B).
The respiratory entrainment of RVLM neurons and
SND, which is a feature common to both reflexes,
is viewed as being mediated by the following two
mechanisms: respiratory synchronous inhibitory inputs
to RVLM neurons originating from the GABAergic
neurons of the CVLM, that normally mediate the
baroreflex, and respiratory-synchronous disfacilitation
caused by respiratory-synchronous inhibitory inputs to
RTN neurons (Fig. 11A and B).
The GABAergic cells of the CVLM are respiratory-
modulated and many have a phase-spanning respiratory
modulation that mirrors that of the sympathoexcitatory
neurons of the RVLM (Mandel & Schreihofer, 2006).
Such characteristics are therefore consistent with the
possibility that these neurons contribute to the respiratory
entrainment of RVLM neurons. Inhibition of CVLM
neurons by muscimol should thus increase the central
sympathetic chemoreflex, as observed in the present
experiments. CVLM blockade should also increase the
peripheral chemoreflex and eliminate its respiratory
oscillations, as observed in prior experiments (Koshiya &
Guyenet, 1996).
The proposed scheme is also consistent with prior
observation that the RTN chemosensitive neurons have
a phase-spanning type of respiratory modulation in
rats (Guyenet et al. 2005a). Like CVLM neurons,
RTN cells are heterogeneous with regard to respiratory
modulation but cases of respiratory patterns that are
identical to those of RVLM sympathoexcitatory neurons
(early inspiratory or post-inspiratory peak) have been
found, consistent with the possibility that these particular
RTN neurons drive RVLM sympathoexcitatory neurons
(Guyenet et al. 2005a). Furthermore, in cats, species
in which RVLM neurons and the vasomotor SND
are inspiratory modulated, the predominant respiratory
pattern of RTN neurons is also inspiratory (Connelly
et al. 1990). The respiratory entrainment of RTN neurons
is most probably due to respiratory-phasic inhibitory
inputs (Guyenet et al. 2005a). Phasic inhibition of
these chemosensitive neurons by the central respiratory
network should therefore attenuate the chemoreflexes by
a process of disfacilitation. We have already demonstrated
that respiratory-rhythmic inhibition of RTN neurons
disappears after injection of muscimol into the CVLM
region whereas the excitatory response of these neurons
to central and peripheral chemoreceptor stimulation
persists (Guyenet et al. 2005a). Therefore, by silencing
the respiratory pattern generator, muscimol inhibition of
the CVLM region should also eliminate the respiratory
modulation of RTN neurons and this effect should also
contribute to increasing the magnitude of the sympathetic
chemoreflex, as was observed.
The present study revealed that the excitatory
mechanisms responsible for the central and the
peripheral chemoreflex are distinct in one essential
respect. Ionotropic glutamatergic receptor blockade in
RVLM virtually eliminates SND activation by peripheral
chemoreceptors whereas it does not attenuate the central
sympathetic chemoreflex (present study). The effect of
Kyn on the peripheral chemoreflex is consistent with
prior anatomical and electrophysiological evidence that
the effect of peripheral chemoreceptor activation is
transmitted to RVLM and RTN neurons by a direct
glutamatergic projection from commNTS (Sun & Reis,
1995; Aicher et al. 1996; Guyenet, 2000; Takakura et al.
2006). This fact accounts for the very large attenuation of
the peripheral chemoreflex by Kyn injection into RVLM
(86% in the present case) since such injections should
block the direct activation of the sympathoexcitatory
neurons and their indirect activation via the RTN neurons.
The resistance of the central sympathetic
chemoreflex to Kyn indicates that the activation of
the RVLM neurons does not involve ionotropic glutamate
receptors. This observation suggests two alternative
possibilities represented in Fig. 11B. The effect of CO2
on RVLM neurons could result from the intrinsic
chemosensitivity of these neurons or it could be caused
by synaptic inputs from chemosensitive cells that do not
operate via ionotropic glutamate receptors. The notion
that RVLM neurons might be intrinsically pH-sensitive
still rests on extremely circumstantial evidence outlined
in the introduction but it cannot be dismissed a priori.
The presence within the RVLM region of central
chemoreceptors that activate the sympathoexcitatory
neurons synaptically is much more plausible however,
and the RTN neurons have all the required characteristics.
Briefly summarized, RTN neurons are activated by pH,
they are located at the rostral end of the RVLM at the
ventral surface and they are in close proximity to the
sympathoexcitatory neurons (Guyenet et al. 2005b). Their
activation by CO2 is independent of ionotropic glutamate
transmission and their discharge pattern becomes
extremely regular after inhibition of the CPG (Mulkey
et al. 2004; Takakura et al. 2006). These cells innervate the
region of the RVLM (Rosin et al. 2006) and, as mentioned
above, a fraction of RTN neurons have the same
phase-spanning respiratory modulation (early inspiratory
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or post-inspiratory) as the sympathoexcitatory neurons of
the RVLM (Guyenet et al. 2005a). The inability of Kyn to
attenuate the central sympathetic chemoreflex (this study)
might seem to exclude RTN neurons a priori because
these cells express VGLUT2 and therefore should release
glutamate (Mulkey et al. 2004). However, RTN neurons
may operate via metabotropic glutamate receptors or they
could release other excitatory transmitters. Metabotropic
glutamate receptors may be present on RVLM neurons
given that agonists of these receptors increase AP
substantially when they are injected into RVLM
(Tsuchihashi et al. 2000). The literature contains many
examples of VGLUT2-expressing CNS neurons that
release another transmitter that appears to play the
dominant role in synaptic transmission, e.g. orexin
neurons (Rosin et al. 2003).
In summary, the hypothetical scheme presented in
Fig. 11 could account satisfactorily for most if not all
existing observations. However, its accuracy will have to
be subjected to further and far more detailed testing.
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Discussão e Conclusão 
Quimiorreceptores centrais e núcleo retrotrapezóide. 
Os resultados mostram que os neurônios do NRT respondem tanto para a 
ativação dos quimiorreceptores centrais quanto para a ativação dos 
quimiorreceptores periféricos. Esses resultados mostram pela primeira vez a 
existência de uma via de interação entre os quimiorreceptores periféricos e os 
neurônios quimiossensíveis do NRT (quimiorreceptores centrais) e que essa 
possível via envolve os neurônios glutamatérgicos localizados na região 
comissural do NTS. Com esse trabalho, nós podemos concluir que os neurônios 
do NRT podem integrar as vias do quimiorreflexo central e periférico e constituir 
um centro importante para a integração cardio-respiratória. 
Os neurônios do NRT  apresentam alta sensibilidade a variações de CO2, 
mesmo em condições de hiperóxia (100% de O2), refletindo, portanto, a sua 
propriedade intrínseca a variações do pH extracelular  (Mulkey e cols., 2004; 
Guyenet e cols., 2005a).  
  Nesse estudo, foi utilizado o anestésico uretana e alfa-cloralose, pois sabe-
se que o anestésico halotana deprime os efeitos da estimulação dos 
quimiorreceptores periféricos. Observou-se apenas pequenas diferenças entre 
esse anestésico e o anestésico halotana (anestésico utilizado quando foi 
demonstrado pela primeira vez as características das células quimiossensíveis do 
NRT) na atividade das células do NRT (Mulkey e cols., 2004). Aparentemente, a 
única diferença observada foi que o limiar para a ativação dos neurônios do NRT 
foi um pouco mais elevado (5% vs. 4.2%) sob o efeito do anestésico uretana e alfa 
cloralose. Por outro lado, o limiar para disparo do nervo frênico foi o mesmo para 
os dois anestésicos. A resposta intrínseca dos neurônios do NRT para variações 
de CO2 é linear e a sua saturação, em altos níveis de CO2, parece ser causado 
por mecanismos inibitórios originados da região geradora do padrão respiratório 
(mais especificamente na região Pré-Botzinger, região que contém os neurônios 
responsáveis pela geração do ritmo respiratório). Nessa situação anestésica, esse 
mecanismo inibitório parece ser mais modesto, pois a modulação respiratória nos 
neurônios do NRT é muito mais reduzida se comparado com a modulação 
respiratória dos neurônios do NRT em condições de anestesia com halotana 
(Mulkey e cols., 2004; Guyente e cols., 2005; Takakura e cols., 2006). 
Todos os neurônios do NRT, analisados nesse estudo, foram, 
intensamente, ativados pelos quimiorreceptores periféricos (períodos de hipóxia 
(10-15%) e injeções endovenosas de cianeto de sódio). Essas respostas foram 
observadas apenas em animais que possuíam os quimiorreceptores periféricos 
intactos, confirmando experimentos anteriores descritos na literatura (Bodineau e 
cols., 2000a; 2000b; Mulkey e cols., 2004) e comprovando os efeitos de ativação 
dos neurônios do NRT quando se tem a ativação dos quimiorreceptores 
periféricos. 
Como já descrito anteriormente, os quimiorreceptores periféricos enviam 
suas aferências para a região do NTScom (Colombari e cols., 1996; Koshiya e 
Guyenet, 1996; Blessing e cols., 1999; Takakura e cols., 2006). A maioria desses 
neurônios projetam-se para a região ventrolateral do bulbo, onde uma dessas 
projeções seria para os neurônios da região do RVL (Aicher e cols., 1996; Koshiya 
e Guyenet, 1996; Paton e cols, 2001). De acordo com nosso estudo, os neurônios 
do NTScom, que são ativados pelos quimiorreceptores periféricos, projetam-se 
para o NRT e essa projeção é glutamatérgica (Trabalho 3: Takakura e cols., 
2006).  
Para confirmar a evidência eletrofisiológica da possível projeção do 
NTScom para o NRT, experimentos de anatomia foram utilizados, envolvendo a 
injeção de traçadores anterógraos e retrógrados. Após a injeção do traçador 
anterógrado (BDA – amina dextrana biotinilada), muitos terminais sinápticos 
encontrados na região do NRT foram observados como sendo glutamatérgicos, 
pois expressavam a vesícula para transporte de glutamato (VGLUT2) (mais de 
50%).  
Quando se combinou experimentos de expressão da proteína Fos, 
juntamente com traçadores retrógrados, observamos que a expressão da proteína 
Fos mostrou, claramente, que a projeção do NTScom para o NRT possui 
neurônios que são ativados por hipóxia. Portanto, a via entre o NTScom e o NRT é 
glutamatérgica, uma vez que mais de 90% dos neurônios do NTScom expressam 
VGLUT2 mRNA. O marcador VGLUT2 mRNA consiste num seletivo marcador de 
neurônios glutamatérgicos, pois sua expressão é necessária e suficiente para 
promover a despolarização e, portanto, mediar a exocitose do glutamato (Stornetta 
e cols., 2002).  
A pequena porcentagem de terminais glutamatérgicos no NRT, comparado 
com o número de neurônios encontrados no NTScom pode ser explicada por uma 
simples razão: a dupla marcação com o traçador anterógrado (BDA) e com a 
vesícula de glutamato (VGLUT2) pode não ser revelado de maneira idêntica, em 
especial na penetração do anticorpo em diferentes profundidades no tecido 
cerebral.  
Em resumo, podemos concluir dessa primeira etapa que a maioria dos 
neurônios do NTScom, sensíveis a variações de hipóxia, são glutamatérgicos. 
Entretanto, uma pequena porção dessa via é inibitória uma vez que 12% dos 
neurônios do NTScom expressam GAD67 mRNA. Essa conclusão é compatível 
com o fato de que uma pequena proporção de terminais sinápticos no NRT são 
imunorreativos para a glutamina ácido descarboxilase (GAD67). A projeção 
inibitória pode não atingir os neurônios quimiossensíveis do NRT, mas pode estar 
envolvida nos neurônios que regulam a atividade simpática para o controle de 
temperatura (no rato a principal fonte de controle de temperatura consiste o tecido 
adiposo marrom). A literatura mostra que a atividade simpática para tecido 
adiposo marrom é inibida após a estimulação dos quimiorreceptores periféricos, 
contribuindo na redução da temperatura corporal e no consumo de oxigênio 
(Madden e Morrison, 2005). 
 A ativação dos neurônios do NRT, mediante alterações nas concentrações 
de CO2, não é secundário a ativação de vias respiratórias. Essa idéia é 
evidenciada pelo fato da atividade dos neurônios do NRT para a hipercapnia não 
ser afetada após a injeção intracerebroventricular de ácido quinurênico (Mulkey e 
cols., 2004; Guyente e cols., 2005a). Consistente com essa interpretação, o 
presente estudo mostra que as respostas de ativação dos neurônios do NRT para 
hipercapnia não são afetadas após a inibição de uma porção da coluna 
respiratória ventral (inibição da região CVL ou Pré-Botzinger) com muscimol. O 
único efeito produzido pelo muscimol foi a regularização do padrão de disparos 
dos neurônios do NRT, fazendo com que os neurônios quimiossensíveis do NRT 
perdessem as suas modulações respiratórias. 
 A estimulação dos quimiorreceptores periféricos produz um aumento nos 
disparos dos neurônios quimiossensíveis do NRT, independente do nível de CO2. 
As alterações de pH e a estimulação dos quimiorreceptores periféricos parece ter 
um efeito aditivo na atividade dos neurônios quimiossensíveis do NRT, pelo 
menos em situações de hipóxia moderada (15%). Esse efeito somatório produz 
uma diminuição no limiar de disparos dos neurônios quimiossensíveis do NRT, isto 
é, esses neurônios, sob uma situação de hipóxia, começam a iniciar sua atividade 
com valores menores de CO2 se comparados a uma situação controle. Da mesma 
maneira, os efeitos do CO2 e da estimulação dos quimiorreceptores periféricos 
sobre a atividade do nervo frênico parece também ter um efeito aditivo (presentes 
resultados; Nattie e cols., 1991). Se o único mecanismo que os quimiorreceptores 
centrais podem reagir são as alterações no pH, parece lógico que as respostas 
dos quimiorreceptores centrais para variações de pH sejam variáveis, isto é 
depende do tipo de informação que esses neurônios recebem. 
 
Papel do núcleo retrotrapezóide no controle da respiração. 
 A injeção bilateral de muscimol no NRT produz a eliminação da atividade do 
nervo frênico em situações basais (controle) e também durante a ativação dos 
quimiorreceptores centrais (hipercapnia) e periféricos (hipóxia). As injeções de 
muscimol foram realizadas embaixo da região caudal do núcleo facial, local onde 
localizam-se a maior concentração de células quimiossensíveis do NRT (Mulkey e 
cols., 2004; Guyenet e cols., 2005a; 2005b; Takakura e cols., 2006).  
 A contribuição do NRT para a respiração não está limitada apenas em 
casos de anestesia. Mesmo após lesões eletrolíticas unilaterias do NRT, pode-se 
observar uma deficiência de, aproximadamente, 40% nas respostas ventilatórias 
para a hipercapnia em ratos acordados (Akilesh e cols., 1997). O fato de a injeção 
de muscimol também ter eliminado os efeitos da ativação dos quimiorreceptores 
periféricos sobre o nervo frênico pode ser visto como uma evidência importante de 
que os neurônios do NRT participam dos padrões respiratórios. 
Nós não podemos também excluir a possibilidade de que a injeção de 
muscimol produziu a eliminação do nervo frênico por atuar em regiões mais 
caudais ao NRT, afetando os neurônios controladores do ritmo respiratório (como 
por exemplo os neurônios da coluna respiratória ventral, incluíndo os neurônios da 
região Pré-Botzinger). A presença de microesferas fluorescentes nas nossas 
injeções de muscimol mostraram que a droga pode ter atingido até 300 µm do 
centro da injeção. Neurônios localizados no bulbo ventrolateral possuem dendritos 
que se espalham por até 200 µm do corpo celular na direção rostro-caudal 
(Pilowsky e cols., 1990; Schreihofer e Guyenet, 1997). Entretanto, pode ser que 
neurônios localizados entre 300 e 600 µm caudais ao limite posterior ao núcleo 
facial podem ter sido parcialmente inibidos pela injeção de muscimol no NRT. 
Alguns experimentos sugerem que os neurônios do NRT podem regular a 
atividade dos músculos expiratórios (Forster e cols., 1995; Janczewski e Feldman, 
2005). A teoria de que os neurônios do NRT são os responsáveis pela expiração 
(Janczewski e Feldman, 2005) parece não ser muito oposta com as observações 
encontradas no presente estudo. Para isso é necessário que a atividade dos 
músculos expiratórios seja aumentada pela ativação dos quimiorreceptores 
centrais e periféricos. Diante disso, os neurônios do NRT podem fazer parte da via 
de ativação desse padrão respiratório. 
A possibilidade de que o NRT projeta-se para diferentes regiões da coluna 
respiratória é consistente com o fato de que os neurônios quimiossensíveis do 
NRT possuem diferentes padrões respiratórios (Guyenet e cols., 2005a). 
Baseando-se na localização, conexões anatômicas e padrões respiratórios, os 
neurônios do NRT podem ser regulados por outras eferências respiratórias, pela 
atividade simpática (coração, rins ou músculos) ou, ainda, pelas eferências 
parassimpáticas (músculo da traquéia) (Millhorn e Eldridge, 1986; Perez Fontan e 
Velloff, 1997; Guyenet e cols., 2005a; Takakura e cols., 2006).  
 Diante de tudo que foi discutido, podemos concluir que a região do NRT 
possui propriedades fisiológicas e anatômicas que são requisitos essenciais para 
a integração do quimiorreflexo central e periférico. Obviamente que não 
descartamos a possibilidade de que outras regiões do SNC possam também 
integrar as vias do quimiorreflexo. 
 
Quimiorreceptores centrais e atividade simpática. 
A próxima etapa do nosso estudo foi procurar mostrar que o aumento da 
atividade simpática causado pelo aumento das concentrações de CO2 
(hipercapnia) parece ser mediado pela ativação de neurônios excitatórios e bulbo-
espinais da região do RVL. Nós também mostramos que a ativação desses 
neurônios não depende de neurônios localizados na região do NTScom e na 
região do CVL. Finalmente, nós mostramos que durante uma situação de 
hipercapnia ocorre a ativação de neurônios inibitórios na região do CVL, reduzindo 
o total de aumento de atividade simpática produzido pelo CO2. Após a inibição da 
região do CVL com muscimol, o aumento das concentrações de CO2 produziram 
uma aumento ainda maior na atividade simpática eferente. Uma descoberta 
essencial, importante e inédita desse trabalho é que os efeitos excitatórios de uma 
situação de hipercapnia parece depender de uma ativação direta do CO2 nos 
neurônios do RVL, mostrando uma propriedade quimiossensível intrínseca desses 
neurônios. Um outro aspecto importante é que a modulação respiratória na 
atividade simpática parece ser atribuída a dois processos: ativação dos neurônios 
GABAérgicos localizados no CVL e uma desinibição dos neurônios do NRT. 
Parece que a modulação respiratória na atividade simpática constitui uma redução 
do total de aumento de atividade simpática causada por uma situação de 
hipercapnia. 
Em situações de anestesia, o aumento da concentração de CO2 promove 
um aumento da atividade simpática em animais vagotomizados e com 
desnervação sino-aórtica (Preiss e Polosa, 1977; Hanna e cols., 1981; Millhorn e 
Eldridge, 1986). Em acordo com os dados da literatura, o aumento de atividade 
simpática produzido pela hipercapnia (variação de CO2 de 5% para 10%) é 
praticamente o triplo de uma situação controle (Moreira e cols., 2006). Alguns 
neurônios do RVL apresentam um pico de aumento de atividade simpática durante 
a fase de inspiração (mesmo pico observado no nervo esplâncnico), enquanto que 
outros neurônios apresentam um pico de aumento de atividade na fase de pós-
inspiração (coincidente com o pico de atividade observado no nervo lombar). Esse 
tipo de modulação respiratória observada na atividade simpática durante a 
ativação dos quimiorreceptores centrais confirmam os dados da literatura (Numao 
e cols., 1987; Darnall e Guyenet, 1990; Guyenet e cols., 1990; Pilowsky e cols., 
1996).  
Em nossos experimentos, a hipercapnia produziu uma hipotensão, que 
seria resultado de um efeito direto do CO2 nos vasos sanguíneos e também, 
possivelmente, na contratilidade cardíaca. Após a hipotensão, a pressão arterial 
começa a voltar aos valores normais e, no fim do episódio da hipercapnia, a 
pressão arterial apresenta uma tendência de aumento. Estamos assumindo que 
esse aumento seria resultante de uma aumento na atividade simpática, quando o 
efeito local do CO2 nos vasos sanguíneos já tenha sido removido.  
A estimulação dos quimiorreceptores centrais, em animais com os 
quimiorreceptores e barorreceptores desnervados, promoveu um aumento de 
aproximadamente 70% na atividade dos neurônios bulbo-espinais do RVL. Até 
então, apenas um trabalho da literatura tinha descrito que os neurônios do RVL 
apresentavam um aumento da atividade durante a ativação dos quimiorreceptores 
centrais (Haselton e Guyenet, 1989). Esse trabalho mostrou que, em situações de 
hipercapnia, os neurônios do RVL apresentam uma aumento de atividade de 
aproximadamente 40% (Haselton e Guyenet, 1989). A diferença desse trabalho 
com o presente deve-se ao fato do tempo de exposição dos neurônios do RVL a 
situações de hipercapnia (aproximadamente 2 min no trabalho de Haselton e 
Guyenet e 5 minutos no presente estudo). É preciso um certo tempo para que 
ocorra o equilíbrio do pH e do fluxo sanguíneo no SNC (Sato e cols., 1992). Uma 
outra explicação poderia ser também relacionada a seleção dos neurônios da 
região do RVL. Nesse estudo, nós selecionamos os neurônios com rápida 
condução, na qual o teste de colisão foi possível ser realizado. Colisões 
espontâneas podem ocorrer entre os neurônios que apresentam condução lenta 
(projeção antidrômica) com os potênciais de ação gerados pela estimulação da 
medula espinal (projeção ortodrômica), dificultando a identificação da projeção 
desses neurônios para a medula espinal. Sete dos onze neurônios registrados 
apresentavam imunorreatividade para a enzima PNMT, o que é consistente com 
as propriedades de neurônios do RVL barosenssíveis e com condução rápida 
(Schreihofer & Guyenet, 1997). Nesse trabalho, não podemos ter absoluta certeza 
de que os neurônios que nós registramos são regulados pelos barorreceptores, 
pois os animais estavam completamente desnervados, condição essa, ideal para 
avaliar os efeitos da ativação dos quimiorreceptores centrais (Toney, 2006). 
Entretanto, trabalhos da literatura mostram que todos os neurônios bulbo-espinais 
localizados na região C1 (neurônios adrenérgicos do RVL) são inibidos pelo 
aumento de pressão arterial (Schreihofer e Guyenet, 1997). 
O aumento da atividade simpática produzido pela ativação dos 
quimiorreceptores centrais corresponde a aproximadamente 100% do valor 
controle. Não podemos concluir que esse aumento seja apenas mediado pelos 
neurônios da região do RVL, os quais apresentam um aumento de 70% em sua 
atividade após a ativação dos quimiorreceptores centrais. Portanto, não excluímos 
que outras regiões do SNC (região A5) podem contribuir no aumento da atividade 
simpática produzido pela ativação dos quimiorreceptores centrais. 
 Quimiorreceptores centrais constituem neurônios que diretamente ou 
indiretamente detectam mudanças de pH no líquido extracelular e promovem 
mudaças no ritmo respiratório e cardiovascular. Esses neurônios foram descritos 
em várias regiões do SNC, incluindo o NTS, o núcleos da rafe, e várias regiões do 
bulbo ventrolateral, como por exemplo a região do CVL e o NRT (Dean e cols., 
1990; Mulkey e col., 2004; Guyenet e cols., 2005; Takakura e col., 2006; Nattie e 
Li, 2006).  
A injeção de muscimol no NTScom não bloqueou a resposta de aumento de 
atividade simpática produzida pela hipercapnia, sugerindo que a região comissural 
do NTS não participa das respostas de aumento da atividade simpática durante a 
ativação dos quimiorreceptores centrais. Por outro lado, a injeção de muscimol na 
mesma região foi capaz de eliminar a ativação dos quimiorreceptores periféricos. 
Resultados da literatura mostram que a acidificação dos neurônios da região do 
NTScom foi capaz de aumentar a respiração em ratos acordados (Nattie e Li, 
2002). A acidificação de uma região via microdiálise não mimetiza exatamente 
uma situação de hipercapnia sistêmica. Um outro fator que deve-se considerar é 
que a anestesia pode também influenciar e eliminar os efeitos no NTS. Por fim, os 
neurônios quimiossensíveis do NTS localizam-se em uma região diferente dos 
neurônios de segunda ordem envolvidos na via do quimiorreflexo periférico. A 
região do NTS que sofreu acidificação (Nattie e Li, 2002) foi localizada um pouco 
mais rostral e lateral a região que fizemos as injeções de muscimol. Portanto, 
permanece em aberto a questão sobre a participação dos neurônios do NTS nas 
respostas de ativação do quimiorreflexo central.    
 A região do CVL também contém neurônios descritos como 
quimiorreceptores centrais (Solomon e cols., 2000; Nattie e Li, 2006). Esses 
neurônios parecem não estar envolvidos na resposta excitatória produzida por 
uma situação de hipercapnia, pois a injeção de muscimol ou ácido quinurênico não 
reduziu os efeitos do CO2 na atividade simpática. Por outro lado, a inibição da 
região do CVL promoveu um aumento ainda maior da atividade simpática 
produzida pela hipercapnia, sugerindo que essa região contém vias inibitórias para 
a região do RVL que são ativadas numa situação de hipercapnia. A região do CVL 
contém neurônios GABAérgicos que possuem modulação respiratória e que essa 
modulação apresenta-se oposto a modulação observada nos neurônios do RVL 
(Mandel e Schreihofer, 2006). Essas caracteristícas são consistentes com a 
possibilidade de que esses neurônios contribuem na modulação respiratória dos 
neurônios do RVL. A inibição da região do CVL com muscimol produziu um 
aumento na atividade dos quimiorreceptores centrais. A inibição da região do CVL 
produz apenas a eliminação da oscilação respiratória da atividade simpática, mas 
não altera a resposta de aumento de atividade simpática produzido pela ativação 
dos quimiorreceptores periféricos (Kohiya e Guyenet, 1996b; presente resulatdos).  
Um aspecto importante a ser discutido é o fato de que os neurônios do NRT 
também possuem uma heterogenocidade, como os neurônios do CVL, no que diz 
respeito às modulações respiratórias. A única diferença é que os neurônios do 
NRT apresentam as mesmas modulações respiratórias observadas nos neurônios 
do RVL (Figura 2). Parece que os neurônios do NRT mantêm a atividade 
respiratória dos neurônios do RVL (Figura 2). O padrão respiratório predominante 
dos neurônios do NRT consiste num aumento de atividade na fase de inspiração 
(Mulkey e cols., 2004; Guyente e cols., 2005a; Takakura e cols., 2006). Os 
neurônios do NRT recebem projeções inibitórias periódicas da região do CVL, o 
que deveria atenuar as respostas do quimiorreflexo por um processo de 
desfacilitação. Resultados anteriores mostraram que a modulação respiratória dos 
neurônios do NRT desapareceu após a injeção de muscimol na região do CVL, 
mas as respostas excitatórias da estimulação dos quimiorreflexos central e 
periférico persistiram (Takakura e cols., 2006). Portanto, a injeção de muscimol na 
região do CVL produz uma eliminação da modulação respiratória dos neurônios do 
NRT e esse efeito contribui no aumento da atividade simpática após a estimulação 
dos quimiorreceptores centrais. 
Os mecanismos excitatórios da ativação dos quimiorreceptores periféricos e 
centrais são distintos em um aspecto essencial. O bloqueio dos receptores 
glutamatérgicos ionotrópicos, com ácido quinurênico, na região do RVL, promoveu 
a eliminação de aumento da atividade simpática promovido pela ativação dos 
quimiorreceptores periféricos, mas não alterou o aumento de atividade simpática 
promovido pela ativação dos quimiorreceptores centrais. O bloqueio da atividade 
simpática e respiratória após a estimulação dos quimiorreceptores periféricos em 
animais com injeção bilateral de ácido quinurênico no RVL é consistente com 
dados da literatura, mostrando que a via dos quimiorreceptores periféricos é 
transmitida para o bulbo ventrolateral (RVL e NRT) sendo mediado por projeções 
glutamatérgicas (Sun e Reis, 1995; Aicher e cols., 1996; Guyenet, 2000; Takakura 
e cols., 2006). Por outro lado, o não efeito da injeção bilateral de ácido quinurênico 
na região do RVL sobre as resposta de estimulação do quimiorreflexo central 
sugere que a ativação desses receptores não envolve receptores glutamatérgicos 
ionotrópicos. Isso sugere que o aumento da concentração de CO2 (ativação dos 
quimiorreceptores centrais) possa ter um efeito quimiossensível intrínseco nos 
neurônios do RVL ou que esse efeito não seja mediado sinapticamente por 
receptores glutamatérgicos ionotrópicos, mas sim por receptores glutamatérgicos 
metabotrópicos ou até mesmo por outros tipos de receptores. Receptores 
glutamatérgicos metabotrópicos estão presentes na região do RVL. Dados da 
literatura mostram que injeções de agonistas glutamatérgicos metabotrópicos no 
RVL promovem um aumento de pressão arterial (Tsuchihashi e cols., 2000). A 
literatura contém também exemplos de neurônios que expressam a enzima que 
produz glutamato, mas liberam outro tipo de neurotransmissor com importante 
papel na transmissão sináptica, como por exemplo a orexina (Rosin e cols., 2003). 
Conclusão 
Em resmo, o esquema proposto abaixo tentar explicar e exemplificar a 
maioria dos mecanismos discutidos nessa segunda parte dessa tese de 
doutorado, na qual o maior enfoque são as possíveis integrações entre os 
quimiorreceptores centrais e periféricos, bem como sua relação na manutenção 
das vias cardiovasculares e respiratórias. Entretanto, novos experimentos são 
necessários para mostrar mais detalhes e estabelecer o verdadeiro papel das vias 
excitatórias, bem como da atividade dos quimiorreceptores centrais, localizadas no 
bulbo, no controle das variáveis cardio-respiratórias. Essa tese de doutorado 
procurou enfatizar também a aplicação de diferentes técnicas experimentais 
(registro de pressão arterial, frequência cardíaca, fluxo sanguíneo, atividade de 
nervos periféricos e atividade de neurônios, imuno-histoquímica e hibridização in-
situ) em estudos de neurofisiologia. Um importante aspecto foi procurar relacionar 
aspectos cardiovasculares e respiratórios, uma vez que essas duas variáveis 
estão intimamente relacionadas.  
 
 
 
 
 
 A) Quimiorreflexo periférico. O aumento da atividade simpatica é mediado 
pela ativação dos neurônios simpato-excitatórios da região do RVL. As aferências 
excitatórias para os neurônios do RVL originam-se de projeções glutamatérgicos 
diretas do NTScom e também de uma via indireta via NRT (local dos neurônios 
quimiossensíveis). A modulação respiratória da atividade simpática e dos 
neurônios do RVL parece ser atribuída à 2 mecanismos. O primeiro mecanismo 
seria a ativação do padrão gerador do ritmo respiratório (região em azul), que 
contém os neurônios GABAérgicos da região do CVL e pré-Botzinger 
(representação do neurônio em vermelho), enquanto que um segundo seria via 
inibições periódicas da região do NRT (flecha em vermelho). A combinação 
desses dois mecanismos diminuiria a ativação dos neurôniops do RVL durante a 
estimulação dos quimiorreceptores periféricos e promoveria a modulação 
respiratória na atividade simpática. B) Quimiorreflexo central. O aumento da 
atividade simpática, causado pelo aumento das concentrações de CO2 parece ser 
devido a uma direta ativação dos neurônios simpato-excitatórios da região do 
RVL. Nossa teoria seria que os neurônios do RVL seriam ativados por 
basicamente dois mecanismos. O primeiro mecanismo seria a ativação de uma 
sinapse indireta via neurônios quimiossensíveis do NRT, enquanto que o segundo 
mecanismo seria um próprio aumento da atividade dos neurônios do RVL. 
Abreviações: PGR, padrão gerador da respiração; CVL, região caudoventrolateral 
do bulbo; NRL, núcleo reticular lateral; NRT, núcleo retrotrapezóide; NTS, núcleo 
do trato solitário; RVL, região rostroventrolateral do bulbo; VII, núcleo facial. 
Referência: modificado de Moreira e cols., 2006.  
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